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Abstract 
This thesis investigated the toxicity of silver nanoparticles (AgNPs) in an 
environmental model bacterium Pseudomonas putida. 
It is unclear whether the antimicrobial activities of AgNPs are exclusively mediated by 
the release of silver ions (Ag+) or, instead, are due to combined nanoparticle and silver 
ion effects. Therefore, it is essential to quantify dissolved Ag in nanosilver suspensions 
for investigations of nanoparticle toxicity, but it is difficult to distinguish Ag+ from 
AgNP effects during toxicity tests. A method to measure dissolved Ag in Ag+/AgNPs 
mixtures was first developed by combining aggregation of AgNPs with centrifugation. 
Silver nanoparticles can be quickly aggregated by 2 mM Ca2+, forming large clusters 
that can be sedimented in a low speed centrifuge. The sedimentation time of AgNPs 
was markedly reduced to 30 min due to Ca2+ mediated aggregation, which provides a 
convenient and inexpensive way to separate dissolved Ag from AgNPs, avoiding the 
long ultracentrifugation times to sediment small nanoparticles. 
The discrepancy in the physicochemical properties of different AgNPs and their 
transformation under different conditions combine to contribute to the complexity of 
toxicity tests. The systematic and time-resolved characterization of AgNPs is required 
for toxicity assays. In this thesis, AgNPs were characterized at synthesis, during storage 
and after addition to microbial media. Stable, uncoated AgNPs were synthesized by a 
reproducible method. The long-term stability of AgNP stocks exposed to ambient air or 
under nitrogen atmosphere was compared. Silver nanoparticles underwent different 
  
degrees of aggregation in Davis minimal media (DMM). Compared to the fast Ag+ 
release in H2O, uncoated AgNPs dissolved much slower in DMM.  
The minimum inhibitory concentrations of Ag+ and AgNPs for Pseudomonas putida 
steadily increased with increasing initial cell densities, suggesting that Ag was titrated 
away by the cells, decreasing the effective Ag concentration. Silver nanoparticles acted 
as a Ag reservoir, releasing new Ag+ to add to the Ag stress. Silver ions had stronger 
toxicity than AgNPs and the toxicity of AgNPs was dominated by dissolved Ag.  
However, whether AgNPs directly contribute to bacteria killing is controversial. 
Experimental evolution was used to ask whether bacteria respond differently to Ag+ and 
AgNPs. It is hypothesized that bacteria will evolve differently in the presence of Ag+ 
and AgNPs if these have different antibacterial activities. A P. putida population that 
has pre-evolved in DMM was treated with Ag+ or AgNPs for 75 d. These populations 
evolved for ~500 generations, adapted to the presence of Ag+ and AgNPs, and gained 
fitness. The mutations in the evolved populations stressed by Ag+ and AgNPs displayed 
different patterns, indicating different toxicity mechanisms. The nonsynonymous 
mutations in AgNP-stressed populations were mostly associated with cell surface 
proteins. In contrast, Ag+ stress selected for mutations in cytoplasmic proteins linked to 
metal metabolism. This suggests the existence of direct AgNP effects targeting the 
bacterial cell surfaces.  
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1.1 Nanomaterials and silver nanoparticles  
1.1.1 Nanomaterials  
Nanomaterials (NM) have obtained increasing attention owing to their distinctive 
physicochemical properties. Nanomaterials are defined as materials that have one or 
more dimensional size in the nanoscale (1-100 nm) [1]. The components of 
nanomaterials include metal, metal oxide, semiconductor, carbon, silicon and organic 
substances with different shapes such as spheres, cubes, rods, plates and tubes (Figure 
1.1). Most of the inorganic NMs have a solid core that is capped with various chemicals 
(e.g. ligand, surfactant, polymers and biomolecules) on the surface for stabilization or 
functionalization [2].  
The speciality of nanomaterials derives from their small size and large surface area-to-
volume ratio, contributing to their quite different chemical [3], electronic [4], magnetic 
[5], and optical [6] properties from molecular and bulk counterparts. The application of 
nanomaterials has extended into broad fields, including medicine [7], biological sensor 
[8], antimicrobial agents [9], energy conservation [10], and catalysts [11]. For instance, 
semiconductor nanoparticles named as quantum dots (QDs) with  a size of 2-10 nm 
have been used as fluorescent labels because of their bright tuneable emission spectra 
[12]. Gold nanoparticles (AuNPs) have been studied for disease diagnoses, drug 
delivery and thermal therapy due to their chemical stability, pronounced absorption of 
visual spectra and capability of efficiently converting light into heat [13]. Iron oxide 
nanoparticles have been explored as contrast agents in magnetic resonance imaging and 
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drug delivery because of their magnetic properties, biocompatibility and 
biodegradability [5]. Metal oxides (ZnO, CuO, CeO, TiO2 and Al2O3), cationic 
antimicrobial peptides and some polymers in the nanoform have shown promising 
application in antimicrobial therapies, which can be used to modify medical devices, 
preventing clinical device-related infection and killing multidrug resistance pathogens 
[14]. Organic nanomaterials, such as liposomes, dendrimers, micelle and polymers, can 
be used as drug carriers for cancer treatments owing to their enhanced permeability and 
retention in tumour tissue and the ability to specifically target cellular surfaces [15]. 
Significant progress has been achieved in the synthesis and application of nanomaterials 
during the last two decades; but nanoscience is challenged by large-scale production 
for commercialization, precise control of size and shape, characterization in vivo, and 
their impacts on environment and human health.  
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Figure 1.1 Morphologies of different nanomaterials 
(a) Uncoated silver nanoparticles by transmission electron microscopy (TEM) [16]. (b) 
High resolution TEM image of uncoated silver nanoparticles [17]. (c) Citrate-capped 
silver nanopaltes (TEM) [18]. (d) Cetyltrimethylammonium bromide capped silver 
nanobars by scanning electron microscopy (SEM) [19]. (e) SEM image of silver 
nanocubes coated by poly(vinyl pyrrolidone) (PVP) [20]. (f) Flower-like gold 
nanoparticles coated by 2-[4-(2-hydroxyethyl)-1-piperazinyl]ethanesulfonic acid 
(HEPES) (TEM) [21]. (g) Cetylpyridinium chloride-capped gold nanocrystals (SEM) 
[22]. (h) High resolution TEM images of CdSe/ZnS core-shell quantum dots (QDs) 
[23]. (i) Core-shell structure of gold-palladium nanoparticles that are produced by 
depositing Pd atoms to the surface of Au nanoparticle seeds (Scanning TEM coupled 
with energy dispersive X-ray spectroscopy). Green colour refers to gold, and red colour 
refers to palladium [24]. (j) Polyvinylpyrrolidone-coated iron oxide nanoparticles [25]. 
(k) Cross-sectional SEM of vertically aligned silicon nanowire [26]. (l) Atomic 
structure of single-walled carbon nanotubes by scanning tunnelling microscopy [27]. 
1.1.2 Silver nanoparticles  
Silver (Ag) is toxic to microorganisms. Silver sulfadiazine, traditionally, has been used 
as an antibacterial agent for a long time [28]. In the early antimicrobial applications, Ag 
was used for the treatment of eye infection and wound [28, 29]. Accompanying 
prolonged silver treatment, however, the deposition of silver in skin or tissue can cause 
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mucous membranes and darkness of skin that are referred to as argyria. Silver ions (Ag+) 
can damage cell membranes, interact with ribosomes to inhibit protein production, and 
affect respiratory chains [30-32]. With the emergence of nanotechnology, silver 
nanoparticles (AgNPs) are one of the widely studied metal nanomaterials [9, 33]. Silver 
atoms gather together forming nanosize particles with different sizes, shape and surface 
coatings [34, 35]. Silver nanoparticles promote the application of Ag owing to their 
capability of delivering Ag to targets and high surface reactivity.  
Silver nanoparticles have been used as antimicrobial agents in water treatment, cloth 
manufacture, burn and wound dressing, food packaging, medicine and medical 
instrument coating [9, 36-38]. Modifying the surface of medical devices and fabrics 
(e.g. heart valves, catheters and wound dressings) with antimicrobial components is 
believed to be an effective way to prevent healthcare-related infections and to improve 
healing performance in clinical practice [7]. According to a systematic comparison of 
antibiotic-impregnated, silver-impregnated and plain external ventricular drainage 
catheters for the prevention of catheter-related infections, the catheters with silver and 
antibiotics have similarly strong effectiveness for infection control [39]. In a clinical 
study, however, the catheters that are coated with chlorhexidine and silver sulfadiazine 
have less efficiency than minocycline and rifampin impregnated catheters in surgical 
intensive care units [40, 41]. The AgNP-modified catheters have also shown no 
significant difference in reducing catheter-related bloodstream infections from 
nonimpregnated catheters [42]. It is found that silver-impregnated external ventricular 
drain catheters may have a preferential reduction in Gram-positive bacteria in a meta-
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analysis of several clinic trails [43]. The toxic effect of AgNPs depends on the 
characteristics of AgNPs and surrounding environment. The complexity of clinical 
setting complicates the action of AgNPs, hindering consistent conclusion from different 
studies.  
Although there is no consensus on the effectiveness of impregnating silver onto a 
surface to prevent bacterial colonization and infection, AgNPs are still considered as a 
new generation of product for biomedical applications [9]. Acticoat, an approved 
AgNPs-coated wound dressing, has shortened healing time in a clinical study compared 
to silver sulfadiazine [37]. Treating wounds with AgNPs-contained dressings can raise 
serum silver levels but these decrease to baseline after stopping the treatment [44]. 
Laboratory-based studies have demonstrated the benefits of AgNPs, which can prevent 
bacterial growth and biofilm formation on the surface of medical devices [45]. 
Depositing AgNPs on a layer of pentafluorophenyl methacrylate that is coated on the 
surface of tracheal prosthesis gives rise to complete bacteria death on the surrounding 
surface and can reduce biofilm fouling [46]. The cover slips that are coated with 
mercaptosuccinic-AgNPs can kill both Gram-positive and Gram-negative pathogens 
and have significant antibiofilm activities without showing any negative effects on the 
function and viability of primary fibroblast cells and innate immune cells [47]. Silver 
nanoparticles undergo different transformations on contact with biological fluids, 
especially after prolonged exposure. One of the important changes is surface 
deactivation that inhibits Ag release, leading to less active Ag+ available for pathogen 
killing [48], which might explain the failure of some clinical trials. 
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Conventional methods may have limits in removing emerging and trace pollutants such 
as pharmaceuticals, personal care products and disinfection by-products to meet the 
increasingly stringent water quality standards. Nanosciences have obtained intensive 
interests in water treatment, water quality monitoring, recovery of contaminated 
environment, and water reuse [49]. Silver nanoparticles are promising candidates for 
water disinfection and membrane fouling control [50]. The AgNPs that are immobilized 
in alginate have reduced cell viability by five orders-of-magnitude after a contact as 
short as 1 min, demonstrating their great potential in killing pathogens in drinking water 
[38]. Sustainability and high efficacy are critical for large-scale commercialization of 
AgNP-based technologies. The AgNPs trapped in a stable metal oxyhydroxide-chitosan 
cage can slowly release Ag+ into water, deactivating bacteria and viruses while 
absorbing chemical contaminants [51]. Incorporating AgNPs into ultrafiltration 
membrane can reduce bacteria attachment and biofilm formation on membrane surfaces, 
which are used to control membrane fouling that usually causes deterioration of 
membrane water treatment plants [52]. The cost and performance stability should also 
be considered in the application of AgNPs in water treatment [53]. 
1.2 Environmental impact of AgNPs 
One of the challenges of nanomaterials is the risk to ecosystem and human health, 
which is not well understood [54]. Silver nanomaterials are of especial concern due to 
their high toxicity towards living organisms, including bacteria [55], fungi [56], algae 
[57], plants [58] and animals [59, 60]. Silver cannot be destroyed or degraded after 
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being extracted. Except for those being recycled or within silver products, most silver 
will be disposed into the natural environment. It is estimated that more than 13 metric 
tons of Ag are globally emitted into the environment, most of which are discharged via 
landfill, in tailings of mining operations or by leaching during Ag separation and 
dissipation [61].  
Jewellery, photography and industry contribute to 95% of total silver consumption [62], 
but the use of silver has changed during the past decade with increasing demand in 
textiles, plastics and medical industries [61]. With the advent of nanotechnology, the 
production of silver nanomaterials is also expected to grow. The annual production of 
silver nanoparticles was about 320 tons/year worldwide in 2012 and was estimated to 
reach 1120 tons/year in 2015 [63, 64]. Currently, AgNPs are mainly used in textiles, 
cosmetics, electronics and anti-microbial coatings [62, 63]. The majority of Ag is 
disposed as waste in municipal solid, electrical and electronic equipment, hazardous 
chemicals, sewage and sewage sludge estimated by a life cycle assessment [61]. For 
instance, the Ag in biocidal products that comprise more than 15% of total silver has 
flowed into wastewater, and is treated in wastewater treatment plants and deposited in 
sewage sludge [65]. Silver nanoparticles in fabrics can be released during washing, and 
disposed through landfill together with the fabrics [66]. Once AgNPs enter the sewage 
collection system, more than 90% of the Ag will be transformed into Ag2S accumulated 
in the sludge of wastewater treatment plants (WWTP) and 10% of silver will be 
disposed into natural surface water [65, 67, 68]. Silver sulphide is extremely insoluble 
in water and is much less toxic towards microorganisms. To fully understand the 
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environmental fate of AgNPs, it is necessary to investigate the changes of silver 
sulphide complexes when the sewage sludge is transferred for landfilling, agricultural 
land or incineration [69]. The solid-waste incinerator can remove engineered 
nanoparticles from emitted gas but shifts most of them into slag and fly ash, since they 
remain stable after incineration, which still carry risk when disposing of the slag and 
fly ash residuals [70]. The increased AgNP levels in the receiving river is reported to 
be correlated with high concentrations of Ag in effluent from WWTP, but will be diluted 
to a few ng/L with water flow [71]. The impact of this low concentration of AgNPs on 
the environment is unknown.  
Silver content in natural water is very low (Figure 1.2), but the bioaccumulation in 
organisms may promote Ag concentrations to a toxic level, which brings the concern 
about their environmental risk owing to the increasing use of silver products. The 
concentration of Ag in the open North Pacific Ocean ranges from 0 to 1.3 ng/L [72]. 
Dissolved Ag in the Bothnian sea is 0.26 ± 0.1 ng/L on average, which is comparable 
to the level in open ocean [73]. Silver-chloride complexes (AgClx(x-1)-) are the dominate 
Ag species in sea water [74]. As a result of anthropogenic input, Ag contents in 
estuarine water and coastal regions are higher, in the range of 0.5-35 ng/L [74, 75]. It is 
predicted by life-cycle simulation that the upper level concentration of nanosilver in air, 
water and soil is 4.4 ng/m3, 80 ng/L and 100 ng/kg, respectively [62]. The predicted 
concentration of Ag nanomaterials in Swiss rivers ranges from 0 to 6.7 ng/L [76]. It has 
been reported that the average concentration of Ag in typical soil in Japan is 0.17 ± 0.08 
mg/kg [77]. A study reveals that the Ag content in sewage-treated soil in Berlin is 16.6 
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mg/kg, which is high compared with 0.62 mg/kg in forest soil [78]. Silver content in 
sewage (8-800 mg/kg) is much higher than the background level (0.1 mg/kg), 
suggesting that long-term use of activated sludge as a soil conditioner poses the risk of 
Ag enrichment [67]. 
 
Figure 1.2 Concentration of Ag in environment 
The arrow indicates an increasing Ag concentration. In open ocean and fresh surface 
water compartments, Ag concentration is lower than 10 ng/L. Silver contents in 
estuarine water and coastal regions (San Francisco Bay) are in the range of 0.5-35 ng/L 
owing to anthropogenic activities. The Ag content in sewage influent is 1.8-100 μg/L 
since many silver-containing products are discharged into wastewater collection 
systems. Wastewater treatment plants have a removal efficiency of >95% for 
immobilization of Ag into sewage sludge. The photographic industry emit large amount 
of Ag-containing waste, the contribution of which is diminishing as digital photographs 
become dominant. The microbial inhibitory concentration of Ag+ ranges from 0.05 to 2 
mg/L, which is much larger than the concentrations in the natural environment. 
1.3 Synthesis of AgNPs  
There are three steps in nanocrystal formation [16, 79] (Figure 1.3). First step is the 
rapid reduction of silver precursor forming a silver nucleus. The burst nucleation forms 
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monomers that are the basic building units of nanocrystals. They diffuse and precipitate 
on the surface of the nucleus to form large particles. Meanwhile, small nanoparticles 
have a tendency to dissolve owing to their high surface energy. The formation process 
of nanoparticles is thermodynamically controlled by the competition between growth 
and dissolution.  
Burst nucleation induces high concentrations of monomers. If the growth process is 
diffusion controlled, it can be described as    
                                        rCCDVdtdr sbm /)(/                                                     (1.1) 
where Cb is the monomer concentration in bulk. Cs is the monomer concentration on 
particle surfaces. r is the size of particles. Smaller particles have higher chemical 
potential and need to overcome higher energy barriers for growth: 
                                        /rRT)Vexp(2S=S m br                                                       (1.2) 
Where Sr and Sb are the solubility of nanocrystals and bulk solid, respectively. σ is the 
specific surface energy. Vm is the molar volume of the material. R is the gas constant. 
T is the temperature. A critical size, r*, exists. Dissolution dominates for the 
nanocrystals that have a size below r* and the nanocrystals that have a size larger than 
r* will form mature nanoparticles. The growth rate is described as: 
                                     1/r)-(1/r1/1/rK=
dt
dr 




                                                    (1.3) 
Where K is a constant that is proportional to the diffusion constant of the monomer. δ 
is the thickness of the diffusion layer. r* is the critical size.  
Another process called Ostward ripening also controls nanoparticle’s growth [79]. The 
critical size will increase after monomers are depleted. Larger particles are more likely 
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to grow by receiving monomers from dissolving particles and smaller particles shrink 
or even disappear, resulting in the restriction of size to certain regions. During the 
formation of AgNPs, the concentration of monomers is changing. Therefore, the critical 
size, growth rate and final stable size distribution, which are dependent on monomer 
concentrations, change accordingly. In addition, nanoparticles with the same 
crystallographic orientation can directly combine together to form large particles, which 
is known as coalescence and aggregative growth [80, 81]. Some capping agents and 
ions preferably interact with certain nanoparticle’s surfaces and can direct nanoparticles 
to grow into different sizes and shapes [35]. 
Frequently, AgNPs are produced by reducing Ag+ into metallic Ag in solution [35, 82]. 
Silver nanostructures in the forms of particles, rods, plates and cubes can be achieved 
by adjusting temperature, precursor concentration, reducing agent, capping agent and 
reaction kinetics [20, 35]. The comparison of standard reduction potential of Ag+/Ag 
with different chemicals is listed in Table 1.1 [83]. Silver ions have a high potential of 
being reduced to metallic Ag due to their strong capability as an electron acceptor. 
Reducing agents such as ethylene glycol [20], citrate [84], sodium borohydride (NaBH4) 
[16], poly(vinyl pyrrolidone) (PVP) [82] and oleylamine [85] have been used to react 
with Ag+ forming AgNPs. Green synthesis of AgNPs can be obtained by using 
environment-friendly reductants such as starch [86], peptides [87] and leaf extract [88]. 
Peptides that contain silver-binding amino acid moieties can selectively provide deposit 
sites for Ag+ and a reducing environment to direct the growth of AgNPs [89]. Given the 
relatively reducing environment and rich content of proteins in bacterial cells, it is not 
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surprising that Pseudomonas stutzeri are capable of reducing Ag+ to different sizes and 
shapes of Ag nanocrystals that are mostly accumulated in the periplasm [90]. 
Demonstrated by darkfield microscopy and hyperspectra, Chlamydomonas reinhardtii 
take up Ag+ and reduce them into AgNPs in cells [91]. Silver nanoparticles have been 
found in natural environment where Ag+ react with natural organic substances to form 
Ag nanocrystals and the generation rate is accelerated under elevated temperatures or 
with intensive light exposure [92]. It is postulated that phenolic natural organic matter 
(DOM) in rivers react with dissolved oxygen under sunshine to produce superoxide free 
radicals that reduce Ag+ to form AgNPs [93]. 
Table 1.1 Standard reduction potential of different chemicals (pH = 7) 
Half-cell reaction Potential (mV) 
CO2 + 4H
+ + 4e- → [CH2O]glucose + H2O -430 
2H+ + 2e- → H2 -420 
NAD+ + 2H+ + 2e- → NADH + H+ -320 
FAD + 2H+ + 2e- → FADH2 -220 
FMN + 2H+ + 2e- → FMNH2 -190 
NO3
- + 6H+ + 5e- → 1/2N2 + 3H2O +740 
Fe3+ + e- → Fe2+ +770 
Ag+ + e-→ Ag +799 
1/2O2 + 2H
+ + 2e- → H2O +820 
To reduce the surface energy, nanomaterial cores have the tendency to absorb or react 
with molecules such as inorganic [94] or organic ions [84] and polymers [20, 95]. The 
surface coating provides an identity for nanoparticles which can be specifically 
functionalized for different purposes, such as molecule sensing and drug delivery [96].  
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Figure 1.3 Schematic diagram of the formation of AgNPs 
(1) Silver ions are reduced to form metallic Ag as nuclei in different sizes (nucleation). 
(2) The nuclei will grow into relatively large AgNPs, this is controlled by Ostward 
ripening and attachment growth. These Ag nanocrystals may have different 
morphologies with a relatively narrow size distribution. (3) If there are more Ag+ 
reduced to atomic Ag, the AgNPs will grow further to generate mature nanoparticles in 
various shapes under the control of capping agents. Finally, ions (for charging) and 
large molecules (for coating) are attached to nanoparticle’s surface for stabilization. 
1.4 Characterization of nanomaterials 
It is important to characterize nanomaterial physical and chemical properties, including 
elemental composition, morphology and surface chemistry, which have fundamental 
roles in nanomaterial interactions with surrounding environments. Energy dispersive 
X-ray spectroscopy, electron energy loss spectroscopy and X-ray powder diffraction 
can be used to detect the elemental compositions of nanomaterials and have been used 
to examine the oxidation [97], sulfidation [98] and dissolution [99] of AgNPs, detect 
AgNPs in organisms [100], and investigate the formation of AgNPs in cells [90]. The 
arrangement of atoms into nanoparticles has been revealed at atomic resolution using 
high-angle annual dark field scanning transmission electron microscopy [101]. It is 
difficult to characterize the surface chemistry of nanoparticles by conventional 
techniques. By investigating p-mercaptobenzonic acid-protected gold nanoparticles 
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through X-ray crystal structure at single atom resolution, it was found that the surface 
ligands not only bind with the surface atoms of nanoparticles but also interact with each 
other through phenyl-phenyl and phenyl-sulphur interactions forming a rigid shell layer 
on the surface [102]. 
It is critical to characterize the size [59, 103] and shape [6, 104] of nanomaterials. Due 
to the resolution limits of light microscope, electron microscopy, including 
transmission electron microscope (TEM) and scanning electron microscope (SEM), is 
applied to observe nanomaterials. But they usually measure the nanomaterial core and 
need tedious sample preparation and image capture. Atomic force microscopy (AFM) 
can be used to measure size and number distribution of nanoparticles [105] as well as 
the change of size [106]. By utilizing the high light reflectivity of metal nanoparticles, 
dark field microscope can detect AgNPs distribution around and inside cells [91, 107]. 
Dynamic light scattering (DLS) is the most common technique for measuring the 
hydrodynamic size of nanomaterials. It calculates nanoparticle size based on the pattern 
of scattered light for different size of nanoparticles, which is induced by the Brownian 
motion of nanoparticles. Asymmetric flow field-flow fraction (AF4) and differential 
centrifugal sedimentation (DCS) are based on the movement of nanoparticles under the 
force of liquid flow and centrifugation, which also measure hydrodynamic size that is 
always larger than nanoparticle’s core size. Single particle inductively coupled plasma 
mass spectrometry (spICP-MS) is an emerging nanoparticle size characterization 
technique and can measure the environmentally relevant concentration of nanoparticles 
and their aggregates in complex matrix but needs complicate initial parameter setting 
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to measure large size nanoparticles (> 20 nm) [108]. Different size characterization 
techniques have their advantages and limitations as listed in Table 1.2. Electron 
microscopy and AFM analyse the sizes of nanoparticle cores. DLS, FFF, DCS and NTA 
measure the hydrodynamic sizes of nanoparticles that include the core, surface coating 
and surrounding solvated ions, which are larger than the diameter of cores. 
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Table 1.2 Comparison of different techniques for characterizing the size of 
nanomaterials 
Technique Advantages Disadvantages 
TEM 
 Observe the structure at atomic level 
 Directly measure size and shape with high 
accuracy  
 Visualize interactions between 
nanomaterials and various objects 
 Small amount of samples  
 Require large number of counts from 
image analysis 
 Potential artefacts, especially 
aggregates during drying and sample 
fixation 
 Cannot measure nanoparticles in 
solution 
SEM 
 Directly observe three-dimensional 
structure at nanometre resolution 
 Measure size and shape of large 
nanoparticles with high accuracy 
 Long time for sample preparation and 
image capture 
 Potential artefacts  
 Cannot measure small nanoparticles 
AFM 
 Roughly measure the size distribution at 
nanometre level 
 Can measure the sample in complex 
environments 
 Cannot observe the detailed structure  
 Need to fix sample on substrate which 
may produce artefacts 
DLS 
 Measure the sample with a broad ranges of 
sizes from nm to μm in solution 
 Convenient and quick operation 
 Only measure the hydrodynamic size  
 Need monodispersed samples 
 Cannot measure very diluted samples 
 Large error for small nanoparticles 
FFF 
 Measure hydrodynamic size of  samples in 
complex environment with good accuracy 
 Can measure poly-dispersed samples in 
liquid 
 Need standards for calibration 
 Time consuming and complex to 
optimize operation  
DCS 
 Measure hydrodynamic size of sample in 
liquid with high accuracy 
 Probably able to measure the thickness of 
surface coating but will need good 
experiment design  
 Sample should be larger than 3 nm 
 Need standards for calibration 
 Limited to concentrated samples for 
high accuracy 
 Long operation time to measure small 
nanoparticles 
NTA 
 Measure the samples with large size in 
complex environment  
 Can give estimate of particle number 
concentration 
 
 Can only measure large nanoparticles (> 
10 nm) with very high refractive index 
with accuracy  
 Low accuracy for poly-dispersed 
samples 
 Needs dilute samples 
spICP-MS 
 Detect low concentration of samples in the 
μg/L range 
 Can measure the number and size 
distribution at the same time 
 Can measure polydispersed samples with 
high precision 
 Require low sample volumes 
 Have the size limitation of 20 nm 
 Complicated parameter setting 
 Need validation with standards 
 Lack of selectivity to detect different 
nanoparticles with different elemental 
compositions 
AFM: atomic force microscopy; NTA: nanoparticle tracking analysis; FFF: field-flow fraction; spICP-
MS: single particle inductively coupled plasma mass spectrometry. 
Metal nanomaterials support localized surface plasmon resonances (LSPR). The 
Chapter One 
18 
 
oscillation of electron conduction bands in metal nanoparticles interacts with the light 
electromagnetic field, enabling strong optical absorption and scattering in the visual 
spectrum, which is associated with nanoparticle’s size [17, 109], shape [6], composition, 
surface chemistry [110] and surrounding environment [6]. Therefore, LSPR has been 
explored to characterize a nanoparticle’s size and concentration [111], aggregation state 
[112] and reaction with molecules [113]. Surface enhanced Raman spectroscopy, which 
is based on LSPR, has been developed for sensitive and selective molecular sensing 
with nanomaterials [114]. Currently, there is a lack of approaches to directly measure 
surface ligands and attached ions. 
1.5 Physical and chemical transformations of AgNPs  
1.5.1 Dissolution  
Silver nanoparticles undergo various physicochemical transformations in different 
environments. Dissolution is one of the important changes which plays a central role in 
the antimicrobial activities of AgNPs. Release of Ag+ from AgNPs is 
thermodynamically favourable at room temperature (ΔG298Ɵ = -11.25 kJ/mol). Silver 
will be oxidized when oxygen is available, followed by a reaction with H2O to release 
free Ag+ (Equation 1.4-1.7) [115]. The dissolution of AgNPs is affected by the 
concentration of dissolved oxygen, temperature, pH, particle size, surface coating and 
anion/organic composition in the dispersion media.  
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            2Ag (s) +1/2O2 ↔ Ag2O (s)                  ΔGƟ(298 K) = -11.25 kJ/mol         (1.4) 
        1/2Ag2O (s) + 1/2H2O ↔ Ag+ + OH-        logKs (298K) = -7.71 ± 0.03          (1.5) 
            1/2Ag2O (s) + 1/2H2O ↔ AgOH           logKs (298K) = -5.75 ± 0.25          (1.6) 
   1/2Ag2O (s) + 1/2H2O + OH- ↔ Ag(OH)2-     logKs (298K) = -3.72 ± 0.03         (1.7) 
Oxygen is a prerequisite for dissolution of AgNPs [97], which is inhibited in anaerobic 
conditions [116]. The presence of H2O2 promotes oxidation and thereby dissolution 
[117]. The reduction of the outer layer of Ag2O by H2 reduces the dissolution [97]. It is 
observed that the outer layer of AgNPs is steadily oxidized into a Ag2O shell upon 
prolonged illumination by UV-blue light in an oxic environment [118]. The oxidation 
rate is thermodynamically enhanced in small nanoparticles according to the change of 
Gibbs free energy  
                                     ΔGƟ(298 K) = -11.25 – 57.5/r kJ/mol                                  (1.8) 
where r is the radius of nanoparticle [119]. The adsorption energy of oxygen to the 
nanoclusters surface decreases with decreasing particle size [120]. Consequently, 
smaller nanoparticles are more likely to be oxidized than larger ones. Additionally, the 
mass faction of Ag2O increases as particle size decreases [97]. One or two layers of 
Ag2O may be formed in AgNP suspension [97], but it also reported that oxygen can 
penetrate into the interior of nanoparticles, resulting in the oxidation of 89% of total 
AgNPs that are deposited on nickel TEM grids in 9.3 h under the enhanced illumination 
by white lamp, according to the red-shift and damping of LSPR [118]. Theoretical study 
has confirmed a red-shift of maximum extinction surface plasmon resonance 
wavelength and a decrease of extinction peak intensity upon increasing oxidation of 
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AgNPs [121]. 
A model based on the Arrhenius Equation suggests that primary size of AgNPs is an 
important factor determining dissolution kinetics of nanoparticles [122]. The relative 
surface area of nanoparticles exponentially increases with a decrease in particle size, 
inducing the accelerated release of Ag+ from small AgNPs [103, 123]. Besides, smaller 
AgNPs have higher solubility in H2O (equation 1.2) [123]. Silver nanoparticle 
aggregates show declined dissolution rate [124]. Decreasing pH accelerates Ag+ release 
(Equation 1.4 and 1.5). Liu et al. have observed that the concentration of dissolved Ag+ 
released from AgNPs is much higher at pH 4 than that at pH 9 in air saturated water 
[117]. In alkaline condition, dissolved Ag may exist in the forms of AgOH and 
Ag(OH)2- (Equation 1.6 and 1.7). The dissolution rate increases with rising temperature 
since this process is thermodynamically favourable [125].  
Complete dissolution of citrate-AgNPs (4.8 ± 1.6 nm) in air-saturated deionized (DI) 
H2O (pH = 5.68) was observed at room temperature [117]. Partial dissolution of AgNPs 
(50 ± 20 nm) was also obtained and the dissolution rate depends on surface coating and 
temperature [125]. It has also reported that citrate-coated AgNPs with a concentration 
of 10.8 mg/L were relatively stable for 104 d when they were stored in dark [126]. It is 
difficult to compare dissolution rates from different studies because nanoparticle’s 
properties and environmental conditions, which are always unique, combine to affect 
dissolution kinetics and equilibrium.  
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1.5.2 Surface chemistry  
Surface ligands will interfere with various transformations of nanoparticles. Citrate has 
been demonstrated to inhibit the dissolution of AgNPs since increasing citrate/AgNPs 
concentration ratio promotes the stability of AgNPs in H2O [126, 127]. Coating agents 
such as cysteine, glutathione and oxidized glutathione can strongly reduce the Ag+ 
release rate due to their potential activities of surface passivation, reversibly binding 
with surface atoms or inducing the formation of insoluble films on the surfaces [127]. 
The inhibition ability of surface ligands might be associated with their affinities for the 
nanoparticle’s surface atoms. For example, cysteine, which is able to strongly bind with 
Ag, can substantially decrease the dissolution of citrate-AgNPs [116]. 
Silver nanoparticles can react with environmental chemicals on their surfaces. In a 
chloride-rich environment such as seawater, Cl- can drive the dissolution of AgNPs 
forming AgCl precipitates in the environment [128], on the other hand the formation of 
AgCl (s) on surface hinders Ag+ release, which has been demonstrated by a slower 
dissolution rate of PVP-AgNPs in NaCl solution than that in H2O [129]. Meanwhile, 
increasing Cl- concentration supports the transformation of AgCl (s) into soluble 
AgClx(x-1)- complexes, which in turn promotes the dissolution of AgNPs [129]. 
Accelerated shrinking of AgNPs that are immobilized on glass substrates was observed 
by AFM upon exposure to increased NaCl concentrations, providing direct evidence to 
support the conclusion that Cl- ions catalyse the dissolution of AgNPs [106].  
In a reducing environment, silver tends to react with sulphide forming Ag2S that might 
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precipitate on the surface of AgNPs [130]. By competing with coating agents for the 
surface reaction the sulfidation of AgNPs might influence desorption of capping agents, 
surface charge, aggregation state and dissolution [130]. Oxidation is likely to be a 
prerequisite for sulfidation of AgNPs since the formation of Ag2S is significantly 
inhibited in an argon atmosphere [98]. In addition, sulfidation preferentially occurs on 
the surface of AgNPs [131]. Under high sulphur concentrations (0.1-1 mM) (e.g. 
wastewater treatment plant), silver directly reacts with sulphur forming Ag2S. In low 
sulphur conditions (e.g. natural water), AgNPs slowly dissolve into Ag+ as the 
intermediate species that reacts with sulphur [98]. Sulfidation of AgNPs leads to 
decreased dissolution [130] since the solubility constant (Ksp) of Ag2S is quite small 
(5.92 × 10-51) compared to other Ag compounds e.g. AgCl (1.77 × 10-10) and Ag2CO3 
(8.46 × 10-12) [119]. There is a strong negative correlation between sulfidation and 
toxicity of AgNPs because the sulfidation transforms Ag into non-soluble Ag2S that is 
much less toxic to microorganisms and thus inhibits Ag+ release and reduces surface 
active area [132]. 
1.5.3 Aggregation  
Nanoparticles are easy to aggregate owing to their high surface energy. The aggregation 
states of AgNPs affect their mobility [133], bioavailability [134] and toxicity [135]. The 
aggregation can be explained by classic Derjaguin-Landau-Verwey-Overbeek (DLVO) 
theory. There are mainly two forces controlling the nanoparticle’s stability: van der 
Waals attractive force and electrostatic repulsive force [136]. Hydration effect, steric 
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effect, coverage and configuration of surface coating also contribute to the interactions 
between nanoparticles [137]. When the distance between nanoparticles decreases to a 
few nanometres, ion-specific effects, ion solvation and polarization of the nanoparticle 
core should be considered, adding to the complexity of a nanoparticle’s interaction at 
the nanoscale [3]. 
Aggregation originates from attachment of individual nanoparticles to form large 
nanoparticle clusters. Silver nanoparticles should have high enough kinetic energy to 
overcome an energy barrier to achieve efficient attachment and many efforts need to be 
made to prevent them from aggregating [138]. Ions are absorbed onto the nanoparticle’s 
surface enabling the charging of AgNPs and large molecules covering the surface have 
steric effects. Both increase the energy barrier. On the other hand, counterions and many 
functional molecules can modify nanoparticle’s surface chemistry, which might reduce 
the energy barrier to trigger aggregation. Silver nanoparticles have a strong tendency to 
aggregate in electrolyte solution as a result of neutralization of surface charge that leads 
to the dominancy of attractive force when AgNPs move close. Decreasing pH can 
reduce the surface potential of negatively-charged AgNPs, accelerating the aggregation 
in NaCl solution [139]. High concentrations of counterions with large valences always 
promote aggregation [140]. In comparison, increasing surface potential with same-
charged chemicals enhances nanoparticle stability. Increased resistance to aggregation 
for citrate-AgNPs (negatively charged) was observed after humic acid (negatively-
charged) was added [140]. Positively-charged polymer (poly(3-(6-(negative1-
methylimidazolium-3-yl)hexyl)thiophene-2,5-diyl bromide, PMHT) induced the 
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aggregation of BO3--AgNPs by neutralizing the surface charge [141]. Interestingly, 
their surface charge changed from negative to positive when more PMHT were added, 
which restabilized the nanoparticles [141]. Surface capping with polymers can reduce 
the susceptibility of AgNPs to aggregate in an electrolytic environment. PVP and BPEI 
coated AgNPs can maintain their stability in 1 M Ca(NO3)2 solution, but H2-AgNPs and 
citrate-AgNPs completely aggregated in 5 mM Ca(NO3)2 solution [142]. Coexistence 
of high concentration of Ca2+ with humic acid induced intermolecular bridging, leading 
to enhanced growth of nanoparticle aggregates [143].  
1.6 Toxicity of Ag+ and AgNPs to microorganisms 
1.6.1 Toxicity of Ag+ 
Many metals are crucial for cellular metabolism and are essential components of 
biomolecules [144]. Bacteria require different orders-of-magnitude of metals for 
cellular process [145], but excessive levels of even essential metals in bacterial cells 
have lethal effects. Some transition metals such as silver (Ag) are not essential for 
microorganisms, and can influence cellular physiology and even kill bacteria at low 
concentration [29, 146]. The toxicity of heavy metals has been reported to be linked to 
their standard redox potential and affinity with sulphide [147]. Metals with high 
reduction potential and low solubility of metal-sulphide complexes have stronger 
bactericidal effects.  
Silver and its compounds have a long history of use as antimicrobial agents [28]. There 
are several mechanisms by which Ag is toxic to bacteria (Figure 1.4). Silver can 
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promote intracellular reactive oxygen species (ROS) stress. The ROS, including 
superoxide (O2-), hydrogen peroxide (H2O2) and hydroxyl radical (HO·), are primarily 
produced by accidental autoxidation in aerobic conditions [148]. Silver might disrupt 
Fe-containing proteins, inducing Fenton-type ROS stress. It has been reported that 
copper displaces the iron atom of iron-sulphur clusters diminishing enzyme activities 
[149]. Similarly, Ag is able to disturb cellular iron homeostasis, releasing Fe2+ that can 
drive a Fenton reaction in cells [148, 150]. Silver might attack antioxidants (e.g. 
glutathione) and ROS-scavenging enzymes, especially those containing thiol groups, 
leaving cells vulnerable to ROS. Silver has high affinity for thiol residuals (e.g. the 
stability constant for Ag-cysteine is 7.9 × 1011) [28, 119]. It is reported that Ag+ disturbs 
the electron transport chain, which imposes superoxide radical stress on bacteria [150, 
151]. For instance, the Ag+ released from Ag-coated titanium substrates attacked thiol 
groups of respiration chain and TCA cycle enzymes, inducing rapid accumulation of 
hydroxyl radicals in Staphylococcus epidermidis [152]. 
Silver can kill Gram-negative and positive bacteria in anaerobic conditions where ROS 
stress is absent [151, 153], suggesting that ROS alone cannot explain the bactericidal 
actions of Ag. Silver can directly attack a variety of proteins [154, 155]. Silver is 
capable of non-specifically binding to proteins, leading to increased membrane 
permeability [150] and damage [156]. Silver can abolish the activities of Fe-S-
dependent dehydratases and mononuclear iron proteins [148]. Silver ions might modify 
membrane protein, leading to the H+ leakage in Vibrio cholera [157]. Small 
concentrations of AgNO3 (≤10 μM) can interfere with the activities of respiratory chain 
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enzymes causing bacterial cell death, or directly interact with cell membrane leading to 
bacterial deformation [30]. Silver ions can also interact with ribosomes inside cells to 
interfere in protein expression and ATP production without attaching to the cell 
membrane [31], demonstrating their direct attack on bacterial compartments. DNA 
bases could be the target of Ag; but there is a lack of evidence of mutations directly 
caused by Ag [158, 159]. Genotoxicity of Ag might be associated with the oxygen 
radicals produced via other Ag-biomolecule interactions. In summary, the high affinity 
of Ag with a variety of biomolecules causes a broad spectrum of bacteria to be 
extremely susceptible to a toxic dose of Ag. 
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Figure 1.4 Antibacterial activities of Ag (Gram-negative bacterium as the model) 
(1) Membrane destruction or damage caused by ROS or through directly binding with 
membrane molecules. (2) Disturb electron transport chain (ETC) via impairing the 
activities of ETC enzymes. (3) Disrupt metabolic pathways such as the TCA cycle. (4) 
Disrupt cellular Fe-containing proteins, releasing free iron that can enhance the Fenton 
reaction and increase ROS stress. (5) Attack metal-binding sites of metalloproteins, 
disabling their function or damaging the protein structure. (6) React with cellular thiol, 
including catalase and superoxide dismutase (SOD), causing dysfunction of 
antioxidants. (7) Damage DNA by Ag or ROS. 
1.6.2 Bacterial resistance to Ag 
Antibiotic resistance is marked as a global crisis owing to the emerging of antibiotic-
resistant pathogens and a lack of novel drugs to treat these bacteria [160, 161]. Given 
the non-selective binding of Ag with various biomolecules, it is generally accepted that 
strong resistance towards Ag in bacteria is not as common as for antibiotics, but it can 
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occur by frequent sublethal exposure of bacteria to Ag (Figure 1.5). Silver resistance 
was firstly reported in Salmonella in a hospital in the 1970s, and was transferable 
among different bacterial species [162]. Later, it was found that the plasmid pMG101 
in the strain was responsible for the Ag resistance [163]. Plasmid pMG101 contains silE 
gene that encodes a periplasmic-specific binding protein, the silRS gene that is closely 
related to a sensor/responder pair and homologous to proRS in copper resistance 
plasmid, the silCBA gene that encodes a three-polypeptide membrane cation/proton 
antiporter efflux pump, and the silP that is deduced to be a member of the P-type 
ATPase heavy metal efflux family [163, 164]. Apart from this plasmid-mediated Ag 
resistance, the active efflux machines associated with chromosomal genes copA and cus 
that are responsible for bacterial Cu resistance also contribute to Ag resistance [165, 
166]. The P-type ATPase transporter, CopA that transports Cu from the cytoplasm into 
the periplasm, has a role in exporting Ag [165]. The RND-type transporter CusCBA 
complex that has the function of pumping Cu+ from cytoplasm or periplasm into 
extracellular space [167] might play an active role in Ag efflux. The E. coli mutants 
selected under Ag+ treatment show strong Ag resistance as a result of a decline in the 
outer membrane permeability and reduced intracellular Ag accumulation [168]. A 
mutant that is deficient in porins (β-barrel proteins that cross cellular membranes) has 
shown comparable Ag susceptibility to the parent strain, suggesting that active Ag 
efflux might also contribute to the Ag resistance [168]. Probably, the active efflux and 
reducing Ag permeability combine to determine bacterial defence against Ag. Because 
a double mutation of ompR that regulates the expression of porin OmpC and OmpF and 
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the gene cus that is responsible for the expression of CusCBA, is required for strong 
Ag resistance [166]. 
Given the reducing environment in bacterial cells, it is not a surprise that Ag+ can be 
reduced to metallic Ag in bacterial cells, which contributes to the Ag detoxification. A 
Pseudomonas strain isolated from a silver mine is capable of transforming Ag+ into 
particulate Ag accumulated in the periplasm [90]. The engineered E. coli HS2019 that 
expresses high Ag-affinity periplasm protein (MBP-AgBP2p) by a plasmid exhibits 
strong tolerance to Ag+ [169]. This Ag-binding peptide protects cells by reducing Ag+ 
to Ag. Small AgNPs have been found evenly distributing in E. coli cells treated with 
Ag+, indicating that Ag+ can be also reduced in the cytoplasm [170]. Microbial 
extracellular substances are capable of protecting bacteria by transforming Ag+ to 
AgNPs and immobilizing the AgNPs outside cells [171].  
Biofilm, which represents the dominant life form of bacteria in the natural environment 
is an important strategy to tackle environmental stress [172]. A bacterial biofilm is the 
assemblage of cells that are embedded in self-produced extracellular polymeric 
substances (EPS) [173, 174]. A concentration gradient of nutrients, signalling 
compounds and bacterial waste is generated within the biofilm due to chemical 
diffusion along with microbial metabolism [173]. Biofilms can have up to 100-fold 
strengthened tolerance to ampicillin, chloramphenicol and other antibiotics [175]. The 
bacteria in biofilms are also less susceptible to heavy metals than their planktonic 
counterparts [147]. Pseudomonas aeruginosa can tolerate up to 25 folds of the 
concentration of metal cations (Cu2+, Ni2+, Co2+, Zn2+, Al3+, and Pb2+) in a biofilm than 
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those in planktonic culture [176]. Several mechanisms are involved in the enhanced 
metal resistance of cells in a biofilm. Extracellular polysaccharides and proteins provide 
a strong and enduring yet flexible physical support structure, acting as a filter that 
protects cells from external chemical assault while allowing diffusion of nutrients [177]. 
Both bacteria and cellular metabolites can bind with Ag+ to reduce the bioavailability 
of free Ag, which will encourage bacterial regrowth and surface colonization in an Ag-
diluted environment [178]. Dead cells and EPS have sorption, complexation or 
precipitation sites that capture and fix Ag in biofilms [147]. Furthermore, the cells in a 
biofilm undergo complex and adaptive physiology changes in response to Ag stress, 
allowing phenotypic diversification to withstand toxic metals [147, 176]. 
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Figure 1.5 Bacterial resistance to Ag 
(a) The mechanisms of bacterial defence against Ag. Bacteria translocate Ag from the 
cytoplasm to extracellular spaces by efflux pumps, or control the expression of 
membrane proteins (porins) to reduce the influx of Ag (1). Silver ions can be 
deactivated through binding with various biomolecules inside cells or extracellular 
substances outside cells (2). Bacteria are capable of reducing Ag+ to metallic Ag or 
AgNPs in different cellular compartments or outside cells (3). (b) Efflux-mediated Ag 
resistance of the sil system in the plasmid pMG 101 in Salmonella enterica serovar 
Typhimurium [179]. The sensor SilS detects Ag in the periplasm and phosphorylates 
SilR that regulates the transcription of silCBA, silP and silE. The SilCBA complex is 
an RND-type transporter that uses proton motive force to drive the efflux of Ag. It 
consists of SilA that spans the inner membrane, SilB that is a membrane fusion protein 
and SilC that is an outer membrane protein. Silver binds to SilB, which triggers the 
SilCBA complex to pump Ag out of cells. SilP is a P-type ATPase efflux pump. SilE is 
a periplasmic protein that binds Ag. (c) Silver resistance related to Cu resistance 
chromosomal genes [167]. The copA and cus system that encodes P-type ATPase 
transporter (CopA) and RND-type transporter (CusCBA), respectively. The CopZ in 
cytoplasm and CusF in periplasm deliver Ag to CopA and CusCBA complex that export 
Ag into extracellular space. 
1.6.3 Toxicity of AgNPs 
Morphology (size and shape) and surface chemistry of nanomaterials play major roles 
in the toxicity [180, 181]. A meta-analysis of cellular toxicity for quantum dots (QD) 
by mining 1741 cell viability data samples has revealed that surface properties, size and 
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nanoparticle concentration have the most influence on their toxicity towards eukaryotes 
[182]. Size, surface chemistry and aggregation state of nanomaterials determine the 
initial deposition of nanomaterials on cell surfaces and subsequent internalization. 
Surface coating also affects nanomaterial behaviours in biological media and 
transformation in the cell cytoplasm. Enhanced membrane attachment and 
internalization of mercaptoundecanoic acid-capped and dodecylamine-modified 
poly(isobutylene-alt-maleic anhydride)-coated AgNPs have been reported causing 
membrane damage, autophagy and cytoskeletal deformation of human cells, but the 
AuNPs coated with poly(ethylene glycol) have limited uptake by cells and thereby 
weak toxicity [183]. AuNPs capped bysurface ligands with same chemical composition 
but different structure have shown different pathways to penetrate into cells [184]. The 
nanoparticles that can penetrate through a cell membrane should be in a critical size 
range, which depends on the surface properties and internalization pathway [185]. For 
instance, only the antibody-coated AuNPs with diameter of 40 and 50 nm that have high 
binding affinity towards the membrane receptors on cellular surfaces can be 
internalized through endocytosis by human breast cancer cells, but the AuNPs with too 
large or small diameters are excluded [186]. 
Starch-capped AgNPs (6-20 nm) can penetrate the cytoplasm of human lung fibroblast 
cells and glioblastoma cells, disrupting the mitochondrial respiratory chain, inducing 
ROS production and interrupting ATP synthesis, and causing DNA damage [187]. 
Oxidative stress is an important mechanism involved in the toxicity of nanomaterials 
[180]. To trigger ROS stress, nanomaterials are able to directly catalyse ROS formation 
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(Fenton reaction and photo activation) (TiO2, Fe2O3), release metal ions to induce ROS 
stress (ZnO, CuO and Ag, etc.), and interact with metabolic processes such as electron 
transport chains and antioxidant defences (TiO2, Fe2O3, ZnO, CuO and Ag, etc.) [188]. 
The silver nanoparticles without surface coating (9-21 nm) have been shown to induce 
elevated levels of intracellular ROS to kill nitrifying bacteria [189]. Citrate-AgNPs (9.3 
± 2.8 nm) can also cause accumulation of envelope proteins precursors, collapse of 
cytoplasmic membrane potential, loss of intracellular potassium and depletion of 
cellular ATP in E. coli [190]. Several studies have demonstrated the disintegration of 
cell membrane induced by AgNPs [191, 192], but it is difficult to distinguish if the 
membrane damage was caused by ROS or through direct attack from AgNPs. Graphite 
nanosheet (0.31-6.87 ηm in average)have been reported to deposit on bacterial 
membranes, inducing membrane and oxidation stress via disrupting the activities of 
glutathione without the detection of superoxide species [193], suggesting that direct 
interaction between nanomaterials with membrane biomolecules plays a role in 
membrane destruction.  
Silver nanoparticles with different sizes and various coatings have been shown to be 
toxic to different organisms, including bacteria [29], yeast [194, 195], algae [57], 
invertebrate [196, 197], plants [58], fish [59] and human cells [187]. For eukaryotic 
cells, nanomaterials can be internalized via endocytosis or diffusion [198]. 
Antibacterial mechanisms of nanomaterials should be different from the toxicity in 
eukaryotes. There is a natural barrier of a cytoplasm membrane and lack of endocytosis 
in bacteria. Currently, there is a lack of evidence that AgNPs can penetrate the bacterial 
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cytoplasm and enter cells. Electron microscopy images have shown AgNPs attached to 
or transported into bacterial cells [192], but the intracellular AgNPs might be the result 
of the reduction of Ag+ [170].  
The toxicity of AgNPs in bacteria is mainly mediated by the release of dissolved Ag+. 
It is unclear whether the antibacterial activities of AgNPs are solely due to the dissolved 
Ag+ or ionic and nanoparticulate Ag combined effects. It is difficult to differentiate Ag+ 
from AgNP effects since Ag+ always coexist with AgNPs [199, 200]. Under anaerobic 
conditions where release of Ag+ is inhibited, the lethal concentration of AgNPs to E. 
coli is reported to be several thousand higher and dissolved Ag+ are responsible for the 
toxicity [201]. In contrast, nano-specific effects have been reported for ZnO 
nanoparticles where their toxicity is inversely proportional to particle size in the 
absence of large amount of free Zn2+ [202].  
Because AgNPs cannot enter bacterial cells, they might attach to the cell surface, release 
toxic Ag+, interfere with the function of membrane proteins, and damage the membrane. 
Nanoparticle-cell membrane interactions are very complicated. The factors not only 
include the physiochemical forces such as electrostatic force, steric repulsive force, van 
de Waals force and solvation effects but are also affected by cell physiology [48]. 
Positively-charged BPEI-AgNPs have shown stronger toxic effects on Bacillus species 
than negatively charged citrate-AgNPs, H2-AgNPs and PVP-AgNPs [203]. Positively-
charged AuNPs also show higher toxicity and larger cellular uptake rate in 3T3 
fibroblast cells in comparison to negatively-charged ones [204].  
It is unclear that AgNPs have a direct role in the toxicity. Different pathways may be 
Chapter One 
36 
 
involved in the bacterial response to treatments of Ag+ and AgNPs. A single-gene 
knockout library of Escherichia coli mutants present different sensitivity profiles 
towards Ag+ and AgNPs [205], suggesting that the toxicity mechanism of 
nanoparticulate Ag could be different from ionic Ag. A transcriptomic study 
demonstrates that exposure of E. coli to Ag+ or AgNPs induces different gene regulation 
and expression that are linked with protein production, iron metabolism and transport 
and redox stress [206]. Direct toxic effects from AgNPs may be not strong but cannot 
be excluded. Silver nanoparticles might mostly act as Ag reservoir that deliver Ag close 
to cells creating a local environment with high concentration of dissolved Ag+ to kill 
bacteria [207, 208]. 
1.7 Overview of the thesis 
This thesis investigated the toxicity mechanisms of AgNPs in an environmental model 
bacterium Pseudomonas putida. Firstly, a new method to separate dissolved Ag from 
AgNPs was developed. This new approach was used to measure the concentrations of 
dissolved Ag+ in AgNP-treated bacterial cell culture. To understand the toxicity 
mechanism of AgNPs in bacteria, real-time toxicity kinetics tests, which combined the 
dynamic transformations of AgNPs in microbial media and their bacteria-killing actions, 
were carried out. An evolution experiment was carried out to explore the different 
toxicity models of Ag+ and AgNPs in P. putida at genetic level.  
(1) A convenient and reliable method was developed to quantify dissolved Ag in 
Ag+/AgNP mixtures by combining aggregation with centrifugation. The aggregation of 
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AgNPs in different concentrations of Ca(NO3)2 solutions was investigated to examine 
how the aggregation mediated by Ca2+ facilitated the sedimentation of AgNPs during 
centrifugation. By comparing with ultrafiltration this new method provided a simple, 
fast and effective way to monitor dissolved Ag in AgNP suspensions. 
(2) The toxicity of AgNPs in a bacterium P. putida was investigated by monitoring 
the transformations of AgNPs and bacterial response over time under as well defined 
conditions as possible. A citrate minimal medium was used to minimize potential 
changes of AgNPs during exposure to test media. Uncoated AgNPs, stored under N2 to 
reduce oxidation, were used to avoid interferences from surface ligands and ensure the 
consistency of primary AgNP dispersions. The aggregation and dissolution of AgNPs 
in Davis minimal medium was measured. The effect of AgNP concentration and 
bacterial cell density on the minimum inhibitory concentration (MIC) was investigated. 
Lower doses of AgNPs which are typical in the environment were used for toxicity 
kinetics studies. The dissolution of AgNPs and corresponding death or growth of 
bacterial populations were examined to investigate how the release of Ag+ governs the 
bactericidal effects of AgNPs over time. Furthermore, dose-response studies of high 
time resolution were carried out to quantify the antibacterial activities of ionic and 
nanoparticulate Ag. 
(3) An evolution experiment was used to investigate the nano-specific toxicity of 
AgNPs in bacteria. It was hypothesised that bacteria will evolve differently in the 
presence of Ag+ and AgNPs if they have different antibacterial activities. Because the 
ancestral P. putida population had not previously evolved in the same environment in 
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the absence of Ag, a pre-evolution experiment was carried out. Five parallel P. putida 
cultures that were from the same strain firstly evolved without Ag stress for 70 d before 
splitting the fittest culture for main evolution. Each independently evolved in the 
presence of Ag+, well defined AgNPs or Ag free controls for 75 d in five replicates. The 
pre-evolved P. putida populations made the adaptions upon the challenges of sublethal 
concentrations of Ag+ or AgNPs. Whole genome sequencing was used to identify 
genetic changes in the evolved populations during the evolution experiment. Different 
mutation patterns in these evolved populations treated by Ag+ or AgNPs were identified. 
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2.1 Introduction 
Nanomaterials (NM) have received increasing attention due to their distinctive 
physicochemical properties at nanosize [10, 53, 209], especially for their medical 
application potential, as multi-drug resistant pathogens become ever more frequent 
[150, 161, 210, 211]. Silver nanoparticles (AgNPs) are widely used nanomaterials due 
to their toxic effects on microorganisms [9, 150, 212]. However, the mechanisms 
involved in their toxicity to microorganisms are still unclear. The antibacterial activities 
of AgNPs are generally thought to be indirectly mediated by the release of silver ions 
(Ag+) [201, 213, 214], but some studies have suggested nanoparticles themselves can 
play a direct role in toxicity to bacteria [205, 206] because of their potential to directly 
interact with microbial components [212] and their large proportion of reactive surface 
sites compared to bulk materials [215]. It is therefore essential to differentiate ionic and 
nano Ag and measure the concentrations of different Ag species to understand their 
bactericidal effects.  
Silver nanoparticles become oxidized, releasing Ag+ in aquatic environments, when 
oxygen is available [103, 117, 122]. The dissolved Ag usually coexists with 
nanoparticles during storage [116]. Quantifying Ag species in AgNP dispersions, 
however, is quite challenging due to the difficulty of separating dissolved Ag+ from 
AgNPs. Ultracentrifugation and ultrafiltration are the methods used routinely. Both 
have their limits. In ultracentrifugation, precipitating the tiny nanoparticles requires 
large centrifugal forces and long running times [216], which might be problematic when 
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AgNPs continuously release Ag+ in an oxic environment. Sorption of Ag+ to membranes 
may occur when ultrafiltration [214, 217] or dialysis is used. Ion-selective electrodes 
(ISE) can be used to measure free Ag+ concentration in bulk liquid but not the total 
dissolved Ag+ that include free Ag+ and any dissolved Ag+ complexed with the 
chemicals in the bulk liquid and attached to the surfaces of AgNPs [213]. Emerging 
techniques such as single particle inductively coupled plasma mass spectrometry (SP-
ICP-MS) and asymmetrical flow field-flow fractionation coupled with inductively 
coupled plasma mass spectrometry (AF4-ICP-MS) are complex to operate and 
standardize but allow small errors in detection of nanoparticles and free ions [108, 218]. 
In this study, a convenient and reliable method was developed to quantify dissolved Ag 
in Ag+/AgNPs mixtures by combining aggregation with centrifugation. Silver 
nanoparticles aggregate in Ca(NO3)2 [140]. Two mM Ca2+ is sufficient to rapidly 
aggregate various concentrations of uncoated AgNPs (10-40 nm) for removal of the 
aggregates by centrifugation. This approach only requires small sample volumes and 
low-speed bench-top centrifuges. This new method can provide a simple, fast and 
effective way to monitor dissolved Ag in AgNP suspensions. 
  
Chapter Two 
42 
 
2.2 Materials and methods 
2.2.1 Synthesis of uncoated AgNPs  
Uncoated AgNPs were produced by the solution-phase method [16, 219]. Silver nitrate 
(AgNO3, Sigma-Aldrich) was used as the precursor and reduced by sodium borohydride 
(NaBH4, Sigma-Aldrich) to form AgNPs at room temperature (19 ± 4 °C). All the 
glassware for AgNPs synthesis was soaked in 10% HNO3 overnight and rinsed with 
copious amounts of deionized (DI) water (18.2 mΩ, Millipore), followed by drying in 
an ambient environment. The AgNO3 solution (100 mL, 0.12 mM) was poured into the 
NaBH4 solution (100 mL, 3 mM) in a 500 mL beaker. The NaBH4 concentration was 
in 25-fold excess. The mixture was homogenized by magnetic stirring (1200 rpm). The 
NaBH4 solution was freshly prepared to reduce the degradation resulting from its 
reaction with water to produce H2 and BO4-. The solution turned to grey within a few 
seconds after mixing and changed to light yellow after a few minutes. As the reaction 
continued, the colour slowly changed to dark yellow at ~25 min and then back to yellow. 
After 1 h, the stirring was stopped, and the solution was stored for 24 h in the dark at 
room temperature. Finally, the stirring bar was removed and the AgNP suspension was 
transferred into glass bottles (250 mL, Duran) and stored at 4 °C in the dark.  
2.2.2 Characterization of uncoated AgNPs  
The localized surface plasmon resonance (LSPR) of uncoated AgNP suspensions was 
measured by UV-Vis spectrometry (UV-Vis 6800, Jenway, Staffordshire, UK). The 
relationship between LSPR signal and AgNP concentration was obtained by measuring 
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the absorption spectra of a dilution series of AgNP suspensions.  
The size distribution of AgNPs was measured by dynamic light scattering (DLS) 
(Zetasizer Nano, Malvern Instruments, Malvern, UK) and differential centrifugal 
sedimentation (DCS) (DC24000, CPS Instruments Europe, Oosterhout, Netherlands).  
The dissolved Ag fraction in AgNP suspensions was obtained by filtering the 
suspensions through a 3 kDa membrane filter (Amicon Ultra-15 Centrifugal Filter Unit, 
Millipore (U.K.) Limited, Hertfordshire, UK) at a centrifugal force of 4000 g for 20 
min at 4 °C. The filtrate was collected and stored at 4 °C for future analysis. Total Ag 
concentration was measured by acidifying 1 mL AgNP suspension with 9 mL 70% 
HNO3 (w/w) overnight at room temperature. The digested suspension was diluted with 
DI H2O (18.2 mΩ, Millipore) to a final HNO3 concentration of 0.2% (w/v). The silver 
content was measured by graphite furnace atomic absorption spectrometry (GFAAS) 
(AAnalyst 600, PerkinElmer Instruments, Massachusetts, USA). A silver concentration 
series (0-25 μg/L) was obtained by diluting a standard AgNO3 solution (1000 μg/mL 
Ag, PerkinElmer Life and Analytical Sciences, Shelton, USA) with 0.2% HNO3 
concentration (w/v). Those standards were measured together with samples to obtain a 
calibration curve for calculating sample concentrations. 
The morphology of AgNPs was imaged by transmission electron microscopy (TEM, 
JEOL 1200EX, Tokyo, Japan). About 20 μL AgNP suspension was loaded onto TEM 
grids (CF300-Cu Grids, Electron Microscopy Sciences, Pennsylvania, USA), followed 
by drying at room temperature. In order to reduce aggregation of AgNPs after loading 
the grids, grids were coated with 20 μL 100 mg/L polylysine, which carries many 
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positive charges while the AgNPs have a negative surface charge. After one hour, the 
grids were rinsed with DI water followed by drying. The morphology of AgNPs in 
Ca(NO3)2 solution was analysed by adding 100 mg/L bovine serum albumin (BSA) to 
stabilize the aggregates before loading the sample on a TEM grid without polylysine. 
BSA can be used to preserve the nanoparticle state in electrolyte solutions to avoid 
artefacts of drying [220]. 
2.2.3 Determining aggregation kinetics of AgNPs in Ca(NO3)2 solutions 
The long-term aggregation of AgNPs in Ca(NO3)2 solution was followed for 96 h after 
mixing 20 mL of a AgNP suspension with the same volume of a 2 mM Ca(NO3)2 
solution by vortexing (~20 s) in screw-cap glass vials (Bijou, capacity 46 mL) and 
allowing the mixture to settle on a lab bench at room temperature (17 ± 1 °C). The 
liquid from the top layer (5 mL) was taken for recording UV-Vis absorption spectra 
after 0, 1, 6, 24, 48 and 96 h. 
The short-term aggregation kinetics was monitored for 0.5-2 h after mixing AgNP and 
Ca(NO3)2 solutions by recording the hydrodynamic size of aggregates by DLS in real-
time. The AgNP suspension (0.5 mL, total Ag 5012 ± 75 μg/L, dissolved Ag 28 ± 0.5 
μg/L at time zero) was mixed with 0.5 mL of different concentrations of Ca(NO3)2 in a 
disposable plastic cuvette and immediately placed in the Zetasizer Nano to record the 
Z-average diameter. Temperature was controlled at 25 °C.  
2.2.4 Centrifugation of AgNPs in Ca(NO3)2  
The sedimentation speeds of AgNPs with or without Ca2+ mediated aggregation were 
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compared at the same centrifugal force. AgNPs were aggregated by mixing 10 mL 
AgNP suspension with 10 mL Ca(NO3)2 solution (2 mM). After 10 min, the 
AgNPs/Ca(NO3)2 mixture was aliquoted into several centrifuge tubes (1 ml for each 
tube). Diluting 10 mL of the same AgNP suspension in 10 mL DI H2O was used as 
control. Centrifugation was undertaken to sediment aggregates or individual AgNPs at 
a centrifugal force of 20,100 g (Centrifuge 5417 C, Eppendorf, Engelsdorf, Germany). 
To investigate the extent to which pre-aggregation can reduce centrifugation time, one 
tube from each treatment was taken to measure the Ag content in the supernatant (0.4-
0.5 mL) at 0, 0.5, 1, 1.5, 2, 2.5, 3 and 4 h. The supernatants were acidified to 1% HNO3 
(w/v) overnight (more than 12 h) at 80 °C, and further diluted to a final HNO3 
concentration of 0.2% (w/v) for Ag concentration measurement by GFAAS. 
2.2.5 Measurement of AgNP content in supernatant after centrifugation of 
AgNPs in Ca(NO3)2  
Suspensions of AgNPs (0.5 mL) were mixed with Ca(NO3)2 (0.5 mL) in 1.5 mL 
microcentrifuge tubes (safe-lock microcentrifuge tubes, Eppendorf, Germany) to form 
large aggregates. After reacting for 10 min, aggregates were centrifuged at 20,100 g for 
30 min. Ten aliquots were processed in parallel. The amount of AgNPs in the 
supernatant was measured by UV-Vis absorption spectroscopy. The supernatants (0.5 
mL) from those ten aliquots were pooled into one tube since 4 mL was the minimum 
volume required for a UV-Vis absorption measurement with a 10 cm path length quartz 
cuvette. Although the UV-Vis absorption of nanoparticles depends on their size, shape, 
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surface coating, aggregation states and surrounding environmental conditions, it can 
still be used for concentration measurement as long as the particles and surrounding 
environmental conditions are similar [221]. A low concentration of AgNPs (< 10 μg/L) 
can be detected by UV-Vis spectrometry using a 10 cm path length quartz cuvette. The 
peak absorbance, typically between 390 and 400 nm, was used to quantify the AgNPs, 
and the absorbance at longer wavelengths (500-700 nm) was used to monitor the 
aggregates [126].  
2.2.6 Measuring dissolved Ag in AgNPs suspension with aggregation-
centrifugation or ultrafiltration 
Different concentrations of AgNPs were prepared by diluting the AgNP stock with DI 
H2O. The total Ag concentration of the AgNP stock was 5012 ± 75 μg/L, and it 
contained around 10% dissolved Ag. Those diluted AgNP suspensions were aggregated 
in 2 mM Ca(NO3) for 10 min and then centrifuged (20,100 g, 30 min). The supernatant 
(0.4-0.5 mL) was collected carefully and stored at -20 °C for dissolved Ag analysis. 
Each concentration was assayed in duplicate. Ultrafiltration was carried out by filtering 
the same AgNP suspensions through 3 kDa membrane filters (Amicon Ultra-15 
Centrifugal Filter Unit, Millipore (U.K.) Limited, Hertfordshire, UK). The filtrates 
were stored at -20 °C. The dissolved Ag concentrations were always analysed by 
GFAAS. 
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2.3 Results  
2.3.1 Synthesis of uncoated AgNPs 
Three batches of AgNP suspensions were synthesized by the same procedure and 
characterised (Table 2.1, Figure 2.1). They were reasonably monodispersed in H2O and 
had a spherical shape (Figure 2.1a). The size distributions of the three batches were 
similar. Measured by DCS, they showed the same peak diameter of 13 ± 1 nm (Figure 
2.1b). Measured by TEM, the diameters of more than 83% of the counted AgNPs ranged 
between 10 and 40 nm (Figure 2.1c). The three batches also had similar UV-Vis 
absorption spectra and the same peak-absorbance wavelength (390 ± 1 nm) (Figure 
2.1d). 
Table 2.1 Characteristics of AgNPs 
All data are shown as mean ± standard deviation of three batches produced with the 
same procedure. Diameters were measured by TEM, DLS (peak size based on intensity 
distribution) and DCS (peak size based on relative weight distribution). 
pH 
Diameter (nm) Zeta potential in DI 
water (mV) TEM  DLS  DCS 
9.6 ± 0.3 17 ± 4.5 27 ± 4.2 13 ± 0.5 -40 ± 17 
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Figure 2.1 Characterisation of uncoated AgNPs and reproducibility of synthesis 
Three batches of uncoated AgNPs were produced by the same procedure. (a) 
Morphology by TEM. (b) Comparison of size distributions measured by DCS. (c) Size 
distributions analysed by ImageJ [222] based on the TEM images. The boxes represent 
interquartiles, and the whiskers represent 5% and 95% percentiles. The points in the 
box are the means, and the bars represent the median. (d) UV-Vis absorption spectra 
one day after synthesis. (e) Photograph of AgNP suspension. 
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2.3.2 AgNPs aggregate in Ca(NO3)2 solutions 
The small particle size made complete separation of AgNPs from ionic Ag difficult. 
Therefore, we investigated whether the particles would aggregate quickly in the 
presence of Ca(NO3)2 and could thus be separated by precipitation (Figure 2.2). 
Individual AgNPs were stable in H2O as the UV-Vis absorption spectra did not change 
significantly during 96 h, indicating lack of aggregation (Figure 2.2a). The absorbance 
of AgNPs (at the wavelength of maximal absorbance) was proportional to the 
concentration of AgNPs and can therefore be used to measure the concentration of 
AgNPs (Figure 2.3). In Ca(NO3)2 solution, the red shift of the peak absorbance 
wavelength from 600 to 650 nm accompanied by the decreasing absorbance at 400 nm 
suggested that the aggregation took place during the first 6 h. The declining absorbance 
at both 400 and 650 nm from 6 to 96 h indicated the sedimentation of the aggregates. 
After 96 h, the absorbance in the range of 350-700 nm declined to less than 0.09, 
suggesting that most of the AgNPs and aggregates had sedimented. This aggregation 
and precipitation of AgNPs in Ca(NO)3 solution was also confirmed by the colour 
transformations from yellow to pink and then blue of the AgNP suspension from 0 to 6 
h (Figure 2.2b). Due to the formation of a dark precipitate at the bottom, the liquid 
phase became colourless at 96 h. 
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Figure 2.2 Aggregation of AgNPs in 2 mM Ca(NO3)2 solution 
(a) UV-Vis absorption spectra of AgNP suspensions in H2O or 2 mM Ca(NO3)2 as a 
function of time, from 0 to 96 h. The AgNP suspension was quite stable in H2O but 
aggregated quickly in the Ca(NO3)2 solution. The top layers of the two mixtures were 
sampled for UV-Vis absorbance measurements. (b) Photographs of the AgNP 
dispersion in 2 mM Ca(NO3)2 taken over time. The colour of the AgNP suspension 
changed from yellow to pink in a few seconds (referred to as 0 min) after mixing the 
AgNP suspension with Ca(NO3)2 solution, followed by light blue during the first hour. 
Afterwards, the colour strength declined slowly, and the dispersion was as colourless 
as DI H2O at 96 h while a dark precipitate had formed at the bottom. 
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Figure 2.3 Calibration of UV-Vis absorption against concentration for AgNPs 
(a) UV-Vis absorption spectra of different concentrations of AgNPs. The shapes of the 
absorption spectra were the same, and all had the peak absorbance at 390 ± 1 nm. (b) 
Linear regression of the absorbance at 390 nm versus AgNP concentration. SE 
represents the standard error of the slope. 
2.3.3 Concentration dependence of aggregation of AgNPs in Ca(NO3)2 
We investigated the Ca(NO3)2 concentration dependence of AgNP aggregation. The 
aggregation rate of AgNPs markedly increased from close to zero to 11 nm/min at the 
initial aggregation phase when the Ca(NO3)2 concentration increased from 0.1 to 0.2 
mM (Figure 2.4a). It did not increase further once the Ca(NO3)2 concentration was 
higher than 0.5 mM (Figure 2.4b). Hence, 2 mM Ca(NO3)2 ensured sufficient 
aggregation to allow separation. Following this, we investigated the AgNP 
concentration dependence of aggregation in 2 and 20 mM Ca(NO3)2. Higher 
concentrations of AgNPs aggregated more quickly, both in 2 and 20 mM Ca(NO3)2 
(Figure 2.4c). When the AgNP concentration increased from 250 to 5012 μg/L, the 
aggregation rate increased from 5 to 24 nm/min. Linear regression was carried out to 
assess the relationship between aggregation rate and AgNP concentration (Figure 2.4d). 
The regression slopes ± SE in nm/min were 17.7 ± 1.6 (p-value = 3.62 × 10-4) and 20.1 
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± 1.7 (p-value = 3.25 × 10-4) in 2 and 20 mM Ca(NO3)2, respectively. Increasing the 
Ca(NO3)2 concentration from 2 to 20 mM increased the aggregation rate only slightly. 
This suggested that a concentration of 2 mM Ca(NO3)2 was sufficient to trigger AgNP 
aggregation, even when the concentration of AgNPs in suspension was quite low. 
Aggregation of AgNPs in Ca(NO3)2 containing media led to formation of large clusters 
(Figure 2.5a, b, c) compared to singly scattering AgNPs in H2O (Figure 2.5d, e, f).  
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Figure 2.4 Aggregation kinetics of AgNPs in Ca(NO3)2 solution 
The total and dissolved Ag concentration (mean ± SD) of the AgNP stock was 5012 ± 
75 and 28 ± 0.5 μg/L, respectively. (a) Dependence of AgNP aggregation kinetics on 
Ca(NO3)2 concentration. The AgNP stock (0.5 mL) was mixed with 0.5 mL Ca(NO3)2 
solution. The hydrodynamic size was measured by DLS. The aggregation process 
appears to be divided into two phases, the faster initial aggregation phase presumably 
corresponds to aggregation of individual AgNPs or small clusters and the second, 
slower aggregation phase corresponds to aggregation of larger aggregates. (b) 
Aggregation rates calculated by linear regression of the first aggregation phase shown 
in panel a. Error bars indicate 95% confidence intervals. (c) Aggregation kinetics of 
different concentrations of AgNPs in 2 and 20 mM Ca(NO3)2. The AgNP stock was 
diluted by DI H2O to obtain different concentrations of AgNPs. Higher AgNP 
concentrations favoured aggregation, and larger aggregates were formed. (d) 
Aggregation rates calculated by linear regression of the first aggregation phase in 2 and 
20 mM Ca(NO3)2 shown in panel c. Error bars indicate 95% confidence intervals. 
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Figure 2.5 TEM images of AgNPs aggregates 
TEM images of AgNPs in 2 mM Ca(NO3)2 (a - c) or H2O (d - f). Individual AgNPs 
formed aggregates in Ca(NO3)2. The AgNP suspension (0.7 mL) was mixed with 0.7 
mL 2 mM Ca(NO3)2 and incubated for 10 min, and the mixture was stabilized by adding 
100 mg/L bovine serum albumin (BSA) to preserve the aggregation state of the AgNPs 
before loading them on TEM grids. The AgNPs in H2O were directly loaded on TEM 
grids. 
2.3.4 Time required to sediment AgNPs after aggregation 
The change of Ag content in the top layer of AgNP/Ca(NO3)2 and AgNP/H2O mixtures 
during centrifugation was measured. After 30 min of centrifugation, 66% of the AgNPs 
had sedimented towards the bottom in H2O. A slower decrease of Ag content in the 
supernatant was observed after this steeper initial decline (Figure 2.6). At least four 
hours of centrifugation were required to sediment all AgNPs in H2O. When AgNPs were 
aggregated by Ca(NO3)2, all the AgNPs sedimented to the bottom of the vessel in 30 
min of centrifugation. Prolonged centrifugation did not further decrease the Ag content 
in the supernatant (Figure 2.6). Hence, 30 min were sufficient to precipitate virtually 
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all AgNPs in 2 mM Ca(NO3)2 solutions. 
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Figure 2.6 The time required to sediment AgNPs 
The Ag content in supernatants after centrifuging AgNPs in 2 mM Ca(NO3)2 or H2O. 
Supernatants were sampled at 0, 30, 60, 90, 120, 150, 180 and 240 min after start of 
centrifugation. Error bars represent the standard deviations of three measurements of 
the sample by GFAAS. 
2.3.5 Sedimentation of Ca2+-aggregated AgNPs is complete 
To investigate the effects of aggregation on nanoparticle sedimentation, AgNPs were 
aggregated in different concentrations of Ca(NO3)2 before centrifugation. The 
absorption spectra of the supernatants had the same shape as absorption spectra of 
monodispersed AgNP suspensions, suggesting that the absorption of supernatants was 
due to individual AgNPs in the supernatant (Figure 2.7a). Therefore, absorbance at the 
wavelength of maximal absorption can be used to quantify AgNPs. Increasing the 
Ca(NO3)2 concentrations from 0 to 0.5 mM progressively reduced the AgNP content in 
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the supernatant from 34% of initial AgNPs to below the detection level of the GFAAS. 
Concentrations of Ca(NO3)2 larger than 0.5 mM ensured that all AgNPs aggregated, 
leading to complete sedimentation as shown by negligible absorption in the long 
wavelength region (550-700 nm) (Figure 2.7a).  
The efficiency of combining aggregation with centrifugation to precipitate different 
concentrations of AgNPs (total Ag, 100-5012 μg/L) was investigated. Supernatants did 
not show any absorption from 350 to 700 nm after aggregating those concentrations of 
AgNPs in 2 mM Ca(NO3)2. By contrast, 21-50% of AgNPs remained in the supernatant 
without Ca2+ (Figure 2.7b). Therefore, 2 mM Ca(NO3)2 was sufficient to aggregate even 
the very dilute AgNPs. 
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Figure 2.7 Sedimentation of AgNPs in Ca(NO3)2 by centrifugation 
(a) UV-Vis absorption spectra of supernatant after centrifugation of AgNPs (100%) in 
various concentrations of Ca(NO3)2. (b) The same for various concentrations of AgNPs 
in 2 mM Ca(NO3)2 or H2O. Three concentrations of AgNPs (100%, 10% and 2% AgNPs) 
were mixed with H2O or Ca(NO3)2. The percentages refer to the dilutions of the AgNP 
stock (100%) with DI H2O. Since the concentration of the AgNP stock (total Ag 5012 
± 75 μg/L; dissolved Ag 283 ± 13 μg/L) was too high for recording the spectrum, it was 
diluted to 20%. 
2.3.6 Measuring dissolved Ag in AgNP suspensions by aggregation or 
ultrafiltration 
Silver nanoparticle samples containing various concentrations of dissolved Ag were 
obtained by diluting the AgNP stock with H2O. The dissolved Ag concentrations in 
these samples should therefore be proportional to the AgNP concentration. This was 
confirmed by linear regression as the adjusted R2 were high in each case (0.974 for 
aggregation-centrifugation and 0.977 for ultrafiltration) (Figure 2.8). However, the 
slope of the regression line for aggregation-centrifugation was 1101 ± 54, i.e. 6.4 times 
larger than the slope for ultrafiltration (173 ± 8). This means that 6.4-fold more 
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dissolved Ag was detected by aggregation-centrifugation. A partial explanation for this 
difference was the loss of Ag during ultrafiltration (Figure 2.9). The amount of Ag lost 
was proportional to the initial Ag+ concentration before filtration. Although Ag 
recovery gradually improved over five cycles of filtration of the same AgNO3 solution, 
there was still a loss of 39-44% of Ag in the last cycle (Figure 2.9). 
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Figure 2.8 Comparison of aggregation-centrifugation with ultrafiltration  
Dissolved Ag content measured by aggregation-centrifugation or ultrafiltration is 
proportional to the concentration of AgNPs. The AgNP suspensions with different 
concentrations of dissolved Ag were obtained by diluting the AgNP stock (100%) with 
DI H2O. Therefore, the dissolved Ag content should be proportional to the AgNP 
concentration. AgNPs were aggregated by 2 mM Ca(NO3)2, followed by centrifugation 
before measuring the dissolved Ag concentration in the supernatants. Error bars indicate 
standard deviation (n = 2). The dissolved Ag content was also measured by 
ultrafiltration. Linear regression of dissolved Ag concentration versus AgNP 
concentration confirmed the proportionality. SE indicates standard error of the slopes 
(the intercept was set to 0). The relative SEs were similar for both methods (0.049 for 
aggregation-centrifugation, 0.046 for ultrafiltration) while the dissolved Ag 
concentration was 6.4-fold higher measured by aggregation-centrifugation than by 
ultrafiltration. 
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Figure 2.9 Adsorption of Ag+ to ultrafiltration units during ultrafiltration 
(a) Ag+ concentrations in filtrates during five cycles of filtration by centrifugation (4 °C, 
4000 g, 20 min) with one of five different concentrations of AgNO3 (2.8, 21, 69, 165 
and 934 µg/L Ag+). After each filtration step, filtrates were collected and the Ag+ 
concentration in the filtrates measured by GFAAS. Error bars indicate the standard 
deviations of three measurements of the sample by GFAAS. (b) Linear regression of 
Ag+ loss versus initial Ag+ concentration for each cycle of filtration. The intercept was 
set to zero. (c) Linear regression of the slopes of the linear regressions in panel b versus 
filtration cycle. The negative slope of this regression line indicates that the fraction of 
Ag+ lost decreased somewhat with each cycle. The error bars represent standard errors 
of the slopes. 
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2.4 Discussion 
2.4.1 Formation of stable, uncapped AgNPs  
This study demonstrated the successful synthesis of monodispersed uncoated AgNPs 
(Figure 2.1). The formation of uncoated AgNPs is controlled by the aggregative growth 
of small AgNPs [16, 223], but aggregation of the NPs can lead to the failure of synthesis 
[94]. Frequently, the electrolyte with highest ionic strength contributes most to the 
aggregation [140, 224]. As expected, by decreasing initial AgNO3 and NaBH4 
concentrations to reduce the ionic strength and increasing the NaBH4/AgNO3 
concentration ratio so more BH4- is available to stabilize uncoated AgNPs [219], stable 
uncoated AgNPs were produced. The process was reproducible, and the three batches 
of AgNPs produced in this manner did not differ significantly in their aggregation in 
Ca(NO3)2 or sedimentation by centrifugation.  
2.4.2 Aggregation of AgNPs in Ca(NO3)2 solution 
According to classic colloidal theory, interactions between nanoparticles are 
determined by van der Waals forces, electrostatic repulsive forces, and steric effects due 
to surface stabilizers and solvation effects [48]. For uncoated AgNPs, negatively 
charged ions such as BH4- adsorb onto the nanoparticles with counter ions enriched near 
the surface [94, 225]. Positively charged Ca2+ ions screen the negative surface charge 
of AgNPs, thus decreasing surface energy and repulsion between nanoparticles. 
Aggregation of AgNPs occurs when the kinetic energy of Brownian motion overcomes 
the nanoparticle-nanoparticle energy barrier, which is reduced in Ca(NO3)2 solution i.e. 
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as nanoparticles become essentially neutral [138]. The structure of aggregates formed, 
such as configuration and monomer numbers, depends on nanoparticle concentration, 
size distribution, surface coating, and conditions in the surrounding liquid [139, 226]. 
The gap between clustered nanoparticles can be as narrow as a few nanometres [3]. 
Under normal gravitational force, gold nanoparticles (40-100 nm) take days or weeks 
to settle a few millimetres [227]. In contrast, the AgNPs completely sedimented to the 
bottom in 2 mM Ca(NO3)2 solution within 4 d (Figure 2.2), suggesting that aggregation 
facilitates sedimentation of AgNPs.  
The aggregation rate of AgNPs increased markedly when the Ca(NO3)2 concentration 
was increased from 0.1 to 0.2 mM, reaching a maximum rate at 0.5 mM (Figure 2.4). 
This suggests that ~0.2 mM was the concentration separating the slow and fast 
aggregation regimes, which is known as the critical coagulation concentration (CCC). 
The aggregation rate was proportional to AgNP concentration in both 2 and 20 mM 
Ca(NO3)2 solutions (Figure 2.4). Increasing AgNP concentration will increase the 
number of AgNPs with high enough kinetic energy to overcome the energy barrier upon 
collision and thereby increase the aggregation rate. Notably, 2 and 20 mM Ca(NO3)2 
aggregated equivalent concentrations of AgNPs equally fast, suggesting that any 
concentration above the CCC is sufficient to ensure optimum aggregation of AgNPs. 
2.4.3 Efficiency of AgNP sedimentation in Ca(NO3)2 solution by centrifugation 
It is predicable that centrifugation will shorten the sedimentation time of AgNP 
aggregates. As the sedimentation velocity is proportional to the square of nanoparticle 
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diameter, the distance settled declines dramatically with decreasing nanoparticle size 
(Figure 2.10) [228]. Consequently, it takes exceedingly long to sediment small AgNPs 
(<10 nm) completely. Centrifugation of AgNPs in H2O will especially increase the 
sedimentation of the larger AgNPs, leading to a steep initial decrease of Ag content in 
the upper layer of the suspension and a slowdown afterwards. In Ca(NO3)2 solutions, 
complete sedimentation was achieved in half an hour (Figure 2.6). As TEM graphs 
showed (Figure 2.5), individual AgNPs assembled into compact clusters that 
sedimented much faster due to their larger sizes.  
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Figure 2.10 Simulation of sedimentation of AgNPs by centrifugation 
Simulation of sedimentation of AgNPs by centrifugation according to [228] assuming 
spherical particles. The distance settled after 30 min was plotted against the diameter 
of AgNPs. The parameters for simulation were set as follows: density of AgNPs 10.49 
g/cm3, density of medium 1 g/cm3, liquid viscosity 1 mPa·s, angular velocity of 
centrifugation 14,000 rpm and rotor radius 9.2 cm. 
Judging from the similar shapes of UV-Vis absorption spectra of supernatant and 
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monodispersed AgNP suspensions, coupled with negligible absorption in the long 
wavelength region that is characteristic for aggregates (Figure 2.7), the aggregates but 
not all individual AgNPs were sedimented by centrifugation. Increasing Ca(NO3)2 
concentrations enhanced the aggregation rate and therefore the sedimentation rate of 
AgNPs. When the Ca(NO3)2 concentration was larger than the CCC, the fast 
aggregation regime was obtained and virtually all AgNPs precipitated, making this pre-
aggregation approach applicable to a broad range of AgNPs concentrations.  
2.4.4 Comparing the aggregation-centrifugation method with ultrafiltration 
Both the aggregation-centrifugation method and ultrafiltration enabled measurement of 
the dissolved Ag concentration in AgNP suspensions. Larger dissolved Ag 
concentrations were obtained by aggregation-centrifugation than by ultrafiltration 
(Figure 2.8). This suggests that some of the dissolved Ag is not effectively separated 
from the AgNPs by ultrafiltration or is lost to the apparatus, either as ions or 
nanoparticles. The various Ag species in AgNP suspensions include nanoparticulate Ag, 
free Ag+ in the bulk liquid [217], Ag bound to ions or organic groups in the bulk liquid 
[127, 129, 229], and Ag+ attached to the nanoparticle surface [225]. During 
ultrafiltration, nano Ag together with any attached Ag+ would presumably be retained 
by the membrane. Silver loss also occurs due to the adsorption of Ag+ to the filter units 
during ultrafiltration (Figure 2.9). Silver ion adsorption by the same brand of 
ultrafiltration units has been reported in several studies [213, 214, 217]. In the 
aggregation-centrifugation method, Ag loss by adsorption is minimized. Presumably, 
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all free Ag+ except that attached to nanoparticle surface in the bulk liquid will remain 
in the supernatant. Once individual AgNPs aggregate into compact clusters by Ca2+ 
bridging, the dissolved Ag+ ions that acted as counter ions to balance the negative 
charges on AgNP surfaces might become released from the AgNP. Additionally, Ca2+ 
could replace the surface-attached Ag+ in the diffuse and Stern layer, releasing Ag+ into 
the bulk liquid. Therefore, more dissolved Ag can be collected by centrifugation after 
aggregation. Since both of these pools of Ag+ species contribute to the toxicity of 
AgNPs, it is advantageous to include their concentration in measurements of dissolved 
Ag in AgNP suspensions.  
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2.5 Conclusions 
In this study, a new method to measure dissolved Ag in AgNP (10-40 nm) suspensions 
was developed. By combining aggregation with centrifugation, only half an hour was 
required to separate dissolved Ag from AgNPs. Uncoated AgNPs were aggregated by 
Ca(NO3)2 and a concentration of 2 mM was sufficient to induce the formation of large 
AgNPs clusters. This pre-aggregation facilitated the sedimentation of a wide range of 
AgNP concentrations by centrifugation. The combined aggregation-centrifugation 
method avoided the loss of Ag in ultrafiltration. That more dissolved Ag was obtained 
by the new method has significant implications for the study of AgNPs toxicity. Since 
the combined aggregation-centrifugation method significantly reduces centrifugation 
time to separate nanoparticles from ions, it will be especially helpful for real-time 
toxicity assays where speed and the convenience of table top centrifugation represent a 
major methodological improvement compared to conventional ultracentrifugation and 
ultrafiltration. The method may also be applicable for separating ions from 
nanoparticles with coatings (electrostatically and sterically stabilized) in the complex 
environment such as toxicity test media. 
 
 66 
 
 
 
 
 
 
3 Chapter Three  
A Real-time Toxicity Study Reveals the Dynamic 
Interactions between Uncoated Silver Nanoparticles and 
Bacteria 
 
 
 
Feng Dong, Eugenia Valsami-Jones, Jan-Ulrich Kreft. A real-time toxicity study 
reveals the dynamic interactions between uncoated silver nanoparticles and bacteria. 
Submitted to Nanotoxicology, 2016. 
 
Chapter Three 
67 
 
3.1 Introduction 
Silver (Ag) is not known to be required for any metabolic process, rather, it disturbs 
cellular metabolism and kills bacteria at low concentrations [29, 146]. Hence, silver and 
its compounds have been used as antimicrobial agents since ancient times [28]. Several 
mechanisms are responsible for the toxicity of Ag for bacteria such as generating 
reactive oxygen species (ROS) [148], abolishing protein activity [30], collapsing 
membrane proton motive force [157], and disturbing gene regulation [206]. Owing to 
the high antimicrobial activity of Ag, AgNPs are heavily used nanomaterials [209, 230]. 
The large surface to volume ratio leads to the high activities of nanomaterials including 
surface reaction and chemical modification [96, 118], dissolution [123] and aggregation 
in electrolyte solutions [140]. It is generally believed that the antibacterial activities of 
AgNPs are entirely due to the released Ag+ [201, 231]. However, it is unclear whether 
nano Ag also has direct toxic effects on bacteria due to the difficulties of disentangling 
Ag+ from nano Ag effects.  
The dissolution of AgNPs is affected by nanoparticle properties such as surface coating 
[232] and particle size [103, 123] as well as environmental conditions such as ionic 
strength [117, 128], light [126], oxygen concentration [116, 125], temperature [117] 
and pH [233] and additionally chemical reactions at the nanoparticle surface including 
silver-chloride complexation [129], oxidation [97], sulfidation [127] and modification 
by organic substances [229, 234]. Silver nanoparticles undergo aggregation upon 
exposure to electrolyte solution [139], toxicity test medium [235] and natural water 
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[236]. The extent of aggregation influences sedimentation rates [133, 237], particle 
accessibility to cells [238] and dissolution kinetics [124]. All these transformations 
combine to control the toxicity of AgNPs towards cells. Therefore, it is critical to 
combine nanoparticle characterization with toxicity assays in real-time to understand 
the toxicity mechanisms. Moreover, any differences in AgNP synthesis, storage and 
toxicity test media compositions can give rise to differences in results, hampering 
comparability of studies [239].  
In this study, AgNPs were systematically characterized and their toxicity to the 
environmental model bacterium Pseudomonas putida was investigated in real-time, 
which also helps understand the environmental risk of AgNPs. To minimize 
nanoparticle changes during exposure to test media, a citrate minimal medium was used. 
Moreover, uncoated AgNPs, stored under N2 to reduce oxidation, were used to avoid 
interferences from surface ligands, in order to investigate the dynamic interactions 
between AgNPs and bacteria under as well defined conditions as possible. It was found 
that the concentration of Ag+ or AgNPs to kill a bacteria population was highly 
corrected with initial population density. Dissolved Ag+ mainly contributed to the 
toxicity of AgNPs that can continuously release Ag+ to inhibit bacterial growth.  
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3.2 Materials and methods 
3.2.1 Synthesis of uncoated AgNPs 
Uncoated AgNPs were synthesized by reducing silver nitrate (AgNO3, Sigma-Aldrich) 
with sodium borohydride (NaBH4, Sigma-Aldrich) at room temperature (19 ± 4 °C) 
according to [16]. All glassware for AgNPs synthesis and storage was soaked in 10% 
HNO3, rinsed with DI water and dried under ambient environment. The procedures for 
synthesis of AgNPs are described in section 2.2.1. 
3.2.2 Characterization of AgNPs 
The LSPR of uncoated AgNP suspensions was measured by UV-Vis absorption 
spectrometry (UV-Vis 6800, Janway). The hydrodynamic size of AgNPs was measured 
by DLS (Zetasizer Nano, Malvern Instruments) and DCS (DC24000, CPS Instruments). 
Zeta potential was measured by Malvern Zetasizer Nano. The morphology of AgNPs 
was examined by TEM (JEOL 1200EX). The sample preparation for TEM is described 
in section 2.2.2. 
3.2.3 Storage of AgNPs 
The stability of AgNPs under ambient air or nitrogen atmosphere at 4 °C in the dark 
was compared by measuring the dissolved Ag concentration in these two atmospheres 
over 4 months by ultrafiltration (Amicon Ultra-15 Centrifugal Filter Unit 3 kDa, Merck 
Millipore) at the centrifugal force of 4,000 g for 30 min at 4 °C (Centrifuge 5804R, 
Eppendorf). For incubation under N2, the bottle (100 or 250 mL, Duran) was flushed 
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with large amounts of nitrogen gas for at least 5 min to minimize O2 in the liquid and 
gas phase. The AgNP-N2 stock was flushed again with N2 and sealed as quickly as 
possible after every sample collection. To determine the total Ag concentration of AgNP 
stocks, the AgNP suspensions were digested by 70% HNO3 (1 mL AgNP suspensions 
added into 9 mL HNO3) overnight at room temperature. The mixture was then diluted 
to a final HNO3 concentration of 0.2% for GFAAS (AAnalyst 600, PerkinElmer 
Instruments). UV-Vis absorption spectra and TEM morphology of these two AgNP 
stocks were monitored during the long-term storage. 
3.2.4 Aggregation of AgNPs in defined medium 
The aggregation kinetics of AgNPs in a minimal medium was determined by real-time 
DLS and time-resolved UV-Vis absorption spectrometry. The hydrodynamic size 
changes of AgNPs in Davis minimal medium salts solution (DMM without the carbon 
source citrate) were measured over two hours. The AgNP suspensions (0.5 mL, total 
Ag 100, 200 and 400 μg/L) were mixed with the same volume of DMM salts solution 
(pH, 7.1) in disposable plastic (polystyrene) cuvettes, followed by immediate sample 
analysis. Thus, the final concentrations of AgNPs and DMM salts solution were halved. 
Temperature was controlled at 25 °C. The AgNP suspensions were obtained by diluting 
the stock (total Ag 2470 ± 183 μg/L, dissolved Ag 304 ± 10 μg/L) with DI H2O. The 
composition of DMM is as follows (per litre) (pH, 7.2): 7.0 g K2HPO4, 2.0 g KH2PO4, 
1.0 g (NH4)2SO4, 0.1 g MgSO4, 1.530 g sodium citrate dihydrate and 1 mL SL10 trace 
elements solution. The SL10 trace elements stock solution contains per litre: 1500 mg 
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FeCl2·4H2O, 190 mg CoCl2·6H2O, 100 mg MnCl2·4H2O, 70 mg ZnCl2, 6 mg H3BO3, 
36 mg Na2MoO4·2H2O, 24 mg NiCl2·6H2O and 2 mg CuCl2·2H2O. Precipitation of 
silver as chloride and sulfate salts in DMM can be neglected according to solubility 
calculations carried out with Visual MINTEQ that is used for chemical equilibrium 
calculations (Version 3.0, The Royal Institute of Technology, Sweden), e.g. Ag+ is 
completely dissolved and 96% of the Ag is free Ag+ for 500 μg/L Ag+ in DMM.  
3.2.5 Dissolution of AgNPs 
The dissolution of AgNPs in DMM salts solution and H2O was examined at 30 °C, the 
same temperature used for the toxicity tests. AgNP suspensions (20 mL with 134, 328 
or 730 μg/L) were mixed with the same volume of DMM salts solutions in 100 mL 
glass flasks, resulting in final Ag concentrations of 67, 164 and 365 μg/L, respectively. 
The glass flasks were cleaned in the following way: soaked in disinfectant (Virkon, 
Rely+On, DuPont) for 1 h, rinsed with tap water, washed with detergent, washed with 
Lanceracid (containing 20-50% acetic acid) (Lancer UK Ltd, Cambridge, UK), rinsed 
with distilled water, dried and sterilized at 160 °C for 2 h. To prevent settling of AgNPs, 
the flasks were shaken at the speed of 120 rpm. The change of concentration of 
dissolved Ag was quantified by the method described in Chapter Two. In brief, 0.5 mL 
AgNPs were aggregated by addition of the same volume of 2 mM Ca(NO3)2 (1 mM 
final concentration after mixing) for 10 min and then centrifuged at 20,100 g for 30 min 
at room temperature (Centrifuge 5417 C, Eppendorf). Supernatants (0.5 mL) were 
carefully collected and stored at -20 °C for future analysis. Before the GFAAS 
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measurement, the supernatants were digested by adding the same volume of 2% HNO3 
at 80 °C for at least 12 h.  
Adsorption of Ag+ to the glass flasks under the same conditions was also examined. 
Silver ions solution (20 mL, 62 or 126 μg/L) was mixed with same volume of DMM 
salts solution or DI H2O in 100 mL glass flasks with shaking at 120 rpm at 30 °C. 
Samples (1 mL) were collected from 0 to 96 h and frozen at -20 °C. The Ag content in 
these samples was measured by GFAAS. 
3.2.6 Bacterial strain and culture conditions 
The environmental model bacterium Pseudomonas putida was chosen in this study. The 
green fluorescent protein (GFP) tagged derivative JB279 of P. putida KT2442 was 
generously donated by Prof. Søren Molin (Technical University of Denmark). A stable 
GFP is expressed from the strong LacI repressible promoter PA1/04/03 that is part of the 
mini-Tn5-Km-T1-T0-gfpmut3*-PA1/04/03 randomly inserted into the bacterial 
chromosome [240]. Davis minimal medium (containing SL10 trace elements as 
described in section 3.2.4) supported growth at 30 °C. The low concentrations of borate 
(< 1.5 mM) introduced with the AgNP suspensions have negligible effects on the 
growth of bacteria [241, 242]. 
3.2.7 Measurement of growth rate  
Pseudomonas putida KT2442 was grown in LB overnight. The overnight culture was 
transferred into 50 mL DMM that contained 50 μg/L kanamycin. The culture was 
aerated at a shaking speed of 200 rpm in a water bath shaker at 30 °C. OD was measured 
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at 600 nm for 10 h using a UV-Vis spectrophotometer (Bioware DNA Life 
Spectrophotometer, WPA).  
A flow-cell was used to monitor the growth of individual cells and biofilm formation. 
A glass cover slip was placed on the top of flow-cell chamber and fixed with glue. P. 
putida can attach to the surface of the cover slip. DMM was pumped through the 
chamber to support bacterial growth. A time-lapse fluorescent microscope was used to 
monitor the bacterial growth at room temperature (18-25 °C), as shown in Figure 3.1.In 
the flow-cell AgNPs can be immobilized on the surfaces of cover slip, which might 
release Ag+ into the main channels of flow-cell. As DMM is continuously pumped 
through the channels the dissolved Ag+ in the channels are expected to be washed away 
by the flow, solely exposing the attached AgNPs to bacterial cells and separating 
nanoparticle from ion effects, which will allow to directly observe the nanoparticle-cell 
interactions. Additionally, the formation of biofilm on the surfaces can also be 
monitored by confocal microscopy. The cells attached to the surfaces of cover slip were 
focused by an oil objective (100.0 × 1.40). An area of 75 μm × 75 μm was scanned with 
8.26 μm in depth for z-stacks at the interval of 2 min for 4 h. After three days, formation 
of biofilm was observed. 
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Figure 3.1 Flow-cell system 
Schematic diagram of flow-cell. The medium (DMM) was supplied by pump into the 
flow-cell chamber. A bubble trapper was used to release sir bubbles. The flow rate was 
controlled by the pump. Waste was collected. A cover slip was placed on the top of 
flow-cell chamber. P. putida cells attach to the surface of cover slip and use the substrate 
in the chamber for growth. The division of individual cells and biofilm formation were 
captured at a resolution of 2 min by a confocal laser scanning microscope (Leica SP2 
Upright Confocal). 
3.2.8 Determination of MICs 
The minimum inhibitory concentrations (MICs) of AgNPs and Ag+ were determined 
according to a standard protocol [243]. The protocol was modified to study the 
influence of cell density on MICs by varying the initial cell numbers. Four or five P. 
putida KT2442 colonies on LB plates were picked and inoculated into DMM 
(containing 50 μg/L kanamycin) for overnight growth at 30 °C. The overnight culture 
was transferred into 50 mL fresh DMM (containing 50 μg/L kanamycin) and grown for 
4-6 h to reach the mid-exponential phase. After the density of the culture reached around 
1.5 × 108 CFU/mL, the culture was diluted with fresh DMM to obtain different densities 
(104, 105, 106, 107 and 108 CFU/mL). Within 30 min, 100 μL of the diluted culture was 
mixed with 100 μL different concentrations of AgNP suspensions or Ag+ solution in a 
96-microwell plate. Each treatment was conducted in triplicate. The plates were 
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covered with lids and incubated at 30 °C for 16-24 h. Optical density (OD) was 
monitored to determine the MICs as the lowest concentrations that prevented growth 
(OD remaining < 0.05). 
3.2.9 AgNP and Ag+ kill kinetics 
Kill kinetics were determined by monitoring cell viability over 5 h at different 
concentrations of AgNPs or Ag+. Low initial bacterial cell densities were chosen to 
avoid titration of AgNPs or Ag+ by the biomass. Overnight cultures were diluted  with 
fresh DMM and grown to mid-exponential phase as above, followed by dilution with 
DMM salts (no carbon source) to obtain final densities around 10,000 CFU/mL. These 
diluted cultures (20 mL) were mixed with the same volumes of AgNP suspensions (0-
100 μg/L) or Ag+ solutions (0-50 μg/L) in 100 mL glass flasks. To prevent 
sedimentation of AgNPs, the cultures were shaken at 120 rpm at 30 °C. Plates were 
immediately set up with taking samples and spreading cell cultures on LB plates for 
viable counts at the interval of 0.5 or 1 h. Dissolved Ag contents in the culture treated 
by AgNPs were determined as described in Chapter Two. The Ag contents in the 
supernatant were measured by GFAAS. For Ag+-treated cultures, 1 mL cell culture was 
centrifuged (20100 g, 30 min), and 0.5 mL supernatants were collected and stored at -
20 °C.  
Dose-response curves were measured as above but with higher time resolution in order 
to obtain the killing rates by linear regression of viable count versus time. The order of 
these treatments was randomized. Viable counts were examined by spreading 100 μL 
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culture on LB plates at time 0, 10, 20, 30, 45 and 60 min.  
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3.3 Results  
3.3.1 Synthesis and characterization of uncoated AgNPs 
Because the sorption of BH4- on the surface of AgNP cores is responsible for the 
stabilization of uncoated AgNPs [94, 219, 244], a high NaBH4/AgNO3 ratio was chosen 
to synthesize AgNPs without surface ligands. Stable, uncoated AgNPs with spherical 
shape were obtained (Figure 3.2a). The characteristics of AgNP suspensions are listed 
in Table 3.1. Nearly 90% of Ag+ was reduced to AgNPs. Most of the AgNPs were in the 
size range between 10 and 40 nm (Figure 3.2b). No aggregates were observed in the 
AgNP suspension with clear light yellow colour. The absorbance peak of the AgNP 
suspension was 394 ± 1 nm (Figure 3.2c), which is in agreement with their surface 
plasmon resonance [17, 109]. 
Table 3.1 Characteristics of uncoated AgNP suspensions 
Zeta potential and pH are shown as mean ± SD of three batches of uncoated AgNPs 
produced in the same way. The diameter (mean ± SD) was based on TEM images of 
the AgNPs used for this study, analysed with ImageJ (n = 438) [222]. The diameters 
from DCS and DLS were the peak diameters of size distribution curves in Figure 3.2. 
The concentrations of total Ag and dissolved Ag+ in the AgNP stock for this study (mean 
± SD) were measured by GFAAS. 
pH 
Diameter (nm) 
Zeta potential in 
DI water (mV) 
Ag species (μg/L) 
TEM DCS DLS Total Ag Ag+ 
9.6 ± 0.3 21 ± 11 13 24 -40 ± 17 2,470 ± 184 272 ± 22 
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Figure 3.2 Characteristics of uncoated AgNPs 
(a) Morphology of uncoated AgNPs by TEM. (b) Size distributions of the AgNP stock. 
The histogram of size distribution (n = 438) was obtained from TEM images analysed 
with ImageJ [222]. The size distributions measured by DLS and DCS show intensity 
and relative weight against diameter, respectively. (c) UV-Vis absorption spectrum of 
an uncoated AgNP stock, peak at 394 ± 1 nm (2 d after the synthesis).  
3.3.2 Stability of AgNPs during long-term storage  
Uncapped AgNP suspensions stored under ambient air slowly released Ag+. The 
dissolved Ag concentration increased from 74 to 627 μg/L in 3 months. Under nitrogen 
atmosphere, in comparison, the dissolved Ag content in AgNP suspensions did not 
change significantly (Figure 3.3a), confirmed by the lack of change of the UV-Vis 
absorption spectra (Figure 3.3b). The morphology of AgNPs under N2 changed little 
Chapter Three 
79 
 
over 100 d (Figure 3.4a-c). The dissolution of AgNPs under air should decrease particle 
size, but instead they tended to fuse into larger particles, even nanobars (Figure 3.4d 
and e). They also transformed from a spherical to a triangular shape (Figure 3.4f).  
0 20 40 60 80 100
0
200
400
600
800
1000
 Air
 Nitrogen
Slope = 0.016 
SE = 0.044
p-value = 0.734
D
is
s
o
lv
e
d
 A
g
 c
o
n
c
e
n
tr
a
ti
o
n
 (

g
/L
)
Time (d)
a
Slope = 5.67 
SE = 0.46
p-value = 0.0003
300 400 500 600
0.0
0.5
1.0
1.5
2.0
 2 d
 10 d
 53 d
 75 d
 103 d
 6 d
 14 d
 37 d
 69 d
 93 d
A
b
s
o
rb
a
n
c
e
Wavelength (nm)
Air Nitrogen
b
 
Figure 3.3 Stability of uncoated AgNPs stored in ambient air or under nitrogen 
Silver nanoparticles were stored in ambient air or under nitrogen atmosphere at 4 °C in 
the dark. The two AgNP stocks were synthesized by the same procedure. (a) Dissolved 
Ag concentration in the two AgNP suspensions over time. The total Ag concentration 
of AgNPs under air and AgNPs under N2 was 25 and 2.28 mg/L, respectively. Error 
bars indicate standard deviations of at least two measurements. Linear regression was 
carried out to test whether the slop is significantly different from zero. (b) UV-Vis 
absorption spectra of AgNPs under air or nitrogen.  
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Figure 3.4 TEM images of AgNPs stored under nitrogen or in ambient air over 
time 
(a, b, and c) Under nitrogen; (d, e and f) In ambient air (numbers indicate days). 
3.3.3 Aggregation of AgNPs in a mineral medium 
The hydrodynamic diameter and UV-Vis absorption spectra of AgNPs in DMM, a 
defined mineral medium for microbial growth, were measured over time to examine 
their potential for aggregation during toxicity testing. Uncoated AgNPs underwent 
different degrees of aggregation in DMM (Figure 3.5). Quicker aggregation leading to 
larger AgNP clusters was observed for higher concentrations of AgNPs in DMM salts 
solution (Figure 3.5a). The hydrodynamic sizes of 200 μg/L AgNPs increased strongly 
compared with the slight rise for 50 μg/L AgNPs. The transformations of UV-Vis 
absorption spectra also demonstrated faster and more extensive aggregation of the 
AgNPs at the highest concentration by the quicker decrease of peak absorption, the 
larger red-shift of the LSPR band and the broadening of the UV-Vis absorption spectra 
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(Figure 3.5b, c and d). These changes are in agreement with the changes of 
hydrodynamic size. 
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Figure 3.5 Aggregation kinetics of AgNPs in DMM salts solution 
(a) The hydrodynamic size (Z-average size) of AgNPs (50, 100 and 200 μg/L) in DMM 
salts solution was measured by real-time DLS. (b, c and d) Time-resolved UV-Vis 
absorption spectra of (b) 200, (c) 100 and (d) 50 μg/L AgNPs in DMM salts solution. 
3.3.4 Dissolution of AgNPs in a mineral medium 
Dissolved Ag plays a central role in the toxicity of AgNPs. Silver nanoparticles release 
Ag+ into solution in oxic conditions. The dissolution kinetics of uncoated AgNPs in 
DMM salts solution and H2O were recorded over 7 d (Figure 3.6). Silver nanoparticles 
dissolved faster in H2O than in DMM salts (Figure 3.6a). In H2O, half of the nano Ag 
dissolved in one day, followed by a slow Ag release over the next several days. A first-
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order dissolution kinetics model (p-value = 2.8 × 10-7) revealed that the equilibrium 
dissolved Ag concentration was 232 ± 16 μg/L. It was calculated that 69% and 13% of 
the AgNPs were dissolved for 365 μg/L AgNPs in H2O and DMM salts solution in 7 d, 
respectively. The salts in media might reduce Ag dissolution but cannot prevent Ag+ 
adsorption (Figure 3.6b). The dissolution rates are listed in Table 3.2. The dissolution 
rates of AgNPs in DMM salts solution were nearly 40-fold smaller than that in H2O.  
Table 3.2 Dissolution rates of AgNPs in DMM salts solution and H2O 
Linear regression was carried out based on the data within the range of 24-154 h in 
DMM salts solution and 0-3 h in H2O, respectively. The dissolution rate was defined as 
slop of regression/initial concentration of AgNPs. 
Concentration of total 
Ag in AgNP 
suspension (μg/L) 
Solution 
Dissolution rate (m ± SE) 
(× 10-3 μg Ag/(μg AgNP⋅h)) 
p-value 
67 
DMM 
salts 
1.9 ± 0.4 0.0130 
164 1.7 ± 0.04 2.27 × 10-6 
365 0.85 ± 0.04 2.25 × 10-4 
365 H2O 80 ± 19 0.0238 
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Figure 3.6 Dissolution or adsorption kinetics of AgNPs in H2O or DMM salts 
solution 
Dissolution or adsorption kinetics of AgNPs in H2O or DMM salts solution at 30 °C. 
The volume loss due to evaporation at this temperature was calibrated to be 0.322 mL/d. 
Error bars indicate the standard errors of triplicates. (a) The concentrations of dissolved 
Ag in H2O or DMM salts solution. The AgNP stock (total Ag 2,470 ± 184 μg/L, 
dissolved Ag 272 ± 22 μg/L) was diluted with DI H2O to obtain different concentrations 
of AgNPs (67, 164 and 365 μg/L). (b) Adsorption kinetics of Ag+ to a glass flask in 
H2O (31 μg/L Ag+) or in DMM salts solution (63 μg/L Ag+). The type of glass flasks, 
washing procedures for glass flasks, volume of liquid and temperature were the same 
as for the dissolution kinetics experiment. The silver samples in the DMM solution or 
H2O were taken from 0 to 96 h and stored at -20 °C. Each sample was measured in 
triplicate by GFAAS. 
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3.3.5 Growth rates of P. putida 
Flow cell was used to observe individual cells. Several cells attached to the surfaces of 
the cover slip (Figure 3.7a). Production of GFP by the strain allows a direct observation 
of growth and division of individual cells by microscopy (Figure 3.7a). After the 
division, some daughter cells stayed on the surface (Figure 3.7a) and form large cell 
clusters in 3 d (Figure 3.7b). The average time between cellular divisions was 75 ± 13 
min (m ± SD) based on the pedigree tree (Figure 3.7c). This generation time was 
slightly larger than 55 ± 5 min calculated from the growth curves (Figure 3.7d). The 
reason could be a lower temperature for cells in the flow-cell. 
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Figure 3.7 Growth rate of P. putida KT2442 
(a) Attachment of individual cells on the surface (0 min) and their division in 234 min 
(scar bar = 10 μm). The green colour indicates a production of GFP. (b) Formation of 
cell clusters on the surface in 3 d (scar bar = 10 μm). (c) Pedigree tree of two P. putida 
cells based on the images from time-lapse microscopy. The length of branch represents 
the generation times of cells. The nodes refer to cell division events. A lack of branch 
indicates detachment of daughter cells from the surface. (d) Growth curves of P. putida 
in DMM containing 500 or 1000 mg/L citrate at 30 °C. 
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3.3.6 Effect of cell density on inhibition 
In the standard protocol for determination of MICs, cell cultures are grown into the 
exponential phase to reach a cell density of 5 × 105 CFU/mL [243]. In this study, MICs 
of AgNPs and Ag+ were examined at various initial bacterial densities. Both MICs 
increased by about one order-of-magnitude when the initial cell density increased by 
three orders-of-magnitude, from 104 to 107 CFU/mL (Figure 3.8). P. putida was more 
susceptible to Ag+ than to AgNPs by more than one order-of-magnitude (Figure 3.8). 
For instance, 30 μg/L Ag+ versus 500 μg/L AgNPs were required to completely inhibit 
bacterial replication at the cell density of 6.4 × 105 CFU/mL. The dissolution of AgNPs 
can occur during incubation of the cells, resulting in additional Ag+ release into the 
culture. As it was not feasible to measure dissolved Ag concentrations over time in the 
small assay volumes of 96-well plates during the MICs tests, flasks with larger culture 
volumes were used for determining toxicity kinetics.  
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Figure 3.8 MICs of Ag+ and AgNPs increase with initial cell densities 
Mid-exponential cultures were diluted to obtain different cell densities which were 
treated with different concentrations of Ag+ or AgNPs. The MICs of AgNPs are shown 
as the total Ag concentration of AgNP suspensions.  
3.3.7 Growth rate depends on Ag+ or AgNP concentration 
As with MICs, specific growth rates decreased more strongly with increasing Ag+ and 
AgNP concentration at lower initial cell densities (Figure 3.9). These data show that 
effects are too dependent on initial cell densities to infer inhibition kinetics reliably, so 
further results were obtained with lower initial cell densities to avoid any density effects. 
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Figure 3.9 Effect of Ag+ and AgNPs on specific growth rate 
The effect of increasing concentrations of Ag+ and AgNPs on specific growth rate of P. 
putida in DMM. The total Ag concentration of the AgNP stock was 2.1 ± 0.6 mg/L. The 
dissolved Ag in the AgNP stock was 0.01 ± 0.003 mg/L, measured by ultrafiltration. 
The AgNP stock was diluted or concentrated to obtain the desired concentrations. 
Different initial densities of cells (107, 108 and 109 CFU/mL) were treated with Ag+ or 
AgNPs. The initial cell densities were calculated based on the relationship between OD 
and viable counts (7×108 CFM/(mL⋅OD)). The ODs were recorded for 5 h to calculate 
growth or death rates. A ‘growth’ rate below zero indicates the complete inhibition of 
growth. The error bars indicate standard deviations of duplicates.  
3.3.8 Inhibition kinetics 
Viable cell counts and dissolved Ag concentrations were monitored over time to 
determine the inhibition kinetics for Ag+ or AgNPs. Figure 3.10a and b show that Ag+ 
and AgNPs killed the cells during the first 1-2 h at this low initial cell density of about 
5,000 CFU/mL. Treatment with 30 μg/L of Ag+ killed all cells within one hour but most 
cells survived treatment with 5 and 10 μg/L of Ag+ for 5 h (Figure 3.10a). Several 
hundred cells/mL survived 20 μg/L of Ag+ for 5 h. Interestingly, the populations treated 
with 0, 5, 10, and 20 μg/L Ag+ recovered during prolonged exposure (72 h), but not at 
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30 μg/L of Ag+ (Table 3.3). The concentrations of dissolved Ag in the cell cultures 
declined during the initial 1-2 h.. Under the treatment with 5, 10, and 20 μg/L of Ag+, 
the dissolved Ag concentration decreased to <1.2 μg/L within 2 h (Figure 3.10c) and to 
undetectable levels after 72 h (Table 3.3). In contrast, relatively high concentrations of 
residual Ag+ (6.5-9 μg/L) remained in the culture treated with 30 μg/L of Ag+, which 
killed all cells (Figure 3.10c, Table 3.3). 
Toxicity of AgNPs was lower than that of Ag+. At 10 μg/L growth was similar to the 
control (Figure 3.10b). At higher concentrations, the larger the AgNPs concentration 
was, the quicker viability declined. Around 50 cells/mL survived treatment with 20 μg/L 
AgNPs. All cells were eradicated by 50 and 100 μg/L AgNPs within 5 h. The 
concentrations of dissolved Ag in the cell cultures also decreased while the bacterial 
cells were killed. After 72 h, no regrowth occurred at 50 and 100 μg/L AgNPs but large 
populations were obtained at lower concentrations (Table 3.3). The initial dissolved Ag+ 
concentration in the 50 μg/L AgNP treatment was 18 μg/L. Regrowth would be 
expected in 72 h at this concentration of dissolved Ag based on the Ag+ inhibition 
kinetics (treatment with 20 μg/L Ag+) (Table 3.3). But continuing dissolution of AgNPs 
released new Ag+ into the culture. At low concentrations of AgNPs (10 and 20 μg/L), 
the amounts of Ag+ released from AgNPs were too limited to kill the cells, allowing 
regrowth. At high concentrations of AgNPs (50 and 100 μg/L AgNP), sufficient Ag+ 
was released to ensure complete killing of bacteria in the long term (Table 3.3). 
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Figure 3.10 Toxicity kinetics of Ag+ or AgNPs to P. putida 
(a and b) Viable cell counts for (a) Ag+ treatment (0, 5, 10, 20 and 30 μg/L) or (b) AgNP 
treatment (0, 10, 20, 50 and 100 μg/L). Error bars represent the SDs of viable counts. 
(c and d) Dissolved Ag concentrations in (c) Ag+-treated cultures corresponding to 
panel (a) or (d) in AgNP-treated cultures corresponding to panel (b). The error bars 
indicate SDs of triplicate measurements of each sample by GFAAS.  
Table 3.3 Cell viability and dissolved Ag concentration 
Cell viability and dissolved Ag concentration (mean ± SD) after exposure to Ag+ or 
AgNPs for 72 h 
Ag+  AgNPs 
Treatment 
(μg/L) 
Viable 
count (×106 
CFU/mL) 
Dissolved  
Ag (μg/L) 
 
Treatment 
(μg/L) 
Viable count 
(×106 
CFU/mL) 
Dissolved 
Ag (μg/L) 
0 22.7 ± 1.5 N/A  0 0.82 ± 0.03 N/A 
5 4.9 ± 0.2 0.19 ± 0.01  10 11.5 ± 0.3  0.10 ± 0.10 
10 4.8 ± 0.2 0.10 ± 0.02  20 4.8 ± 0.2  0.05 ± 0.06 
20 8.0 ± 0.9 0.18 ± 0.06  50 0 14.8 ± 0.5 
30 0 8.4 ± 0.3  100 0 17.8 ± 0.2 
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3.3.9 High-resolution inhibition kinetics 
Since most of the change in viability happened very quickly (Figure 3.10), the inhibition 
kinetics with a higher time resolution were further performed (Figure 3.11). The number 
of cells at the start of the experiment varied somewhat, which may explain why fewer 
cells, 3 rather than 680 CFU/mL, survived at 10 than at 15 μg/L of Ag+. Therefore, the 
toxicity in terms of death rate was quantified by linear regression of cell viability 
against time (Figure 3.12a). The death rates gradually increased from about 0 to 86 ± 
17 CFU/(mL⋅min) when Ag+ concentrations increased from 0 to 32 μg/L. A further 
increase to 40 μg/L did not significantly increase toxicity. Silver nanoparticles’ highest 
death rate was somewhat lower, 64 ± 7 CFU/(mL⋅min), at the higher concentration of 
80 μg/L. Assuming that the toxicity of AgNPs is solely due to dissolved Ag, the toxicity 
of AgNPs can be expressed in terms of dissolved Ag. As expected, the AgNP death rates 
in terms of dissolved Ag were closer to the death rates for Ag+ (Figure 3.12a). There 
was no significant difference in the specific death rates for Ag+ and dissolved Ag in 
AgNP suspension (Figure 3.12b, Table 3.4). This suggested that the toxicity of AgNPs 
was mainly due to dissolved Ag.  
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Figure 3.11 High-resolution inhibition kinetics 
High-resolution inhibition kinetics for (a) Ag+ and (b) AgNPs. The initial cell densities 
varied within the range of 1,400-4,500 CFU/mL. Error bars indicate SDs of viable 
counts.  
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Figure 3.12 Dependence of death rates on silver concentrations 
(a) Death rate versus initial concentrations of Ag+, dissolved Ag in AgNP suspension 
or total Ag in AgNP suspension. The death rates were calculated by linear regression of 
cell viability against time shown in Figure 3.11. The error bars are standard errors of 
the regression slopes. (b) Specific death rates, defined as death rate per Ag 
concentration data in panel (a) (intercept = 0), within the range of 0-32 μg/L for Ag+, 
0-80 μg/L for total Ag in AgNPs and 0-27 μg/L for dissolved Ag in AgNPs. The error 
bars are 95% confidence intervals. The p-values of comparing the difference among the 
three specific death rates were carried out with t-test using R (Version 2.9.2). 
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Table 3.4 Specific death rate 
Values of specific death rates, standard errors (SE) and p-values of linear regression 
with analysis of variance (ANOVA) by F-test using OriginLab (OriginPro, v8.0724, 
Northampton, USA) 
Silver species 
Specific death rate 
(CFU/(mL∙min∙g/L)) 
SE p-value 
Ag+ 3.61 0.54 5.2 × 10-4 
Dissolved Ag in 
AgNP suspension 
2.89 0.33 4.7 × 10-5 
Total Ag in AgNP 
suspension 
0.94 0.11 1.2 × 10-4 
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3.4 Discussion 
3.4.1 Formation and stability of uncapped AgNPs 
This study demonstrated that stable, uncoated AgNPs could be obtained when the 
AgNO3 concentration was decreased and the BH4-/Ag+ concentration ratio was 
increased (Figure 3.2). The dissolution of AgNPs could be prevented in an anoxic 
environment. There are two steps involved in the dissolution of AgNPs [245]. The first 
step is the thermodynamically favourable oxidation of AgNPs, forming AgxOy on the 
surface of the nanoparticle. The second step is hydrolysis of the AgxOy layer in H2O, 
resulting in Ag+ release into the surrounding liquid. The high surface energy of AgNPs 
promotes oxidation and dissolution, leading to quicker dissolution of smaller AgNPs 
[79, 119, 123]. Oxidation of AgNPs is prevented in N2, thereby also avoiding 
dissolution (Figure 3.3). Storing AgNP suspensions under nitrogen atmosphere ensures 
stability of AgNPs and should reduce variation between batches. 
3.4.2 Aggregation of AgNPs in mineral growth medium 
Higher AgNP concentrations favour aggregation by increasing the chances of effective 
collision that enables nanoparticles to overcome the energy barrier to form aggregates 
[138, 140]. The relatively small changes of hydrodynamic size and stable UV-Vis 
absorption spectra suggested that low concentrations of AgNPs were relatively stable 
in DMM, a defined, mineral growth medium (Figure 3.5). Sedimentation of AgNPs in 
cultures or assays was not observed and was not likely to take place in this study [238] 
since the aggregates were not large enough to settle rapidly [227]. 
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3.4.3 Dissolution of AgNPs in H2O and mineral growth medium 
Silver nanoparticles spontaneously dissolve in the presence of oxygen in biological 
media. Their aggregation state and surface modification might contribute to the slow 
dissolution of uncoated AgNPs in DMM. Aggregates of nanoparticles have fewer active 
sites on their surface, which reduces oxidation and dissolution [124]. This could explain 
the higher dissolution rate of lower AgNP concentrations as they would have a lower 
degree of aggregation (Table 3.2). However, this aggregation effect is unlikely to be 
sufficient to explain the decrease of dissolution rates by two orders of magnitude since 
the aggregation of low concentrations of AgNPs in DMM was not strong (Figure 3.5). 
Instead, the much reduced AgNP dissolution in DMM suggests that chemicals in the 
medium not only affect aggregation of AgNPs but also govern their surface chemistry, 
which has a fundamental role in dissolution. Complexation and removal of Ag+ from 
AgNP’s surface by chloride can drive Ag release [106], whereas Ag2S formation 
inhibits the dissolution of AgNPs [127]. In this study, an influence of Cl- or S2- is 
unlikely as precipitation equilibrium calculations by MINTEQ predict no precipitation, 
but Cl-, phosphate and sulphate may decrease surface activity. A similar, rapid Zn2+ 
release in H2O but slow dissolution in phosphate solution has been reported for ZnO 
nanoparticles as a result of phosphate reacting with the particle surface [246]. Given 
the high concentrations of phosphate (55 mM) and sulphate (8.4 mM) in DMM, Ag3PO4 
or Ag2SO4 complexes might have formed on the AgNP surface, slowing down Ag+ 
release. 
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Silver sorption to culture vessels cannot be excluded under our experimental conditions. 
The chemical properties of solutes in the medium and the vessel geometry, surface 
chemistry and material all affect Ag sorption [247-250]. The original Ag+ concentration 
and the Ag+ contents in the bulk liquid were measured during the dissolution studies. 
Silver loss might occur by adsorption to the vessel wall and membrane. It is desirable 
to quantify the lost Ag+ with mass balance calculation that includes the AgNPs, free 
Ag+ and attached Ag+. Further experiments will be needed to quantify the attached Ag+, 
which was not feasible in this study. While we could not quantify Ag sorption to the 
vessels or bacterial cells, we could measure the concentration of dissolved Ag+ in the 
media and show that it was mainly responsible for the toxicity of AgNPs. 
3.4.4 Cell density effects  
Silver ions were more toxic in P. putida than AgNPs. The MICs for Ag+ and AgNPs 
were dependent on initial cell densities (Figure 3.8). Such an inoculum effect has been 
previously observed with antibiotics [251] and can be simulated via a direct antibiotic-
biomolecule reaction [252]. Compared to essential cellular metals (e.g., K, Zn, Fe, Mg), 
Ag has a higher affinity to various biomolecules, especially those containing thiol 
groups [253, 254]. It is therefore expected that bacterial components such as 
extracellular polysaccharides, lipoproteins and proteins complex Ag [170, 254, 255]. 
The interactions between Ag and bacteria can be understood as metal-cell complexation, 
through which Ag interrupts molecular structure and function, imposing stress on 
bacterial cells while leading to the chelation of free Ag. The cell density effect was 
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proposed to be due to titration of Ag by the biomass. The higher the bacterial density 
was, the larger the fraction of Ag that will be sequestered by the inhibited or killed cells. 
This lowering of the active concentration of Ag+ apparently reduces Ag+ toxicity.  
3.4.5 Inhibition kinetics of Ag+ and AgNPs  
The kinetics of inhibition or death were complicated by the simultaneous decline of 
dissolved Ag concentration. The decrease of Ag might be attributed to Ag titration by 
bacterial cells and the sorption of Ag to the flask surface. Silver titration can also 
explain the cell density effect. Ag sorption to the flasks leads to a drop of Ag 
concentration only at the start of experiments (Figure 3.6).  
Some bacteria survived long exposures to Ag and the population subsequently regrew 
(Table 3.3), suggesting the presence of persisters in the population [256]. At higher 
initial concentrations of Ag+, there will still be enough Ag+ left to kill any persisters, 
explaining the absence of regrowth at high Ag concentrations. For AgNPs, toxicity 
effects are complicated by the continuous dissolution of AgNPs replenishing dissolved 
Ag (Figure 3.10), which would be an advantage for killing persisters.  
3.4.6 Quantifying the toxicity of Ag+ and AgNPs  
Larger concentrations of Ag+ or AgNPs caused faster cell death (Figure 3.12). Silver 
ions had stronger toxicity towards P. putida than AgNPs (Figures 3.10, 3.12). The 
toxicity of AgNPs with different coatings and sizes in bacteria is believed to be 
exclusively due to the dissolved Ag+ in anoxic environments [201]. To our knowledge, 
there is no evidence that AgNPs can penetrate the bacterial cell wall as intact particles 
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(they could form inside the cell by reduction of Ag+). It is the intracellular dissolved Ag 
that ultimately causes the toxicity of AgNPs [207]. Silver nanoparticles thus only 
function as a Ag reservoir releasing Ag+. On the other hand, larger concentrations of 
ions accumulate on the surface of AgNPs compared to the concentration of 
homogeneous ions in the bulk liquid [225]. Therefore, AgNPs trapped by the cell wall 
could deliver higher concentrations of Ag+ at the cell surface, which could enhance the 
toxic effects of AgNPs. Our results suggest that the concentration of dissolved Ag+ in 
AgNP suspensions is sufficient to explain the bactericidal effects of AgNPs since there 
was no significant difference between the toxicity of  Ag+ and the dissolved Ag+ in the 
AgNP suspensions (Figure 3.12b) from the t-test. 
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3.5 Conclusions 
In this study, the time-resolved transformations of AgNPs in microbial media was 
captured and the bacterial response was quantified, revealing the dynamic interactions 
between AgNPs and cells, which have important implications for application and 
environmental risk assessment of AgNPs. Preventing exposure of AgNPs to oxygen 
reduced the dissolution of AgNPs and their morphological transformations. Uncoated 
AgNPs underwent aggregation in a defined, mineral medium, which slowed down their 
dissolution. Higher concentrations of Ag+ or AgNPs resulted in higher death rates. The 
MICs of Ag+ or AgNPs increased with initial cell densities. Silver ions were more toxic 
than the same concentration of AgNPs in terms of total Ag mass per volume. The 
continuous release of Ag+ from AgNPs replenishes dissolved Ag facilitating longer-
term inhibition. The bactericidal effects of AgNPs could be mostly attributed to the 
concentration of dissolved Ag in AgNP suspensions.  
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4.1 Introduction 
Silver (Ag) is not an essential element for microorganisms. It has been used as an 
antimicrobial agent to preserve food and control infections [28]. The antimicrobial 
properties of Ag result from its high affinity to a variety of biomolecules [253]. Silver 
targets proteins in both Gram-positive and -negative bacteria [155], disrupts cellular 
metabolism such as respiration [30], interacts with ribosomes [31], disturbs iron 
homeostasis and inhibits protein disulfide bond formation [150], induces ROS stress 
[257], damages the membrane [156], and ultimately leads to cell death. During the last 
decades, Ag in the nano form such as AgNPs has received increasing interest for 
antimicrobial applications [9, 51]. Silver nanoparticles are toxic to microorganisms, 
plants and animals, posing potential ecological risks [237, 258, 259]. Silver 
nanoparticles have the same bactericidal effects as Ag+ on different species [214, 260]. 
The dissolved Ag released from AgNPs is considered to be the only factor that causes 
cell death [201]. It is unknown whether AgNPs themselves have a direct role in killing 
bacteria. Different sensibilities of single-gene mutants [205] and different gene 
regulation [206] have been observed when bacteria were treated with Ag+ and AgNPs, 
suggesting that AgNPs and Ag+ might have somewhat different toxicity pathways. 
Considering that Ag binds non-selectively to a broad range of biomolecules, it is 
generally accepted that evolution of Ag resistance in bacteria is uncommon, yet Ag 
resistance has been reported under prolonged Ag-exposure such as Ag-treated burn 
patients [162] and in silver mines [90], where bacteria can tolerate Ag+ at concentrations 
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up to 10 and 50 mM, respectively. This is much higher than the MICs for wild type 
strains (0.06-0.3 mM) [175]. There are several bacterial Ag resistance mechanisms, 
including efflux [179, 261], reducing Ag+ to less toxic metallic Ag [90, 262], and 
deactivating Ag through binding, adsorption or chelation [147, 169, 263]. 
Bacteria steadily evolve gaining advantages over the competition for environmental 
resources [264] or surviving harsh environments [160]. For instance, many bacteria 
have evolved resistance to antibiotics [210]. The mutations reveal the targets and 
mechanisms of antibiotic action [265]. Evolutionary experiments have been used to 
investigate the mechanisms of killing and resistance for antibiotics [266, 267]. The 
trajectories of evolution may diverge in different environments [268] and bacteria may 
adapt in different ways under different environmental stresses [267].  
In this study, we hypothesised that bacteria will evolve differently in the presence of 
Ag+ and AgNPs if they have different antibacterial models. We found some differential 
mutations in cell surface structures suggesting that AgNPs affect cells in ways that are 
independent from the release of Ag+.  
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4.2 Materials and methods 
4.2.1 Preparation of AgNPs  
Uncoated AgNPs were produced according to the method described in section 2.2.1. 
Within 4 d after the synthesis, the AgNP suspension was washed with DI water to 
remove dissolved Ag and reactants (BH4-, B(OH)4-, NO3- and Na+). Briefly, AgNP stock 
was filtered through a membrane with pore size of 3 kDa (Ultracel® 3 KDa 
Ultrafiltration Discs, Millipore, Billerica, USA) under the pressure of nitrogen gas (1 
bar) using an Amicon® stirrer cell (400 mL, Millipore, Billerica, USA). Fresh DI water 
was added when the volume of the AgNP suspension had decreased to 1/3-1/2 of the 
original volume. After 10 such cycles, the dissolved chemicals in AgNP suspension 
should have been diluted at least 1,000 fold (210). The trace amounts of B(OH)4- (<1.5 
μM), Na+ (<1.5 μM) and NO3- (<0.06 μM) left were assumed not to interfere with 
bacterial evolution. Some Ag+ unavoidably remained in the suspension due to the 
ongoing dissolution of AgNPs. The washed AgNP suspension was sterilized by 
filtration through a membrane with a pore size of 0.2 μm. To prevent oxidation, the 
AgNP containing bottle was flushed with copious amounts of nitrogen gas (passed 
through a 0.2 μm pore size filter). The concentration of total and dissolved Ag in the 
AgNP stock was 3,228 ± 469 and 537 ± 13 μg/L after the washing, respectively.  
4.2.2 Characterization of AgNPs 
The size distribution of washed AgNPs was measured by DLS (Zetasizer Nano, 
Malvern Instruments, Malvern, UK) and DCS (DC24000, CPS Instruments Europe, 
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Oosterhout, Netherlands). Localized surface plasmon resonance of uncoated AgNPs in 
suspension was measured by UV-Vis absorption spectrometry (UV-Vis 6800, Jenway, 
Staffordshire, UK). Zeta potential was measured by Malvern Zetasizer Nano. The 
morphology of AgNPs was examined by TEM (JEOL 1200EX, Tokyo, Japan). The 
sample preparation of TEM is described in section 2.2.2.  
To examine the stability of AgNPs during storage, the concentration of dissolved Ag in 
the AgNP stock suspension was monitored during the evolution experiment based on a 
combined aggregation-centrifugation method described in Chapter 2. The aggregation 
kinetics of washed AgNPs in different concentrations of Ca(NO3)2 were examined. The 
procedures were described in section 2.2.3. Since a Ca(NO3)2 concentration of 20 mM 
was needed to quickly aggregate washed AgNPs, The AgNP suspension (0.5 mL) was 
mixed with 20 mM Ca(NO3)2 (0.5 mL) for aggregation (final Ca2+ concentration, 10 
mM). After 10 min, the mixture was centrifuged at 20,100 g for 30 min to separate 
AgNPs from Ag+ (Centrifuge 5804R, Eppendorf, Engelsdorf, Germany). Supernatant 
(0.5 mL) was carefully taken and stored at -20 °C. The method for sample preparation 
and measurement of concentrations of dissolved Ag was described in section 2.2.2 and 
2.2.4.  
To examine the aggregation state of AgNPs in the microbial media, the AgNP stock (0.5 
mL) was mixed with DMM (0.5 mL) in a cuvette using the pipette and the changes of 
hydrodynamic diameter were immediately recorded for 2 h by the Malvern Zetasizer 
Nano.  
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4.2.3 Bacterial strains and media  
The strain for the evolution experiment was a wild type Pseudomonas putida KT2440 
that was kindly donated by Víctor de Lorenzo (Centro Nacional de Biotecnología, 
CNB-CSIC, Madrid, Spain). A Pseudomonas putida KT2440 tagged with GFP was 
used as the reference ancestor in competition assays between evolved bacterial 
population and the reference and also kindly donated by Víctor de Lorenzo. Davis 
minimal medium (include SL10 trace elements as described in section 3.2.4) 
supplemented with citrate instead of glucose as the sole carbon and energy source was 
used to grow cells. 
4.2.4 Evolution experiment 
The evolution experiment was divided into two stages: pre-evolution and main 
evolution (Figure 4.1). The P. putida KT2440 strain will have experienced various 
environments and selective pressures before the evolution experiment. Therefore, a pre-
evolution was carried out to ensure this strain effective adaption to the conditions of the 
evolution experiment in the absence of silver stress.  
Chapter Four 
106 
 
 
Figure 4.1 Schematic diagram of evolution experiment 
Ten individual Pseudomonas putida colonies were picked from LB plates and grew in 
DMM into stationary phase, designated as ancestral population. The evolution 
experiment was divided into two stages: pre-evolution and main evolution. In pre-
evolution experiment, five parallel populations that were seeded from the ancestral 
population evolved independently for 70 d in DMM. In the main evolution experiment, 
the fittest population amongst the five pre-evolved populations was divided into 15 
populations and evolved 75 d in the presence of Ag+ (5 μg/L), AgNPs (20 μg/L) or in 
Ag-free condition. Five replicates were carried out for each condition. 
Ten individual P. putida colonies on LB plates were picked and grown in 20 mL DMM 
overnight. This culture was designated as the ancestral population. Ancestor culture (0.1 
mL) was transferred into 9.9 mL fresh DMM and grown in a 100 mL glass flask at 
30 °C. Cultures were aerated by shaking at 150 rpm in a water bath shaker. Every 24 h, 
0.1 mL of the evolving cultures in stationary phase were transferred into 9.9 mL fresh 
DMM. This 100-fold dilution resulted in an initial cell density of ~107 CFU/mL and 
6.64 (log2100) generations each day. Five parallel populations inoculated from the same 
ancestor culture were transferred independently for 70 d (465 generations). To store the 
bacterial populations, whole evolved cultures were collected by centrifugation (4000 g, 
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8 min) and resuspended in 15% glycerol, split into several microtubes and frozen at -
80 °C. Evolved populations were frozen every 3 d at the early stage (1-27 d) and every 
7 d later.  
Before the main evolution experiment, MICs for Ag+ and AgNPs were measured 
according to the standard protocol [243]. Overnight cultures (ancestral cells) were 
grown into mid-exponential phase and diluted to a cell density of ~106 CFU/mL. This 
diluted culture was then treated with Ag+ or AgNPs in a concentration series in a 96-
well plate (Corning Incorporated, New York, USA), where 100 μL inoculum was mixed 
with 100 μL Ag+ solution or AgNP suspension synthesized according to Sally et al. [94] 
(total Ag 5,200 μg/L, dissolved Ag 124 μg/L). The plate, covered with a lid, was 
incubated at 30 °C for 16-24 h. OD at 600 nm was measured to determine the MIC as 
the lowest concentration of Ag+ or AgNPs that completely inhibited bacterial growth 
(OD < 0.05).  
The population with the highest fitness amongst the five parallel cultures after 465 
generations of the pre-evolution experiment was chosen as the founding population for 
the main evolution experiment. This pre-evolved population was revived in DMM 
overnight and 100 µL culture was transferred into 9.9 mL fresh DMM that contained 5 
μg/L Ag+ (AgNO3) or 20 μg/L AgNPs (nanoparticulate Ag 16.7 ± 3 μg/L, dissolved 
Ag3.3 ± 0.1 μg/L) to start the main evolution. They were designated as the Ag+-
population and AgNP-population, respectively. Another five parallel cultures evolved 
in DMM devoid of Ag+ and AgNPs, designated as the control. The 15 populations were 
propagated independently for 75 d (500 generations) in the same way as in the pre-
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evolution experiment apart from the Ag or AgNP additions to the medium.  
To ensure the consistency of the Ag+ or AgNP stress during the main evolution 
experiment, the same AgNO3 and AgNP stocks were used throughout and the AgNP 
stock was kept under N2 to prevent dissolution.  
4.2.5 Fitness assay 
In this study, fitness differences between evolved and ancestral populations, or relative 
fitness, was assessed by competition in the same medium [269]. The evolved population 
was competed against a GFP tagged P. putida KT2440 reference strain. Viable cells 
were counted before and after the 24 h competition experiment. The constitutive 
expression of the chromosomally inserted GFP gene enabled us to distinguish evolved 
and reference strains on the same LB agar plates. The competitions were prepared by 
reviving frozen stock cultures of the two populations in DMM overnight. These were 
then mixed together in approximately equal numbers. The relative fitness F is defined 
as  
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where Ne0 and Ne24 are the initial and final (24 h) cell densities for the evolved 
population, respectively, and Nr0 and Nr24 are the initial and final (24 h) cell densities 
for the reference population, respectively. The GFP tagged reference strain had the same 
fitness (1.01 ± 0.03, mean ± SD, n = 9) as the ancestral cells when they were competed 
in DMM. 
The reproducibility of the fitness assay was examined by competing one evolved 
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population (culture 1 from the control conditions of the main evolution experiment, 
generation 500) against the reference strain in six replicates as described above. After 
6 h of growth, when the two populations were expected to be at the end of the 
exponential phase, 1 mL of the competitor mix was collected, pelleted (centrifuged at 
5,100 g for 10 min), resuspended in DMM without carbon source, and stored at 4 °C. 
Viable cell counting was carried out by spreading on LB plates the next day. The initial 
population was counted in triplicate to estimate the variance due to viable counting. 
Additionally, the whole procedure was repeated one week later.  
To assess the fitnesses of cultures from the main evolution experiment, the competitions 
were carried out as described above but in DMM containing either no silver, 5 μg/L Ag+ 
or 20 μg/L AgNPs. Due to the large number of combinations of three evolved 
populations (control, Ag+-population and AgNP-population assayed under three types 
of stress (Ag+, AgNPs and Ag-free) it was necessary to pool all five parallel cultures for 
competition with the reference strain. After reviving the 15 frozen cultures in DMM 
overnight, the five populations from the same treatment were pooled and mixed before 
competing against the reference culture as described above. 
4.2.6 Whole genome sequencing 
Reviving the frozen populations was performed by streaking the stock cultures on LB 
plates. Bacteria from these plates were harvested with a sterile loop and transferred into 
Microbank tubes (MicrobankTM, Pro-Lab Diagnostics, Canada) that contain beads for 
binding the bacterial cells. For DNA extraction, three beads from each tube were 
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washed with extraction buffer containing lysozyme and RNase A and incubated for 25 
min at 37 °C. Then, proteinase K and RNaseA were added and the mixture incubated 
for another 5 min at 65 °C. Genomic DNA was purified using SPRI beads and 
resuspended in an elution buffer.  
DNA library preparation, whole-genome sequencing and aligning the reads to the 
KT2440 reference genome were performed by the microbesNG service at the 
University of Birmingham. DNA samples were quantified with the Quantit dsDNA HS 
assay in triplicate with a plate reader (Eppendorf AF2200). Genomic DNA libraries 
were prepared for Illumina sequencing using Nextera XT Library Prep Kit (Illumina, 
San Diego, USA) according to the manufacturer’s protocol with the following 
modifications: two nanograms of DNA instead of one were used as input, and PCR 
elongation time was increased to 1 min from 30 seconds. DNA quantification and 
library preparation were carried out on a Hamilton Microlab STAR automated liquid 
handling system. Pooled libraries were quantified using the Kapa Biosystems Library 
Quantification Kit on a Roche light cycler 96 qPCR machine. Libraries were sequenced 
by Illumina MiSeq using a 250 bp paired end protocol. 
4.2.7 Variant calling  
The raw reads were trimmed with the tool Trimmomatic to remove adapters and bases 
with quality scores <15. The reads were aligned to the Pseudomonas putida KT2440 
(NC_002947.4, GenBank) reference genome using Burrows-Wheeler Aligner (BWA) 
and SAMtools. Variant calling (defined as identifying the existence of single nucleotide 
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variants by comparing the nucleotide at a given position in an individual genome or 
transcriptome with the reference in the next generation sequencing) was performed by 
VarScan with the following settings: Phred score ≥ 15, depth of variant-supporting 
bases ≥ 3, variant allele frequency ≥ 0.1, p-value for calling variants ≤ 0.05. A manual 
filtration was performed as 0.1 ≤ frequency of variants-supporting bases on one strand 
≤ 0.9. SNPs in a homopolymer tract of length ≥ 8 bp were then manually excluded.  
4.2.8 Association of mutations with selective pressures 
Any association between mutations (wild type vs mutant) and selective pressures (Ag, 
AgNP or control) was tested with a modified version of Fisher’s exact test that accounts 
for the discrete nature of the results by calculating mid-p-values [270]. Such mid-p-
values for the two-tailed test were calculated with the oddsratio.fisher function in R 
(part of the epitools package) (Table 4.1). 
Table 4.1 Mid-p-values calculated with a modified Fisher’s exact test for 
association between mutation and condition  
Mid-p-values for all possible combinations of mutant frequencies in the parallel 
cultures evolved under different conditions calculated with a modified Fisher’s exact 
test[270] for association between mutation and condition. WT indicates the number of 
cultures evolved in parallel without mutation (from 0 to 5). Likewise, mutant indicates 
the number of cultures evolved in parallel with the mutation (from 0 to 5). 
WT, Mutant 
Condition 2 
0, 5 1, 4 2, 3 3, 2 4, 1 5, 0 
Condition 1 
5, 0 0.0040 0.0238 0.0833 0.2222 0.5 1 
4, 1 0.0238 0.1071 0.2857 0.5833 1 0.5 
3, 2 0.0833 0.2857 0.6032 1 0.5833 0.2222 
2, 3 0.2222 0.5833 1 0.6032 0.2857 0.0833 
1, 4 0.5 1 0.5833 0.2857 0.1071 0.0238 
0, 5 1 0.5 0.2222 0.0833 0.0238 0.0040 
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4.3 Results  
4.3.1 Synthesis and stability of AgNPs 
The uncoated AgNPs that were synthesized were spherical and monodispersed (Figure 
4.2a). The average diameter was 12.4 ± 4 nm and more than 95% were between 5 and 
25 nm based on the TEM image (Figure 4.2b). A similar size distribution measured by 
DCS confirmed the successful synthesis of uncoated AgNPs. Absence of detection of 
large particles by DLS indicated that the AgNPs had not aggregated. The AgNPs had a 
zeta potential of -23.0 ± 3.9 mV at a pH of 7.7 ± 0.6 in H2O. The pH of the AgNP stock 
suspension was 7.2 ± 0.4. 
The stability of the AgNPs during storage was also examined. The concentration of 
dissolved Ag in the AgNP stock stored under N2 was approximately constant over 76 d 
(Figure 4.2c). Slight loss observed could be due to adsorption of Ag to the glass surface 
[249, 250]. The stability of AgNPs was also confirmed by UV-Vis absorption spectra, 
which did not change over 44 d (Figure 4.2d). No obvious aggregation was observed 
for the AgNP stock suspension (3,228 ± 469 μg/L) in the DMM growth medium over 2 
h (Figure 4.2e). At the lower concentration of AgNPs (161-fold dilution) that was used 
for the main evolution experiment, aggregation would be less likely since dilution of 
AgNPs substantially reduces aggregation. A concentration of 20 mM Ca(NO3)2 was 
high enough to aggregate the washed AgNPs (Figure 4.2f). This concentration of 
Ca(NO3)2 was added into same volume of AgNP suspensions to trigger the aggregation 
of AgNPs for the measurements of dissolved Ag concentrations. 
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Figure 4.2 Properties of AgNPs for evolution experiment 
Properties of AgNPs and their stability in H2O or microbial minimal media. (a) 
Morphology obtained by TEM. (b) Diameter distribution based on TEM images 
analyzed by ImageJ [222] and measured by DLS and DCS. (c) The concentration of 
dissolved Ag in the AgNP stock over time during the main evolution experiment. (d) 
UV-Vis absorption spectra. (e) The change of hydrodynamic diameter of the AgNP 
stock suspension in DMM measured by DLS. (f) Aggregation rates of the washed 
AgNPs that were used for evolution experiment in different concentrations of Ca(NO3)2. 
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4.3.2 Fitness of evolved populations 
Fitness of evolved populations is expected to become more competitive in the 
environment in which they evolve. The relative fitness was measured by competing 
evolved populations against a reference P. putida KT2440 strain tagged with GFP to 
distinguish it from the evolved cells (Figure 4.3). Because large variations of fitness 
values seemed to be characteristic of the competition assays, the reproducibility of the 
assay was examined (Figure 4.4a). The fitness values of 18 replicates were 1.38-1.64 
and the coefficient of variation (standard deviation/mean) was 4.6%. The experiment 
with 18 replicates was repeated another week with very similar results (there was no 
significant difference in the mean and variance of fitness values for the two batches of 
experiments: p-value = 0.636 for mean, paired t-test; p-value = 0.798 for variance, F-
test) (Figure 4.4a). This shows that the method is accurate (no systematic bias) but not 
precise (high variance) so fitness values have to be treated with caution.  
The fitness of the GFP free KT2440 ancestor was 1.01 ± 0.03 relative to the GFP 
reference strain in DMM (Figure 4.4b), indicating that the GFP tag did not affect fitness. 
After propagating the five parallel cultures for 70 d (~465 generations), their fitness 
ranged from 1.16 ± 0.02 to 1.04 ± 0.02 and the mean fitness had increased to 1.10 ± 
0.05 (Figure 4.4b). The fitness was significantly improved during the pre-evolution 
experiment. 
Chapter Four 
115 
 
 
Figure 4.3 Evolved and reference cells on the same LB plate 
The larger, white colonies represent evolved cells. Green colonies represent the GFP 
tagged reference cells. (a) Under natural light. (b) Illuminated by UV light. 
The population with the largest fitness improvement in the pre-evolution experiment 
was chosen as the founding population for the main evolution experiment. The MICs 
for Ag+ and AgNPs for the ancestor were 50 and 200 μg/L, respectively. Therefore, we 
chose 10% of these values, 5 μg/L Ag+ or 20 μg/L AgNPs, to select for resistance to 
silver stress in the main evolution experiment as these low concentrations enabled the 
bacteria to grow and evolve.  
Dissolution of the AgNPs was reduced by storage under a nitrogen atmosphere and the 
concentration of dissolved Ag+ in the AgNP stock changed only slightly during the main 
evolution experiment. The concentration of dissolved Ag+ added to the cultures with 
the 20 μg/L AgNP dosage was 2.2-3.6 μg/L. Moreover, silver nanoparticles will release 
Ag+ upon addition to the bacterial culture at a rate of up to 0.03 μg Ag+/(L∙h), calculated 
from the maximal dissolution rate of AgNPs in DMM of 1.9 ± 0.4 × 10-3 μg Ag+/(μg 
AgNP∙h), corresponding to 0.72 μg Ag+/L released in 24 h (see section 3.3.4). This 
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means that the AgNP stress was a combined Ag+ and AgNP stress. 
To measure the fitness of the populations in the main evolution experiment that evolved 
under Ag+ or AgNP stress or in the silver-free control medium, competitions were set 
up under the same three conditions, giving 9 combinations. The five parallel 
populations were pooled to determine their fitness at the start and end of the main 
evolution experiment (generation 1 and 500) (Figure 4.4c). Considering the large 
variance of fitness values (Figure 4.4a, c), one has to interpret these results cautiously 
even when the error bars happen to be small. One would expect that the cultures that 
were evolving without silver stress in the main evolution experiment, therefore 
continuing to evolve under the same conditions as in the pre-evolution experiment, 
would only slightly increase further in fitness. Also, one would expect these control 
cultures to be fitter without silver stress than in the presence of Ag+ or AgNPs. The 
results are consistent with these expectations. Further, one would expect that the 
cultures that were evolving under AgNP stress would have a higher fitness competing 
under AgNP stress than under Ag+ stress or without stress. The results suggest that the 
AgNP evolved cultures have a higher fitness under AgNP stress than Ag+ stress, but 
they appear to have also gained higher fitness without stress, compared to the cultures 
that evolved without stress. Likewise, one would expect that the cultures that were 
evolving under Ag+ stress would have a higher fitness competing under Ag+ stress than 
under AgNP stress or without stress. The results suggest that this is not the case as they 
seem to have a higher fitness under AgNP stress than under Ag+ stress, and a higher 
fitness without silver stress than the cultures that had evolved without silver stress. It 
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seems that fitness values under Ag+ stress were consistently lower than under AgNP 
stress or without stress, regardless of which conditions the cultures had evolved in 
(Figure 4.4c). 
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Figure 4.4 Reproducibility of the fitness assay and relative fitnesses of the 
evolved populations 
(a) Reproducibility of the fitness assay for a population of the control in main evolution 
(culture 1, generation 500). Two batches of fitness tests with 18 replicates each were 
carried out in separate weeks. Data points are individual replicates. Boxes represent 
SDs, bars medians, open circles means, whiskers 5-95 percentiles. The p-value of 
comparing the mean fitness of ancestral and pre-evolved population was calculated with 
t-test. (b) Fitnesses of the ancestral and pre-evolved populations. The data points for 
the ancestral culture are replicate assays of the same ancestral population competing 
against the GFP tagged reference strain, showing that the GFP tag had no significant 
effect (mean fitness ± SD, 1.01 ± 0.03) and also indicating reproducibility of the assay. 
The data points for the pre-evolved cultures are fitness values for the five parallel 
populations after 465 generations of pre-evolution. Boxes refer to SDs, bars to medians, 
open circles to means, and whiskers to 5-95 percentiles.The p-value of comparing the 
mean fitness of batch 1 and 2 was calculated with t-test. (c) Fitnesses of three 
populations evolved in the presence of Ag+, AgNPs or silver-free control medium and 
competing in the presence of Ag+, AgNP or silver-free control medium. Error bars for 
generation 1 represent the SDs of three replicate measurements. Error bars for 
generation 500 represent SDs derived from the viable counts assuming that cells were 
randomly sampled and counts therefore Poisson distributed (Clegg et al. unpublished).  
4.3.3 Mutations during the pre-evolution experiment 
Contamination of sequenced cultures was not detected because the GC content 
distribution of the contigs was the same and because more than 99.9% of the reads 
mapped to the Pseudomonadaceae family. To identify the mutations in the pre-evolved 
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population, the quality filtered reads from the ancestral and pre-evolved populations 
were aligned with the Pseudomonas putida KT2440 reference genome that has been 
well characterized [271, 272] (Appendix 1). Twenty-four single nucleotide 
polymorphisms (SNPs) were identified in the pre-evolved population after 465 
generations, 7 SNPs were located in intergenic regions, 13 SNPs were located in a 
putative surface adhesion protein gene (PP_0168), and 4 other SNPs were located in 
other coding regions (CDS) (gacS, felQ, flgK and PP_4920). 
4.3.4 Mutations during the main evolution experiment 
All 15 populations of the main evolution experiment were sequenced after 500 
generations. The mutations are listed in Appendix 2. There were 198, 194 and 218 
mutations in the population that evolved without stress, with Ag+ and AgNPs stress, 
respectively. Most of these mutations did not occur in all parallel cultures that had 
evolved under the same conditions. Half of the mutations were only found in one 
population. Populations from the three selective conditions had similar distributions of 
the number of parallel mutations (Figure 4.5a).  
The total number of mutations in the evolved lineages varied in the range from 52 to 
124 (Figure 4.5b), with on average 91 mutations in the Ag+-populations, 90 in the 
controls and 104 in the AgNP populations. Multiple mutations in gene PP_0168 and 
PP_5662 were found in all populations, which encode a putative surface adhesion 
protein and an apparent pseudogene, respectively, which accounted for 81-93% of the 
mutations in CDS. Figure 4.5c shows the total number of nonsynonymous mutations. 
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More mutations were located in coding regions for the populations treated with Ag+ or 
AgNPs than for the controls, most of which caused amino acid substitutions. On 
average, 12.6 ± 4.1, 12.2 ± 2.2 and 10.2 ± 2.4 nonsynonymous mutations were identified 
for the populations treated with Ag+, AgNPs, and the control, accounting for 14.2 ± 
4.0%, 11.7 ± 1.7% and 11.3 ± 1.1% of the total mutations, respectively. There was no 
significant difference in the total number of mutations or the number of mutations in 
CDS among the control, Ag+-population and AgNP-population.  
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Figure 4.5 Number of mutations in populations in main evolution experiment 
Number of mutations in populations that had evolved for 500 generations under Ag+ or 
AgNP stress or without stress (control). Open circles are means. Boxes refer to SD. 
Bars in the boxes are medians. Whiskers are 5-95 percentiles. The p-values were 
calculated by comparing the means with t-test. (a) The frequency of mutations that 
occurred 1, 2, 3, 4 or 5 times in the five parallel cultures. (b) Total number of mutations 
in the 15 populations. (c) Number of nonsynonymous mutations in coding sequences in 
the 15 populations.  
4.3.5 Mutations that differ between exposure to Ag+ or AgNPs 
All mutations were listed and compared to determine whether they were associated with 
different Ag stresses (Appendix 2). As shown in Figure 4.6a, the three evolved 
populations shared approximately half of the mutations at the same positions, some of 
which were nonsynonymous (Figure 4.6b). Many single mutations were found in 
various chromosomal locations in the three populations (Appendix 3). Despite most 
mutations occurred in only one of the 15 populations (Figure 4.6a, b), some mutations 
appeared repeatedly in parallel populations. A modified Fisher’s exact test was used to 
determine how many times a mutation has to have occurred in one treatment versus 
another treatment to show a statistically significant association between mutation and 
treatment (Table 4.1). Nine such mutations were identified as statistically significant 
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with p-values ≤ 0.05, including two mutations in intergenic regions, one mutation in a 
16S ribosomal RNA gene, and six mutations (genes ftsZ, gacS, uvrY and PP_2758) in 
protein coding sequences (Figure 4.6c). Other genes may well be associated with 
treatment but with only five parallel cultures these will remain uncertain. 
In addition to the mutations with statistically significant associations to treatments, 
double and triple mutations in the same genes were found in several genes in the 
populations treated with Ag+ or AgNPs but mostly absent in the control populations 
(Figure 4.6c). CopA is a P-type ATPase Cu-transporter associated with Cu/Ag 
resistance [261, 273]. The multi-point mutation of copA in Ag+- and AgNP-populations 
might be linked with positive adaptation. A triple mutation in thiL was only observed 
in one Ag+-population. The different double mutations in envZ, tauB-II and PP_2397 
in Ag+- and AgNP-populations further suggest that AgNPs and Ag+ had different 
mechanisms of toxicity selecting for different mutations.  
Chapter Four 
123 
 
 
Figure 4.6 Mutations in the populations of the main evolution experiment 
Venn diagram of counts of all mutations (a) and nonsynonymous mutations (b). The 
numbers in the green, blue and red circles refer to the counts of mutations in the AgNP 
populations, Ag+ populations and control, respectively. (c) List of non-synonymous 
mutations with mid-p-values ≤ 0.05 in Fisher’s exact test (genes with the names in bold) 
and the genes with mutations in multiple positions. Five parallel populations had each 
evolved under three different conditions indicated by colors. The solid squares indicate 
mutation, and the open squares indicate no mutation. For amino acid changes, “*” refers 
to a stop codon.  
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4.4 Discussion 
4.4.1 Silver nanoparticles for the evolution experiment 
The AgNP suspension should change as little as possible to maintain similar selective 
conditions throughout the whole evolution experiment. The fraction of Ag+ in AgNP 
suspensions should remain constant since they have different antibacterial activities 
[201, 205, 206]. Therefore, the AgNP stock suspension was stored under N2 to prevent 
dissolution due to oxidation. As a result, the concentrations of Ag+ and AgNPs remained 
almost constant. Uncoated AgNPs were used to avoid any effects that surface coatings 
such as PVP might have effect on the attachment of nanoparticles to bacterial cell walls 
[203]. Moreover, the dissolved chemicals left after synthesis were removed to avoid 
any confounding effects on the evolution of the bacteria. Overall, selective conditions 
in the AgNP treatment hardly changed during the extended exposures.  
4.4.2 Pre-evolution experiment 
To our knowledge, our study is the first to have carried out a pre-evolution experiment 
to adapt the ancestor to the selection regime without the specific stress of interest in 
order to disentangle selection for confounding conditions from selection for conditions 
of interest. We note that this attempt was not entirely successful. While the ancestor 
gained fitness by accumulating mutations in the pre-evolution experiment, the 
populations that continued to evolve under the same Ag stress free conditions did not 
appear to further increase fitness but did acquire further mutations.  
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4.4.3 Fitness improvements 
Fitness is a phenotypic property reflecting genetic changes, which is dependent on the 
environment and can be used as an overall indicator to quantify bacterial evolution 
[274]. Positive adaption leads to an increase of population fitness. Lenski et al. showed 
that the increase of mean fitness over time in the long term evolution experiment of 
Escherichia coli in a constant environment fits a power law [275, 276]. Based on this 
power law model (Relative fitness = (0.00515 × generations + 1)0.0950), the mean fitness 
of P. putida populations after 465 generations of the pre-evolution experiment was 
predicted to be 1.12, close to the measured value of 1.10 ± 0.05. The relative SD of 
fitness of 4.5% among the five parallel populations was similar to the variance reported 
by Wiser and Lenski [277]. The rate of accumulation of beneficial mutations is faster 
at the beginning and then slows down increasingly [278]. Although fitness gains were 
not expected to cease, they might acquire sufficient adjustment to DMM within 465 
generations. 
We chose a low dosage of Ag+ and AgNPs to make sure that the bacteria were able to 
grow and evolve. Such a low stress tends to enable bacteria to explore diverse mutation 
paths [279] rather than shorter paths leading to larger fitness gains, if they exist, under 
strong selection [280]. The unavoidable coexistence of Ag+ and AgNPs in the AgNP 
treatment complicates the comparison of Ag+ and AgNP treatments. Since the AgNP 
populations had the opportunity to adapt to both Ag+ and AgNPs, one would expect 
these populations to have gained a higher fitness under Ag+ stress than the control 
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populations, and higher fitness under AgNP stress than the Ag+ and control populations. 
However, if the toxic effects of AgNPs result entirely from ionic Ag, the Ag+ evolved 
population should have a similar fitness upon AgNP stress. The results were not quite 
as expected. The AgNP evolved populations had a higher fitness under AgNP stress 
than Ag+ stress, suggesting that the AgNP effects are not entirely due to the release of 
Ag+ but also due to some direct effects of AgNPs. On the other hand, the Ag+ evolved 
populations had a higher fitness under AgNP stress than Ag+ stress. Overall, the fitness 
results alone have not answered the question whether AgNPs have direct effects on cells. 
4.4.4 Differential mutation profiles 
While the fitness changes remained inconclusive, the differences in the mutation 
profiles of Ag+ and AgNP evolved populations identified by whole-genome sequencing 
might be able to answer the question of whether bacteria have different mutational 
strategies in response to ionic or nanoparticulate Ag stress. Typically, bacteria have a 
spontaneous mutation rate of 10-9-10-10 per base pair per replication [279]. Given an 
initial population density of 107 CFU/mL and a genome size of ~6 Mb for P. putida 
KT2440, the evolving population would have explored 0.3-3 × 107 new mutations after 
465 generations of pre-evolution. Since only 24 mutations were detected in the 
population, 87.5% of which are likely to be more or less neutral as they did not alter 
the amino acid sequence, the overwhelming number of mutations appears to have been 
selected against. The long-term evolution study of Lenski et al. found an average 
mutation accumulation rate of 2-3 mutations/1000 generations at the early stage of E. 
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coli evolution in a batch environment [278]. The observed 2 nonsynonymous SNPs in 
our pre-evolution experiment were close to this mutation rate.  
In the main evolution experiment, many identical mutations were found in parallel 
populations, despite the randomness of mutations and diversified evolutionary paths. 
Furthermore, multiple mutations in different positions of the same genes were identified, 
which is also much higher than expected from random mutations. This suggests strong 
selection of the identified mutations. 
4.4.5 Differential mutations in response to AgNP versus Ag+ stress 
The populations that evolved under Ag+ or AgNP treatment shared many similar 
mutations with the control populations, but some mutations appeared to be specific to 
the selective conditions. If at least four of the five parallel cultures acquired the same 
unique mutation (not present in cultures evolved in the other conditions), the association 
between mutation and treatment is statistically significant (Table 4.1). It is likely that 
more mutations would have shown significant associations if the sample size would 
have been higher than five. The treatment with Ag+ had a similar mutation profile to 
the control with only one gene significantly associated with Ag+ treatment (PP_16SE, 
Figure 4.6). By contrast, mutations in five genes were significantly associated with 
AgNP treatment (ftsZ, gacS, uvrY, PP_2758 and PP_16SE, Figure 4.6). This suggests 
that AgNPs affected the cells differently from Ag+ in a way that different mutations 
were positively selected in response.  
Multiple mutations in the same gene in the Ag+ populations that were absent in the 
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control populations demonstrated that Ag+ did select for specific genetic changes (copA, 
thiL, tauB-II and PP_2397, Figure 4.6). The AgNP selected populations were expected 
to have all the same mutations that appeared in the Ag+ selected populations since the 
AgNP suspension contained Ag+, but the genes with multiple mutations in Ag+ and 
AgNP selected populations were different, i.e. the mutations in PP_2758 and envZ were 
only observed in the AgNP-populations and the mutations in thiL, tauB-II and PP_2397 
were only found in the Ag+-populations (Figure 4.6), further suggesting that AgNPs 
exerted different selective pressures.  
4.4.6 Functions of mutated genes  
Previous studies have demonstrated that the CusCFBA efflux system [166], the 
plasmid-related SilCFBA system [179], the outer membrane protein (porin) [168] and 
periplasmic proteins (SilE and engineered Ag-binding protein) [169, 263] participate in 
bacterial detoxification of Ag+. A mutation in cus was not detected in any evolved 
populations. Instead, copA, which has a role in Ag efflux [261], was mutated in multiple 
positions in Ag+ and AgNP stressed populations, providing direct evidence of 
adaptation. The other mutations found in the evolved populations have not been 
previously reported to be linked with Ag resistance, suggesting that novel mechanisms 
are involved in the bacterial response to Ag stress.  
Faster growth rate and larger cell size are phenotypic changes of evolved cells in the 
long-term evolution experiment [281]. FtsZ, which is recruited to the cell membrane to 
form the Z-ring for cell division, is associated with bacterial growth rate [282]. In ftsZ, 
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all five parallel AgNP-populations acquired a mutation turning a stop codon into a 
codon for Ser (serine), while in all five Ag+ populations, Arg (arginine) was substituted 
with Cys (cysteine). A similar phenomenon was observed in gacS, which encodes a 
transmembrane signal sensor protein that is coupled with the response regulator GacA, 
comprising a two-component system [283]. The mutation of uvrY, which is homologous 
to gacA, occurred in the Ag+ and the control populations but was mostly absent in the 
AgNP-populations, suggesting different regulatory strategies in response to the 
different Ag species.  
The two AgNP-specific mutations in envZ (encoding an inner membrane protein that 
activates the production of the outer membrane protein porin [284]) and in PP_2758 
(encoding a putative periplasmic protein) could indicate a direct attack of AgNPs on 
the bacterial cell wall. The genes thiL and PP_2397, mutated in Ag+-populations, 
encode a thiamin monophosphate kinase and an EF-hand domain protein, which are 
located in the cytosol and have magnesium and calcium binding domains, respectively. 
The mutation in tau-II, coding for the taurine ABC transmembrane transporter ATP-
binding subunit that is located at the cytoplasmic side, might suggest that this 
transporter is facilitating the uptake of Ag+ into the cytosol, selecting mutations that 
reduce uptake. The different adaption models of P. putida under the treatment of Ag+ 
or AgNP were compared (Figure 4.7). Because AgNPs cannot penetrate the bacterial 
cell wall, the mutations selected by AgNPs were associated with proteins in the 
periplasm and outer membrane. In contrast, Ag+ mostly selected for mutations in 
cytoplasmic proteins, indicating a response to intracellular Ag+.  
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P. putida evolved somewhat different adaptations upon exposure to low doses of Ag+ 
versus AgNPs. Silver nanoparticles might have direct effects on the outer membrane 
and periplasm while silver ions selected several mutations in cytoplasmic proteins, 
possibly adapting to effects of silver uptake.  
 
Figure 4.7 Different adaption models in Pseudomonas putida under the stress of 
Ag+ or AgNPs 
Adaption mechanisms in Ag+-evolved (left side of the dividing cell) and AgNP-evolved 
populations (right side of the dividing cell) were compared. Silver ions and 
nanoparticles may interact with FtsZ to influence cell division in different pathways. In 
Ag+-evolved populations, CopA transport Ag+ in the cytoplasm into periplasmic space. 
GacS senses Ag+ in the environment and may active UvrY to regulate the production 
of membrane proteins to reduce Ag+ uptake or promote Ag+ efflux. The cytoplasmic 
proteins PP_2397 and ThiL bind cytoplasmic Ag+ to reduce the availability of 
intracellular Ag+. The interaction between TauB and Ag+ may induce the transporter 
TauABC complex to reduce Ag+ influx. Silver nanoparticles cannot penetrate bacterial 
cells due to the physical barrier of bacterial membrane (i.e. the mean pore size of 
peptidoglycan in bacteria is < 5 nm [285]), but they might attach to bacterial outer 
membrane and release Ag+ into cells. In AgNP-evolved populations, CopA transports 
Ag+ that is released from AgNPs out of cells. The GacS/UvrY two-component system 
may control the production of membrane proteins for Ag resistance. The membrane 
protein EnvZ may also participate in regulating outer membrane protein for AgNP 
resistance. The periplasmic protein PP_2758 may deactivate AgNPs in the periplasmic 
region.  
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4.5 Conclusions 
This study demonstrated the distinct evolution of P. putida upon prolonged exposure to 
low concentrations of Ag+ or AgNPs. Fitness improved in the pre-evolution experiment 
and under the silver stresses in the main evolution experiment, including in conditions 
that were not selected for. The different mutation patterns in populations that evolved 
under Ag+ or AgNP stress indicate somewhat different antibacterial activities of Ag+ 
and AgNPs. Mutations unique to AgNP populations were mostly associated with the 
cell surface and two-component systems. By contrast, the mutations specific to Ag+ 
populations were in uptake systems and metal-binding proteins in the cytosol. These 
results suggest different toxicity pathways for ionic and nanoparticulate Ag in bacteria. 
Significantly different mutations associated with the treatment of Ag+ versus AgNPs 
were identified in the evolved populations, implying that nano-specific effects cannot 
be excluded in the toxicity of AgNPs, which has important implications for the 
application of AgNPs and their environmental risk assessment for the regulatory 
purpose. 
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5.1 Conclusions 
Nanotechnology as a promising new science has already been applied in a variety of 
fields. Silver nanoparticles are one of the widely used nanomaterials, especially in 
killing pathogens, owing to their outstanding antimicrobial properties. But the 
mechanisms involved in the killing of bacteria by AgNPs are not clear. The studies in 
this thesis investigated the interactions between AgNPs and bacteria, including the 
synthesis of uncoated AgNPs, long-term storage, physicochemical transformations of 
AgNPs in microbial media, their dynamic toxicity in a bacterium Pseudomonas putida, 
and the bacterial response upon the prolonged exposure to low concentrations of AgNPs. 
The cellular and genetic mechanisms in the toxicity of AgNPs on bacteria are explored 
in this thesis. 
Firstly, a rapid, convenient and inexpensive method of measuring the concentration of 
dissolved Ag+ in AgNP suspensions was developed by combining aggregation with 
centrifugation (Chapter 2). Compared to several hours in conventional 
ultracentrifugation, the time to separate AgNPs from dissolved Ag was reduced to half 
hour with centrifugation based on pre-aggregating the AgNPs with Ca2+. This method 
is especially helpful for real-time toxicity assays, in which quantification of the 
concentrations of Ag species is needed. To maintain the stability of AgNPs, storing 
AgNP stocks in an anoxic environment can prevent dissolution for three months. In 
addition to a concentration-dependent aggregation, AgNPs undergo slow dissolution in 
microbial media, influencing AgNP’s state and their toxicity in bacteria (Chapter 2 and 
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3).  
In Chapter 3, the toxicity of AgNPs in an environmental model bacterium 
Pseudomonas putida was investigated. The MICs of Ag+ and AgNPs are strongly 
correlated with initial cell densities. Silver ions are more toxic to bacteria than AgNPs. 
Accompanying the bacteria-killing, Ag+ and AgNPs might be inactivated or fixed by 
cells, leading to a decrease of Ag concentration in cell culture, which might mitigate 
the Ag stress, allowing the recovery of the bacterial population. However, the 
dissolution of AgNPs results in continuous release of Ag+, inhibiting the repopulation. 
The bacteria-killing ability of AgNPs is mainly attributed to the dissolved Ag.  
The nano-specific effect of AgNPs was investigated in an experimental evolution study. 
The mutations in response to Ag+ and AgNP stress were identified and compared. P. 
putida evolved in different patterns while they were treated by 5 and 20 μg/L Ag+ and 
AgNPs (Chapter 4). The distinct mutation profiles in the populations stressed by 
different Ag species might indicate different toxicity models of action of Ag+ and 
AgNPs. It was found that the toxicity of AgNPs is mostly associated with cell surface 
metabolism and Ag+ is associated with the proteins for uptake and binding of metals in 
cytosol, demonstrating nano-specific effects in the antibacterial activities of AgNPs.  
5.2 Future work 
The properties of AgNPs have fundamental roles in their antibacterial activities. The 
surface chemistry, especially the ions around nanoparticle’s core, determines the initial 
attachment of AgNPs to bacterial cells and the toxicity, which needs additional 
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investigation. The population-density related bacteria-killing by AgNPs found in this 
thesis should be considered for toxicity assays. Considering that bacteria typically live 
in the natural environment and medical settings as biofilm, it is necessary to measure 
the minimum biofilm eradication concentration such as crystal violent staining based 
assays to investigate the toxicity of AgNPs in more realistic environmental scenarios. 
Future studies of bacteria-killing kinetics by varying initial cell population densities 
will further provide evidences to support the inoculum effect in Ag+/AgNP-cell 
interactions. The mechanisms of how Ag+ penetrate into cells, AgNPs attach to cell 
surfaces, and their fate in bacterial cells are crucial to understand this inoculum effect, 
which needs further investigation. Further experiments are needed to differentiate the 
Ag adsorption by bacterial cells and those attached to the vessel surfaces with mass 
balance calculation, which can be explored to quantify the Ag+ required to kill a given 
density of bacterial cells. The Ag degradation that leads to the decrease of the 
concentration of active Ag in the cell culture might weaken the Ag stress, but some 
bacteria are certainly less susceptible, allowing the recovery of bacteria populations. 
The heterogeneous susceptibility of individual cells might be linked with bacterial 
defences against Ag, which is unknown. To understand why partial bacterial population 
survive the Ag treatment, it will be helpful to isolate the potential resistant strains and 
measure their Ag tolerance, which will have important medical implications to optimize 
Ag dosage for infectious disease treatment. Although the evolved P. putida population 
gained fitness under the treatments of low concentrations of Ag+ or AgNPs, it is not 
clear of whether the mutants can tolerate higher concentrations of Ag+ or AgNPs. 
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Further experiments to measure the tolerance of mutated strains under higher 
concentrations of Ag+ or AgNPs can be carried out to quantify the Ag tolerance in the 
evolved populations. As shown in the evolution experiment, P. putida evolved in 
different patterns in response to the stress of Ag+ and AgNPs. Most of the mutated genes 
have not been reported to be linked with the toxicity of Ag+ or AgNPs. An 
understanding of the relationship between these genes and the antibacterial activities of 
AgNPs as well as the potential for Ag resistance will be important for better design of 
AgNP products and their applications and for regulatory decisions regarding AgNP-
containing medical and consumer products. 
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Appendix 1 Mutations in population in the pre-evolution experiment 
Mutations in the population with the highest fitness after evolving for 465 generations in the pre-evolution experiment. Gene names and 
functions were obtained from the annotation in GenBank (RefSepq, NC_002947.4).  
Gene 
name 
Gene function 
Mutation 
position 
Reference Effect 
Codon 
change 
Amino 
acid 
change 
  178,396 A Intergenic   
PP_0168 Putative surface adhesion protein 195,505 C Synonymous gcC/gcG A337 
PP_0168 Putative surface adhesion protein 195,559 C Synonymous acC/acA T355 
PP_0168 Putative surface adhesion protein 195,634 C Synonymous acC/acT T380 
PP_0168 Putative surface adhesion protein 196,459 C Synonymous acC/acA T655 
PP_0168 Putative surface adhesion protein 196,489 T Synonymous aaT/aaC N665 
PP_0168 Putative surface adhesion protein 196,672 G Synonymous aaG/aaA K726 
PP_0168 Putative surface adhesion protein 196,795 G Synonymous acG/acC T767 
PP_0168 Putative surface adhesion protein 196,927 A Synonymous acA/acC T811 
PP_0168 Putative surface adhesion protein 197,128 T Synonymous gaT/gaC D878 
PP_0168 Putative surface adhesion protein 197,572 G Synonymous aaG/aaA K1026 
PP_0168 Putative surface adhesion protein 197,590 T Synonymous gaT/gaC D1032 
PP_0168 Putative surface adhesion protein 197,632 T Synonymous acT/acC T1046 
PP_0168 Putative surface adhesion protein 197,695 G Synonymous acG/acC T1067 
gacS Sensor protein GacS 1,843,901 C Non Synonymous cGc/cAc R298H 
  2,069,557 T Intergenic   
  4,022,306 G Intergenic   
  4,022,307 G Intergenic   
fleQ Transcriptional regulator Fleq 4,964,454 C Non Synonymous Gac/Aac D302N 
flgK Flagellar hook-associated protein Flgk 4,974,437 CAG Frame Shift ctg/ L389 
PP_4920 Lipoprotein 5,592,669 G Synonymous acG/acA T205 
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Gene 
name 
Gene function 
Mutation 
position 
Reference Effect 
Codon 
change 
Amino 
acid 
change 
  5,988,889 C Intergenic   
  5,988,905 T Intergenic   
  5,988,910 CA Intergenic   
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Appendix 2 Mutations in populations in main evolution experiment 
List of mutations in the 15 populations after evolving for 500 generations in the main evolution experiment. The reads of the evolved populations 
were aligned with the Pseudomonas putida KT2440 reference genome (RefSepq, NC_002947.4, GenBank) and variants called as described in 
section 4.2.7. Gene names were obtained from the annotation of the reference genome. REF represents the reference genome. ALT represents the 
mutation. There were three types of population, evolved under different conditions: control (populations evolved without Ag stress); Ag+ population 
(evolved in the presence of Ag+); AgNP population (evolved in the presence of AgNPs). Mutations were only called when they passed quality 
thresholds: 0 refers to no mutation; 1 refers to mutation. Under each condition (control, Ag+ treatment and AgNP treatment), there were five parallel 
population (C1-5). A modified Fisher’s exact test was used to calculate the mid-p-values for association of mutation with treatment (see section 
4.2.8). The cells with p-values smaller than 0.05 are highlighted in red. 
Gene 
name 
Mutation 
position 
R
E
F 
A
L
T 
Effect 
Mutation call 
Total number of 
parallel 
mutations 
p-values for association  
Control Ag+ population AgNP population 
C
1 
C
2 
C
3 
C
4 
C
5 
C
1 
C
2 
C
3 
C
4 
C
5 
C
1 
C
2 
C
3 
C
4 
C
5 
Co
ntr
ol 
Ag+ 
Ag
NP 
Ag+ vs 
Control 
AgNP vs 
Control  
AgNP vs 
Ag+ 
  172,966 A G Intergenic 1 1 1 1 1 1 1 1 1 0 0 1 1 1 1 5 4 4 0.50 0.5 1 
  173,074 A G Intergenic 0 0 0 0 0 1 0 0 0 0 1 1 1 1 0 0 1 4 0.5 0.024 0.1071 
  178,396 A G Intergenic 1 1 1 0 0 1 1 1 1 0 1 0 0 1 0 3 4 2 0.58 0.603 0.2857 
  178,437 C T Intergenic 1 1 1 1 1 1 1 1 1 0 1 1 0 1 0 5 4 3 0.5 0.222 0.5833 
  178,504 A G Intergenic 1 0 0 0 0 0 0 1 1 0 1 1 1 1 1 1 2 5 0.58 0.024 0.08333 
PP_0168 195,406 C T Synonymous 0 0 0 0 1 0 0 0 0 0 0 1 0 1 0 1 0 2 0.5 0.583 0.2222 
PP_0168 195,424 G A Synonymous 0 1 1 0 1 1 0 0 1 0 1 0 1 1 0 3 2 3 0.6 1 0.6032 
PP_0168 195,449 G A Nonsynonymous 0 0 0 0 0 1 0 0 0 0 0 0 1 0 0 0 1 1 0.5 0.5 1 
PP_0168 19,450 T C Nonsynonymous 0 0 0 0 0 1 0 1 0 1 0 0 0 0 0 0 3 0 0.08 1 0.08333 
PP_0168 195,457 T C Synonymous 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 1 1 0 1 0.5 0.5 
PP_0168 195,472 A G Synonymous 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0.22 0.222 1 
PP_0168 195,505 C G Synonymous 1 0 1 1 1 1 0 0 1 1 1 0 1 1 1 4 3 4 0.58 1 0.5833 
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Gene 
name 
Mutation 
position 
R
E
F 
A
L
T 
Effect 
Mutation call 
Total number of 
parallel 
mutations 
p-values for association  
Control Ag+ population AgNP population 
C
1 
C
2 
C
3 
C
4 
C
5 
C
1 
C
2 
C
3 
C
4 
C
5 
C
1 
C
2 
C
3 
C
4 
C
5 
Co
ntr
ol 
Ag+ 
Ag
NP 
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PP_0168 195,559 C A Synonymous 1 1 1 1 1 1 1 1 1 1 1 0 1 0 1 5 5 3 1 0.222 0.2222 
PP_0168 195,568 T C Synonymous 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 1 0 0.5 1 0.5 
PP_0168 195,589 T C Synonymous 0 0 1 0 1 0 1 1 1 1 1 1 1 1 1 2 4 5 0.29 0.083 1 
PP_0168 195,628 C T Synonymous 1 1 1 1 1 1 0 1 0 0 0 1 0 1 0 5 2 2 0.08 0.083 1 
PP_0168 195,629 A G Nonsynonymous 1 1 1 1 1 1 0 1 0 1 0 1 0 1 0 5 3 2 0.22 0.083 0.6032 
PP_0168 195,634 C T Synonymous 1 1 1 1 1 1 1 1 1 1 1 0 1 1 1 5 5 4 1 0.5 0.5 
PP_0168 195,685 T C Synonymous 1 0 1 0 0 0 1 1 1 1 1 1 0 1 1 2 4 4 0.29 0.286 1 
PP_0168 195,724 A G Synonymous 0 0 0 0 0 1 0 1 0 0 1 0 0 0 0 0 2 1 0.22 0.5 0.5833 
PP_0168 195,732 A C Nonsynonymous 1 1 1 0 1 0 1 1 1 1 1 1 1 1 1 4 4 5 1 1 1 
PP_0168 195,766 G C Synonymous 0 1 0 0 0 1 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 
PP_0168 195,769 T C Synonymous 0 1 1 0 1 1 0 0 0 0 0 0 1 0 1 3 1 2 0.29 0.603 0.5833 
PP_0168 195,805 C G Synonymous 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0.5 0.5 1 
PP_0168 195,826 C T Synonymous 0 0 0 0 1 0 0 0 1 0 0 0 0 0 1 1 1 1 1 1 1 
PP_0168 195,852 G A Nonsynonymous 0 1 1 1 1 1 0 0 0 0 0 1 0 0 0 4 1 1 0.11 0.107 1 
PP_0168 195,877 G A Synonymous 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0.5 0.5 1 
PP_0168 195,929 A G Nonsynonymous 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0.5 0.5 1 
PP_0168 195,934 C T Synonymous 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 1 0.5 0.5 
PP_0168 195,979 G A Synonymous 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 0 0.5 1 0.5 
PP_0168 195,985 C T Synonymous 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 1 0.5 0.5 
PP_0168 196,027 T C Synonymous 1 1 1 0 0 1 0 1 1 1 1 1 1 1 1 3 4 5 0.58 0.222 1 
PP_0168 196,051 G C Synonymous 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0.5 0.5 1 
PP_0168 196,066 G C Synonymous 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 2 1 0.222 0.2222 
PP_0168 196,069 T C Synonymous 0 0 1 0 0 0 0 0 1 0 0 1 0 0 0 1 1 1 1 1 1 
PP_0168 196,132 G C Synonymous 0 0 1 0 1 1 1 0 1 1 1 1 1 1 1 2 4 5 0.29 0.083 1 
PP_0168 196,159 G A Synonymous 1 0 1 0 1 1 0 0 1 1 0 0 1 1 1 3 3 3 1 1 1 
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PP_0168 196,195 G C Synonymous 1 0 1 0 0 0 1 0 0 0 0 0 0 1 1 2 1 2 0.58 1 0.5833 
PP_0168 196,234 T C Synonymous 1 0 1 1 1 1 1 1 1 0 1 1 1 1 1 4 4 5 1 1 1 
PP_0168 196,285 T C Synonymous 1 0 0 0 1 1 1 1 1 0 0 1 0 1 1 2 4 3 0.29 0.603 0.5833 
PP_0168 196,306 T C Synonymous 1 1 1 1 1 1 1 1 0 1 1 1 1 1 1 5 4 5 0.5 1 1 
PP_0168 196,324 G A Synonymous 0 0 0 0 0 0 0 0 0 0 0 1 0 1 1 0 0 3 1 0.083 0.08333 
PP_0168 196,327 A C Synonymous 1 1 1 1 1 1 1 1 1 0 1 1 1 1 1 5 4 5 0.5 1 1 
PP_0168 196,351 C G Synonymous 1 1 1 1 1 1 1 1 0 1 1 1 1 1 1 5 4 5 0.5 1 1 
PP_0168 196,366 C G Synonymous 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 1 0.5 0.5 
PP_0168 196,369 C T Synonymous 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 1 0.5 0.5 
PP_0168 196,372 A G Synonymous 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 5 5 5 1 1 1 
PP_0168 196,390 T C Synonymous 1 1 1 0 1 0 1 1 0 1 1 0 1 1 1 4 3 4 0.58 1 0.5833 
PP_0168 196,405 G C Synonymous 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 1 0.5 0.5 
PP_0168 196,432 T C Synonymous 0 1 0 1 0 0 0 0 0 0 0 0 0 0 1 2 0 1 0.22 0.583 0.5 
PP_0168 196,459 C A Synonymous 0 1 0 1 1 1 1 1 0 1 1 1 1 1 1 3 4 5 0.58 0.222 1 
PP_0168 196,489 T C Synonymous 1 1 1 0 1 1 1 1 1 0 1 1 1 1 1 4 4 5 1 1 1 
PP_0168 196,495 G C Synonymous 1 1 1 1 1 1 1 1 1 0 1 1 1 1 1 5 4 5 0.5 1 1 
PP_0168 196,528 T C Synonymous 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 1 0.5 0.5 
PP_0168 196,579 G A Synonymous 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 5 5 5 1 1 1 
PP_0168 196,585 C T Synonymous 0 0 1 1 0 1 1 0 1 0 0 0 1 0 0 2 3 1 0.6 0.583 0.2857 
PP_0168 196,606 T C Synonymous 0 0 0 1 0 0 0 0 1 0 0 0 0 0 0 1 1 0 1 0.5 0.5 
PP_0168 196,624 G A Synonymous 0 0 0 1 1 0 0 0 1 0 0 0 0 0 0 2 1 0 0.58 0.222 0.5 
PP_0168 196,627 A C Synonymous 1 1 1 1 1 1 1 1 1 1 0 1 1 1 1 5 5 4 1 0.5 0.5 
PP_0168 196,672 G A Synonymous 1 0 0 0 1 0 1 0 0 0 1 0 0 0 0 2 1 1 0.58 0.583 1 
PP_0168 196,705 G C Synonymous 1 1 1 0 0 0 1 1 0 0 0 0 0 1 1 3 2 2 0.6 0.603 1 
PP_0168 196,752 A G Nonsynonymous 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 1 0 0.5 1 0.5 
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PP_0168 196,759 T 
C,
A 
Synonymous 1 1 1 0 1 1 1 1 0 1 1 1 0 1 1 4 4 4 1 1 1 
PP_0168 196,795 G C Synonymous 0 0 0 0 1 0 0 1 0 0 0 1 0 0 0 1 1 1 1 1 1 
PP_0168 196,828 T C Synonymous 0 1 0 0 0 0 0 0 0 0 0 1 0 0 0 1 0 1 0.5 1 0.5 
PP_0168 196,829 G A Nonsynonymous 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0.5 0.5 1 
PP_0168 196,885 C T Synonymous 1 1 1 1 0 0 1 1 1 1 1 1 1 0 0 4 4 3 1 0.583 0.5833 
PP_0168 196,906 T C Synonymous 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0.5 0.5 1 
PP_0168 196,924 G A Synonymous 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0.5 0.5 1 
PP_0168 196,927 A C Synonymous 1 1 1 1 1 1 1 1 1 0 1 1 1 1 1 5 4 5 0.5 1 1 
PP_0168 196,972 G A Synonymous 1 1 1 1 1 1 1 0 1 0 1 1 1 1 0 5 3 4 0.22 0.5 0.5833 
PP_0168 197,128 T C Synonymous 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 2 1 0.222 0.2222 
PP_0168 197,129 G A Nonsynonymous 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 2 1 0.222 0.2222 
PP_0168 197,179 A G Synonymous 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 4 5 5 1 1 1 
PP_0168 197,185 C T Synonymous                               0 0 0 1 1 1 
PP_0168 197,206 T C Synonymous 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 1 0 0.5 1 0.5 
PP_0168 197,224 A G Synonymous 1 0 0 0 0 1 0 1 1 1 1 0 0 0 1 1 4 2 0.11 0.583 0.2857 
PP_0168 197,227 C A Synonymous 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 1 0.5 0.5 
PP_0168 197,250 T C Nonsynonymous 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 1 0 0 0.5 0.5 1 
PP_0168 197,257 T C Synonymous 1 0 0 0 0 0 0 0 0 1 1 0 0 0 0 1 1 1 1 1 1 
PP_0168 197,326 T C Synonymous 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 1 0 0.5 1 0.5 
PP_0168 197,395 G C Synonymous 0 0 1 0 0 1 0 0 0 0 0 0 0 0 0 1 1 0 1 0.5 0.5 
PP_0168 197,479 G A Synonymous 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0.22 0.222 1 
PP_0168 197,496 T C Nonsynonymous 0 1 1 1 1 1 1 1 1 1 1 1 0 1 1 4 5 4 1 1 0.5 
PP_0168 197,524 A G Synonymous 0 0 0 1 0 0 0 0 0 1 0 0 0 0 0 1 1 0 1 0.5 0.5 
PP_0168 197,551 C G Synonymous 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 1 1 0.5 0.5 1 
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PP_0168 197,572 G A Synonymous 1 1 0 1 1 1 1 1 1 1 1 1 1 1 0 4 5 4 1 1 0.5 
PP_0168 197,590 T C Synonymous 1 0 0 1 1 1 1 1 1 1 1 1 0 1 0 3 5 3 0.22 1 0.2222 
PP_0168 197,605 G C Synonymous 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 0 0.5 1 0.5 
PP_0168 197,632 T C Synonymous 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 5 5 5 1 1 1 
PP_0168 197,665 T C Synonymous 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 0 0.5 1 0.5 
PP_0168 197,689 C T Synonymous 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0.5 0.5 1 
PP_0168 197,695 G C Synonymous 1 1 1 0 0 0 1 0 1 0 1 1 0 1 1 3 2 4 0.6 0.583 0.2857 
PP_0168 197,715 C A Nonsynonymous 1 1 0 0 0 0 1 0 0 0 0 1 0 1 0 2 1 2 0.58 1 0.5833 
PP_0168 197,834 T C Synonymous 1 1 1 1 1 1 1 1 0 0 1 1 1 1 1 5 3 5 0.22 1 0.2222 
PP_0168 197,866 G C Synonymous 0 1 1 1 0 0 0 0 0 1 1 0 1 0 1 3 1 3 0.29 1 0.2857 
PP_0168 197,869 T C Synonymous 0 1 1 1 0 1 1 0 0 1 1 1 1 0 0 3 3 3 1 1 1 
PP_0168 197,872 A G Synonymous 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 1 0.5 0.5 
PP_0168 197,926 C T Synonymous 0 0 0 1 0 0 0 0 0 1 0 0 0 0 0 1 1 0 1 0.5 0.5 
PP_0168 198,400 C G Synonymous 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0.5 0.5 1 
PP_0168 199,318 T G Synonymous 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 1 1 0 1 0.5 0.5 
PP_0168 199,480 T C Synonymous 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 1 1 0.5 0.5 
PP_0168 199,550 T C Synonymous 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 0 0 2 1 0.222 0.2222 
PP_0168 199,744 T C Synonymous 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 1 0.5 0.5 
PP_0168 199,822 G C Synonymous 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0.5 0.5 1 
PP_0168 200,113 T C Synonymous 0 0 0 0 0 1 1 0 0 0 0 0 0 0 1 0 2 1 0.22 0.5 0.5833 
PP_0168 200,164 T C Synonymous 0 0 1 1 0 0 0 0 0 0 0 0 0 0 1 2 0 1 0.22 0.583 0.5 
PP_0168 200,338 G C Synonymous 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 1 0 0.5 1 0.5 
PP_0168 200,473 T C Synonymous 0 0 1 0 0 0 1 0 1 0 0 0 0 0 0 1 2 0 0.58 0.5 0.2222 
PP_0168 201,007 T C Synonymous 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 1 0.5 0.5 
PP_0168 201,043 T C Synonymous 0 0 0 1 0 0 0 0 0 0 0 0 0 0 1 1 0 1 0.5 1 0.5 
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PP_0168 201,100 T C Synonymous 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 1 0.5 0.5 
PP_0168 201,175 T C Synonymous 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0.22 0.222 1 
PP_0168 201,622 C G Synonymous 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 1 0.5 0.5 
PP_0168 201,652 G C Synonymous 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0 0 2 1 0.222 0.2222 
PP_0168 201,685 G C Synonymous 0 0 0 1 0 0 0 0 0 0 1 0 1 0 0 1 0 2 0.5 0.583 0.2222 
PP_0168 201,715 T C Synonymous 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 1 0 0.5 1 0.5 
PP_0168 201,798 T C Nonsynonymous 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 1 0.5 0.5 
PP_0168 201,859 G C Synonymous 0 0 0 0 0 0 0 0 1 0 0 1 0 1 0 0 1 2 0.5 0.222 0.5833 
PP_0168 201,997 T C Synonymous 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 1 0.5 0.5 
PP_0168 202,111 G A Synonymous 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0.5 0.5 1 
PP_0168 202,117 T C Synonymous 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0.5 0.5 1 
PP_0168 202,321 T C Synonymous 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0.5 0.5 1 
PP_0168 203,227 C G Synonymous 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 1 0 0.5 1 0.5 
PP_0168 203,422 T C Synonymous 0 0 0 0 1 0 0 0 1 1 0 0 1 0 0 1 2 1 0.58 1 0.5833 
PP_0168 203,647 T C Synonymous 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0.5 0.5 1 
PP_0168 203,674 T C Synonymous 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0 1 0.5 1 0.5 
PP_0168 204,180 A C Nonsynonymous 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 1 0.5 0.5 
PP_0168 204,532 T C Synonymous 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0.5 0.5 1 
PP_0168 205,120 A T Synonymous 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 1 0.5 0.5 
PP_0168 205,327 C G Synonymous 0 0 1 0 0 0 0 0 0 0 0 1 0 0 0 1 0 1 0.5 1 0.5 
PP_0168 205,672 T C Synonymous 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0.5 0.5 1 
PP_0168 205,789 C T Synonymous 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0.5 0.5 1 
PP_0168 205,912 G C Synonymous 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0.5 0.5 1 
PP_0168 206,143 A G Synonymous 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 1 0.5 1 0.5 
PP_0168 206,311 G C Synonymous 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 1 0.5 0.5 
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PP_0168 206,440 T C Synonymous 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0.5 0.5 1 
PP_0168 206,461 G C Synonymous 0 1 0 0 1 0 0 0 0 0 0 0 1 0 0 2 0 1 0.22 0.583 0.5 
PP_0168 206,830 T C Synonymous 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 1 0.5 0.5 
PP_0168 206,966 T C Synonymous 0 0 0 0 1 0 0 0 0 0 0 0 0 0 1 1 0 1 0.5 1 0.5 
PP_0168 207,133 T C Synonymous 0 0 0 0 1 0 0 0 0 0 1 1 0 0 1 1 0 3 0.5 0.286 0.08333 
PP_0168 207,136 C G Synonymous 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 1 0.5 0.5 
PP_0168 207,235 G A Synonymous 0 0 1 0 0 0 0 0 0 0 0 1 0 0 0 1 0 1 0.5 1 0.5 
PP_0168 207,370 G T Synonymous 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0.5 0.5 1 
PP_0168 207,796 G C Synonymous 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0.5 0.5 1 
PP_0168 208,015 A G Synonymous 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0.5 0.5 1 
PP_0168 208,027 T C Synonymous 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0.5 0.5 1 
PP_0168 208,030 T G Synonymous 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0.5 0.5 1 
PP_0168 208,150 T C Synonymous 0 0 1 1 0 0 0 0 0 0 0 0 0 1 0 2 0 1 0.22 0.583 0.5 
PP_0168 208,399 T C Synonymous 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 1 0.5 0.5 
PP_0168 208,456 C G Synonymous 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0.5 0.5 1 
PP_0168 208,564 A G Synonymous 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 1 0 0.5 1 0.5 
PP_0168 208,675 G A Synonymous 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0.5 0.5 1 
PP_0168 209,404 T C Synonymous 0 1 0 0 0 1 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 
PP_0168 209,638 T C Synonymous 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 1 0 0.5 1 0.5 
PP_0168 209,782 T C Synonymous 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 1 0 0.5 1 0.5 
PP_0168 209,942 T C Synonymous 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0.5 0.5 1 
PP_0168 210,088 A G Synonymous 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 1 0 0 0.5 0.5 1 
PP_0168 210,121 T C Synonymous 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 1 0.5 0.5 
PP_0168 210,271 T C Synonymous 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0.5 0.5 1 
PP_0168 210,691 T C Synonymous 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 1 0.5 0.5 
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PP_0168 210,721 T C Synonymous 1 0 1 0 0 0 0 0 0 0 0 0 1 0 0 2 0 1 0.22 0.583 0.5 
PP_0168 211,417 T C Synonymous 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0.5 0.5 1 
PP_0168 211,669 T C Synonymous 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 1 0.5 0.5 
PP_0168 212,026 T C Synonymous 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 1 0 0.5 1 0.5 
PP_0168 212,056 T C Synonymous 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0.5 0.5 1 
PP_0168 212,080 T C Synonymous 0 0 0 0 0 1 0 0 0 0 0 0 1 0 0 0 1 1 0.5 0.5 1 
PP_0168 212,134 T C Synonymous 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 1 0.5 0.5 
PP_0168 212,302 T C Synonymous 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 1 0 0.5 1 0.5 
PP_0168 212,311 T C Synonymous 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 1 0 0.5 1 0.5 
PP_0168 212,581 G A Synonymous 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 1 0.5 0.5 
PP_0168 212,617 C G Synonymous 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 1 0.5 0.5 
PP_0168 212,861 G C Nonsynonymous 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0.5 0.5 1 
PP_0168 212,941 C G Synonymous 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 1 0 0.5 1 0.5 
PP_0168 213,028 G C Synonymous 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 1 0.5 0.5 
PP_0168 213,415 A G Synonymous 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 1 0.5 0.5 
PP_0168 213,619 T C Synonymous 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 1 0 0 0.5 0.5 1 
PP_0168 213,874 T G Synonymous 0 0 0 0 0 1 0 0 0 0 0 0 1 0 0 0 1 1 0.5 0.5 1 
PP_0168 213,918 C T Nonsynonymous 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 1 0.5 0.5 
PP_0168 214,699 T C Synonymous 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 1 0.5 0.5 
PP_0168 214,777 G T Synonymous 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0.5 0.5 1 
PP_0168 215,035 T C Synonymous 0 0 0 0 1 0 0 0 0 0 0 0 0 0 1 1 0 1 0.5 1 0.5 
PP_0168 215,047 C T Synonymous 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0.5 0.5 1 
PP_0168 215,077 T C Synonymous 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 1 0.5 0.5 
PP_0168 215,383 A G Synonymous 0 0 0 0 1 0 0 0 0 0 0 1 1 0 0 1 0 2 0.5 0.583 0.2222 
PP_0168 215,897 C T Synonymous 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 1 0.5 0.5 
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AgNP vs 
Control  
AgNP vs 
Ag+ 
PP_0168 215,929 T C Synonymous 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0.5 0.5 1 
PP_0168 215,950 A G Synonymous 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0.5 0.5 1 
PP_0168 215,962 T C Synonymous 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0.5 0.5 1 
PP_0168 216,016 T C Synonymous 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 1 0 0.5 1 0.5 
PP_0168 216,085 T C Synonymous 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0.5 0.5 1 
PP_0168 216,334 T C Synonymous 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 1 0 0.5 1 0.5 
PP_0168 216,499 A G Synonymous 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 1 0.5 0.5 
PP_0168 216,715 G A Synonymous 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0.5 0.5 1 
PP_0174 226,226 T A Nonsynonymous 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 1 0 0.5 1 0.5 
  235,390 G A Intergenic 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0.5 0.5 1 
PP_0188 204,531 G C Nonsynonymous 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0.5 0.5 1 
PP_0188 240,536 G C Synonymous 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0.5 0.5 1 
  278,742 T 
T
A 
Intergenic 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 5 5 5 1 1 1 
tauB-II 287,067 G C Nonsynonymous 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 0 0.5 1 0.5 
tauB-II 287,068 G C Nonsynonymous 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 0 0.5 1 0.5 
envZ 302,935 G C Nonsynonymous 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 1 0.5 0.5 
envZ 303,121 G 
G
G
C
T 
Codon change/Codon 
insertion 
0 0 0 0 0 0 0 0 0 0 1 1 1 0 0 0 0 3 1 0.083 0.08333 
  308,738 C T Intergenic 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 2 0 0 0.22 0.222 1 
  308,739 A G Intergenic 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 2 0 0 0.22 0.222 1 
  336,298 T A Intergenic 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 0 0.5 1 0.5 
  353,067 A G Intergenic 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 5 5 5 1 1 1 
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Gene 
name 
Mutation 
position 
R
E
F 
A
L
T 
Effect 
Mutation call 
Total number of 
parallel 
mutations 
p-values for association  
Control Ag+ population AgNP population 
C
1 
C
2 
C
3 
C
4 
C
5 
C
1 
C
2 
C
3 
C
4 
C
5 
C
1 
C
2 
C
3 
C
4 
C
5 
Co
ntr
ol 
Ag+ 
Ag
NP 
Ag+ vs 
Control 
AgNP vs 
Control  
AgNP vs 
Ag+ 
  364,577 T A Intergenic 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 1 0 0.5 1 0.5 
thiL 605,121 G A Nonsynonymous 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 0 0.5 1 0.5 
thiL 605,126 A T Nonsynonymous 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 0 0.5 1 0.5 
thiL 605,131 T C Synonymous 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 0 0.5 1 0.5 
  661,588 C T Intergenic 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 1 0 0.5 1 0.5 
  786,604 T C Intergenic 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 1 0.5 0.5 
hemH 863,376 A T Synonymous 0 0 1 1 0 1 0 1 0 0 0 0 1 0 0 2 2 1 1 0.583 0.5833 
  975,287 A T Intergenic 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 1 0 0.5 1 0.5 
  975,288 A T Intergenic 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 1 0 0.5 1 0.5 
PP_0861 999,625 C G Nonsynonymous 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 1 0 0.5 1 0.5 
PP_0904 1,044,757 
C
A
G
C
A
C
G
G
C
T
G
C
C
T
G
T
C 
Codon change/Codon 
deletion 
0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 1 0.5 0.5 
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Gene 
name 
Mutation 
position 
R
E
F 
A
L
T 
Effect 
Mutation call 
Total number of 
parallel 
mutations 
p-values for association  
Control Ag+ population AgNP population 
C
1 
C
2 
C
3 
C
4 
C
5 
C
1 
C
2 
C
3 
C
4 
C
5 
C
1 
C
2 
C
3 
C
4 
C
5 
Co
ntr
ol 
Ag+ 
Ag
NP 
Ag+ vs 
Control 
AgNP vs 
Control  
AgNP vs 
Ag+ 
A
T
G
G
C
A 
  1,159,239 T G Intergenic 0 0 0 0 0 0 0 1 0 0 1 0 0 0 0 0 1 1 0.5 0.5 1 
  1,184,536 
G
C 
G Intergenic 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 1 0 0.5 1 0.5 
xcpY 1,202,854 A C Nonsynonymous 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 1 0 0.5 1 0.5 
dtcD-II 1,221,046 C A Nonsynonymous 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0.5 0.5 1 
PP_16SE 1,326,938 G A Intragenic 1 0 0 0 0 1 1 1 1 1 0 0 0 0 0 1 5 0 0.02381 0.5 0.003968 
PP_1175 1,350,104 C A 
Stop lost/Splice site 
region 
0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 1 0 0.5 1 0.5 
PP_1175 1,350,119 A G Synonymous 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0.5 0.5 1 
PP_1195 1,370,775 
G
G
G
T
C
G
A
A
A
A 
G 
Codon change/Codon 
deletion 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 1 0.5 0.5 
PP_1256 1,435,822 A T Nonsynonymous 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 1 0 0.5 1 0.5 
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Gene 
name 
Mutation 
position 
R
E
F 
A
L
T 
Effect 
Mutation call 
Total number of 
parallel 
mutations 
p-values for association  
Control Ag+ population AgNP population 
C
1 
C
2 
C
3 
C
4 
C
5 
C
1 
C
2 
C
3 
C
4 
C
5 
C
1 
C
2 
C
3 
C
4 
C
5 
Co
ntr
ol 
Ag+ 
Ag
NP 
Ag+ vs 
Control 
AgNP vs 
Control  
AgNP vs 
Ag+ 
  1,499,497 T 
T
C 
Intergenic 0 0 1 0 1 0 1 0 0 1 0 0 1 1 0 2 2 2 1 1 1 
PP_1325 1,511,070 T A Nonsynonymous 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 1 0.5 0.5 
ftsZ 1,503,160 C T Nonsynonymous 0 0 0 0 0 0 1 0 0 0 1 1 1 1 1 0 1 5 0.5 0.004 0.02381 
ftsZ 1,530,173 A C 
Stop lost/Splice site 
region 
1 1 1 1 1 1 1 1 1 1 0 0 0 0 0 5 5 0 1 0.004 0.003968 
PP_1344 1,531,780 G T Nonsynonymous 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 1 0.5 0.5 
  1,617,777 C T Intergenic 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 1 1 0.5 0.5 
  1,617,782 C G Intergenic 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 1 1 0.5 0.5 
  1,777,419 G A Intergenic 0 1 0 0 1 1 1 0 1 1 1 1 0 0 1 2 4 3 0.29 0.603 0.5833 
  1,777,422 C A Intergenic 0 1 0 0 1 1 1 0 1 1 1 1 0 0 0 2 4 2 0.29 1 0.2857 
  1,777,428 G A Intergenic 0 1 0 0 1 1 1 0 1 1 1 0 0 0 0 2 4 1 0.29 0.583 0.1071 
  1,780,067 C T Intergenic 0 1 0 0 0 1 1 0 0 0 0 0 1 0 0 1 2 1 0.58 1 0.5833 
  1,838,142 G A Intergenic 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 1 0 0.5 1 0.5 
gacS 1,843,091 A C Nonsynonymous 1 1 1 0 1 1 1 1 1 1 0 0 0 0 1 4 5 1 1 0.107 0.02381 
gacS 1,843,901 C T Nonsynonymous                               0 0 0 1  1 1 
gacS 1,844,166 T A Stop gained 0 0 0 0 0 0 1 0 0 0 1 1 1 1 0 0 1 4 0.5 0.02381 0.1071 
PP_1666 1,863,240 T A Nonsynonymous 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 1 0.5 0.5 
PP_1666 1,863,278 G C Nonsynonymous 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0.5 0.5 1 
PP_1703 1,901,761 A T Nonsynonymous 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 0 0.5 1 0.5 
  2,051,065 T A Intergenic 1 0 0 0 0 0 1 1 1 0 0 0 0 0 0 1 3 0 0.29 0.5 0.08333 
  2,063,185 C G Intergenic 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 1 0 0.5 1 0.5 
  2,068,151 A T Intergenic 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 1 0 0.5 1 0.5 
  2,068,152 A T Intergenic 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 1 0 0.5 1 0.5 
  2,069,557 T C Intergenic 1 0 0 0 0 1 1 1 0 1 1 1 0 0 0 1 4 2 0.11 0.583 0.2857 
 171 
 
Gene 
name 
Mutation 
position 
R
E
F 
A
L
T 
Effect 
Mutation call 
Total number of 
parallel 
mutations 
p-values for association  
Control Ag+ population AgNP population 
C
1 
C
2 
C
3 
C
4 
C
5 
C
1 
C
2 
C
3 
C
4 
C
5 
C
1 
C
2 
C
3 
C
4 
C
5 
Co
ntr
ol 
Ag+ 
Ag
NP 
Ag+ vs 
Control 
AgNP vs 
Control  
AgNP vs 
Ag+ 
  2,087,422 C T Intergenic 0 0 0 0 0 0 1 0 0 0 0 0 0 1 0 0 1 1 0.5 0.5 1 
  2,087,428 G A Intergenic 1 0 0 0 0 0 1 0 0 1 1 0 1 0 0 1 2 2 0.58 0.583 1 
  2,087,439 G A Intergenic 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 1 0 0.5 1 0.5 
  2,087,463 G A Intergenic 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 1 0 0.5 1 0.5 
  2,087,635 T C Intergenic 0 0 0 0 1 1 0 1 0 0 0 0 1 0 0 1 2 1 0.58 1 0.5833 
PP_5491 2,187,722 
G
T 
G Intergenic 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 1 0 0.5 1 0.5 
  2,256,267 C T Intergenic 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 1 0.5 0.5 
  2,256,290 C T Intergenic 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 1 0.5 0.5 
PP_2068 2,354,379 T G Nonsynonymous 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0.5 0.5 1 
  2,414,802 C G Intergenic 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 1 0.5 0.5 
  2,550,588 A G Intergenic 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 1 0 0.5 1 0.5 
PP_2397 2,742,917 C T Nonsynonymous 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 1 0 0.5 1 0.5 
PP_2397 2,742,918 A G Nonsynonymous 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 1 0 0.5 1 0.5 
PP_2478 2,824,518 A C Nonsynonymous 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 1 0 0 0.5 0.5 1 
  2,935,858 C G Intergenic 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 1 0.5 0.5 
PP_2638 3,021,030 A T Nonsynonymous 0 0 1 0 0 0 0 1 0 0 1 0 0 1 0 1 1 2 1 0.583 0.5833 
pp_2757 3,141,492 
G
T 
G Frame shift 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 1 0.5 0.5 
PP_2758 3,142,272 C T Nonsynonymous 0 0 0 0 0 0 0 0 0 0 1 1 1 1 0 0 0 4 1 0.02381 0.02381 
PP_3045 3,430,349 G C Synonymous 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 1 0.5 0.5 
PP_3221 3,656,539 T G Synonymous 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 1 1 0.5 0.5 
PP_5743/
PP_3334 
3,774,247 C G Intragenic 1 0 0 0 0 1 0 0 0 0 0 0 0 0 0 1 1 0 1 0.5 0.5 
oprN 3,881,829 A T Nonsynonymous 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0.5 0.5 1 
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Gene 
name 
Mutation 
position 
R
E
F 
A
L
T 
Effect 
Mutation call 
Total number of 
parallel 
mutations 
p-values for association  
Control Ag+ population AgNP population 
C
1 
C
2 
C
3 
C
4 
C
5 
C
1 
C
2 
C
3 
C
4 
C
5 
C
1 
C
2 
C
3 
C
4 
C
5 
Co
ntr
ol 
Ag+ 
Ag
NP 
Ag+ vs 
Control 
AgNP vs 
Control  
AgNP vs 
Ag+ 
  4,022,306 G C Intergenic 0 0 0 1 0 1 1 1 1 0 1 0 1 1 0 1 4 3 0.11 0.286 0.5833 
  4,022,307 G C Intergenic 0 0 0 1 0 1 1 1 1 0 1 0 1 1 0 1 4 3 0.11 0.286 0.5833 
  4,022,806 C G Intergenic 1 0 0 0 0 1 0 1 0 0 0 0 1 1 0 1 2 2 0.58 0.583 1 
  4,022,807 C G Intergenic 1 0 0 0 0 1 0 1 0 0 1 1 1 1 0 1 2 4 0.58 0.107 0.2857 
PP_3563 4,042,322 T G Nonsynonymous 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 1 0 0.5 1 0.5 
PP_3573 4,053,476 A T Nonsynonymous 0 1 0 0 1 0 0 1 0 0 0 0 1 0 0 2 1 1 0.58 0.583 1 
  4,293,218 G C Intergenic 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 1 1 0.5 0.5 
yrpB 4,353,296 C G Nonsynonymous 0 0 0 0 0 0 0 1 0 0 1 0 0 0 0 0 1 1 0.5 0.5 1 
clpA 4,518,633 C T Nonsynonymous 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 1 0.5 0.5 
idh 4,522,716 G A Nonsynonymous 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0.5 0.5 1 
malQ 4,568,619 C G Synonymous 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0.5 0.5 1 
mccB 4,990,049 T C Nonsynonymous 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 1 1 0.5 0.5 
uvrY 4,635,590 T C Nonsynonymous 1 1 1 1 1 1 1 1 1 1 0 0 0 0 1 5 5 1 1 0.02381 0.02381 
PP_5662 4,741,229 A C Intergenic 1 1 1 0 1 1 1 1 1 0 1 1 1 1 1 4 4 5 1 1 1 
PP_5662 4,741,231 C G Intergenic 1 1 1 0 1 1 1 1 0 0 1 1 1 1 1 4 3 5 0.58 1 0.2222 
PP_5662 4,741,234 C T Intergenic 1 1 1 0 1 1 1 1 1 0 1 1 1 1 1 4 4 5 1 1 1 
PP_5662 4,741,236 G T Intergenic 1 1 1 0 1 1 1 1 1 0 1 1 1 1 1 4 4 5 1 1 1 
PP_5662 4,741,237 C G Intergenic 1 1 1 0 1 1 1 1 1 0 1 1 1 1 1 4 4 5 1 1 1 
PP_5662 4,741,239 A G Intergenic 1 1 1 0 1 1 1 1 1 0 1 1 1 1 1 4 4 5 1 1 1 
PP_5662 4,741,243 G T Intergenic 1 1 1 0 1 1 1 1 1 0 1 1 1 1 1 4 4 5 1 1 1 
PP_5662 4,741,244 C G Intergenic 1 1 1 0 1 1 1 1 1 0 1 1 1 1 1 4 4 5 1 1 1 
PP_5662 4,741,245 A C Intergenic 1 1 1 0 1 1 1 1 1 0 1 1 1 1 1 4 4 5 1 1 1 
PP_5662 4,741,255 C T Intergenic 1 1 1 0 1 1 1 1 1 0 1 1 1 1 1 4 4 5 1 1 1 
PP_5662 4,741,257 A C Intergenic 1 1 1 0 1 1 1 1 1 0 1 1 1 1 1 4 4 5 1 1 1 
  4,741,260 C G Intergenic 1 1 1 0 1 1 1 1 1 0 1 1 1 1 1 4 4 5 1 1 1 
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Gene 
name 
Mutation 
position 
R
E
F 
A
L
T 
Effect 
Mutation call 
Total number of 
parallel 
mutations 
p-values for association  
Control Ag+ population AgNP population 
C
1 
C
2 
C
3 
C
4 
C
5 
C
1 
C
2 
C
3 
C
4 
C
5 
C
1 
C
2 
C
3 
C
4 
C
5 
Co
ntr
ol 
Ag+ 
Ag
NP 
Ag+ vs 
Control 
AgNP vs 
Control  
AgNP vs 
Ag+ 
  4,741,261 A C Intergenic 1 1 1 0 1 1 1 1 1 0 1 1 1 1 1 4 4 5 1 1 1 
  4,741,263 A C Intergenic 1 1 1 0 1 1 1 1 1 0 1 1 1 1 1 4 4 5 1 1 1 
  4,741,272 A G Intergenic 1 1 1 0 1 1 1 1 1 0 1 1 1 1 1 4 4 5 1 1 1 
  4,741,274 A C Intergenic 1 1 1 0 1 1 1 1 1 0 1 1 1 1 1 4 4 5 1 1 1 
  4,741,276 G C Intergenic 1 1 1 0 1 1 1 1 1 0 1 1 1 1 1 4 4 5 1 1 1 
  4,741,278 C T Intergenic 1 1 1 0 1 1 1 1 1 0 1 1 1 1 1 4 4 5 1 1 1 
  4,741,283 C 
C
T 
Intergenic 1 1 1 0 1 1 1 1 1 0 1 1 1 1 1 4 4 5 1 1 1 
  4,741,289 C G Intergenic 1 1 1 0 1 1 1 1 1 0 1 1 1 1 1 4 4 5 1 1 1 
  4,741,292 C T Intergenic 1 1 1 0 1 1 1 1 1 0 1 1 1 1 1 4 4 5 1 1 1 
  4,741,294 C G Intergenic 1 1 1 0 1 1 1 1 1 0 1 1 1 1 1 4 4 5 1 1 1 
  4,741,296 A C Intergenic 1 1 1 0 1 1 1 1 1 0 1 1 1 1 1 4 4 5 1 1 1 
  4,741,298 C T Intergenic 1 1 1 0 1 1 1 1 1 0 1 1 1 1 1 4 4 5 1 1 1 
  4,808,166 
G
A
G
C
G
C
C
G
C
C
C
G
C
G Intergenic 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 0 0.5 1 0.5 
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Gene 
name 
Mutation 
position 
R
E
F 
A
L
T 
Effect 
Mutation call 
Total number of 
parallel 
mutations 
p-values for association  
Control Ag+ population AgNP population 
C
1 
C
2 
C
3 
C
4 
C
5 
C
1 
C
2 
C
3 
C
4 
C
5 
C
1 
C
2 
C
3 
C
4 
C
5 
Co
ntr
ol 
Ag+ 
Ag
NP 
Ag+ vs 
Control 
AgNP vs 
Control  
AgNP vs 
Ag+ 
G
A 
  4,861,127 A G Intergenic 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 1 0.5 0.5 
  4,861,219 C T Intergenic 0 0 0 0 0 1 1 0 0 0 1 0 0 1 0 0 2 2 0.22 0.222 1 
ccmE 4,914,726 T A Nonsynonymous 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 1 1 0.5 0.5 
  4,945,198 C G Intergenic 0 0 1 0 0 1 0 0 0 0 1 0 0 0 1 1 1 2 1 0.583 0.5833 
  4,945,201 C G Intergenic 0 0 1 0 0 1 0 0 0 0 1 0 0 0 0 1 1 1 1 1 1 
  4,945,389 G C Intergenic 1 0 0 0 0 0 1 0 0 0 0 1 0 0 0 1 1 1 1 1 1 
  4,945,392 G C Intergenic 1 0 0 0 0 0 1 0 0 0 0 1 0 0 0 1 1 1 1 1 1 
fliF 4,960,263 C A Nonsynonymous 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 1 0.5 0.5 
flgK 4,974,437 
C
A
G 
A
G 
Frameshift                               0 0 0 1 1 1 
astB 5,087,105 A T Nonsynonymous 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 2 1 0.222 0.2222 
  5,119,601 A G Intergenic 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 1 0.5 0.5 
  5,257,856 T C Intergenic 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 1 0 0.5 1 0.5 
  5,459,560 T G Intergenic 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 1 0 0.5 1 0.5 
  5,459,561 C A Intergenic 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 1 0 0.5 1 0.5 
  5,509,759 C T Intergenic 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 1 0.5 0.5 
hisZ 5,559,943 T A Nonsynonymous 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 1 0 0.5  1 0.5 
PP_4941 5,623,261 A T Nonsynonymous 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 1 1 0.5 0.5 
  5,692,563 C T Intergenic 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 1 1 0.5 0.5 
  5,743,331 G A Intergenic 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 1 0.5 0.5 
  5,743,335 T C Intergenic 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 1 0.5 0.5 
  5,743,390 G A Intergenic 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 1 0 0.5 1 0.5 
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Gene 
name 
Mutation 
position 
R
E
F 
A
L
T 
Effect 
Mutation call 
Total number of 
parallel 
mutations 
p-values for association  
Control Ag+ population AgNP population 
C
1 
C
2 
C
3 
C
4 
C
5 
C
1 
C
2 
C
3 
C
4 
C
5 
C
1 
C
2 
C
3 
C
4 
C
5 
Co
ntr
ol 
Ag+ 
Ag
NP 
Ag+ vs 
Control 
AgNP vs 
Control  
AgNP vs 
Ag+ 
  5,743,394 T C Intergenic 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 1 0 0.5 1 0.5 
metW 5,821,897 T A Nonsynonymous 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0.5 0.5 1 
ubiH 5,931,283 C G Nonsynonymous 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 1 0.5 0.5 
  5,988,760 C G Intergenic 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 2 1 0.222 0.2222 
  5,988,763 C G Intergenic 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 2 1 0.222 0.2222 
  5,988,803 G T Intergenic 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 2 0 0.22  1 0.2222 
  5,988,889 C A Intergenic 0 0 0 1 1 1 0 0 0 0 1 0 1 0 1 2 1 3 0.58 0.603 0.2857 
  5,988,894 C T Intergenic 0 0 0 1 1 1 0 0 0 0 1 0 1 0 1 2 1 3 0.58 0.603 0.2857 
  5,988,895 A G Intergenic 0 0 0 1 1 1 0 0 0 0 1 0 1 0 1 2 1 3 0.58 0.603 0.2857 
  5,988,905 T C Intergenic 1 0 0 1 0 1 0 1 0 1 0 1 1 0 1 2 3 3 0.6 0.603 1 
  5,988,910 
C
A 
C Intergenic 1 0 0 1 0 1 0 1 0 1 0 1 1 0 1 2 3 3 0.6 0.603 1 
  5,988,951 G C Intergenic 0 1 1 1 1 1 1 1 0 0 1 1 0 1 1 4 3 4 0.58 1 0.5833 
  5,988,954 G C Intergenic 0 1 1 1 1 1 1 1 0 0 1 1 1 1 1 4 3 5 0.58 1 0.2222 
copA 6,132,511 C T Nonsynonymous 0 0 0 0 1 1 0 0 0 1 0 0 0 1 0 1 2 1 0.58 1 0.5833 
copA 6,131,525 T C Nonsynonymous 0 0 0 0 0 1 0 0 1 0 1 0 1 1 0 0 2 3 0.22 0.083 0.6032 
copA 6,132,542 A G Synonymous 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 1 1 0.5 0.5 
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Appendix 3 List of mutations in the coding regions for the populations in main evolution experiment 
List of mutations in the coding regions for the 15 populations and corresponding gene products. The gene name, codon substrate and amino acid 
change were obtained by aligning the reads from the evolved populations to the Pseudomonas putida KT2440 reference genome [271, 272]. The 
annotations of product type, EC number and product were extracted from MicroScope platform [271]. The capitalized bases in the codon substrate 
are the changed nucleotides. The mutations called were marked in red. The p-values ≤0.05 are marked in red. 
Gene 
name 
Mutatio
n 
Position 
Product type 
EC 
Number 
Product 
Codon 
substrate 
Amino 
acid 
change 
Mutation call 
p-value for comparison of 
total mutant number Control 
Ag+ 
population 
AgNP 
population 
C
1 
C
2 
C
3 
C
4 
C
5 
C
1 
C
2 
C
3 
C
4 
C
5 
C
1 
C
2 
C
3 
C
4 
C
5 
Ag+ vs 
Contro
l 
AgNP 
vs 
Contro
l 
Ag+ vs 
AgNP 
PP_0174 226226 N/A N/A 
Conserved protein of unknown 
function 
cTg/cAg L151Q 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0.5 1 0.5 
PP_0188 240531 
Putative 
enzyme 
N/A 
Putative uroporphyrin-III C-
methyltransferase 
Gcc/Ccc A276P 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.5 0.5 1 
PP_0188 240536 
Putative 
enzyme 
N/A 
Putative uroporphyrin-III C-
methyltransferase 
ggG/ggC G277 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.5 0.5 1 
tauB-II 287067 Transporter 3.6.3.36 
Taurine transporter subunit ; 
ATP-binding component of 
ABC superfamily 
cCg/cGg P19R 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0.5 1 0.5 
tauB-II 287068 Transporter 3.6.3.36 
Taurine transporter subunit ; 
ATP-binding component of 
ABC superfamily 
Ccg/Gcg P19A 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0.5 1 0.5 
envZ 302935 Regulator N/A 
Osmolarity sensor protein 
EnvZ,sensory histidine kinase in 
two-component regulatory 
system with OmpR 
gGt/gCt G367A 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 0.5 0.5 
envZ 303121 Regulator N/A 
Osmolarity sensor protein 
EnvZ,sensory histidine kinase in 
two-component regulatory 
system with OmpR 
ccg/cTGC
cg 
P433LP 0 0 0 0 0 0 0 0 0 0 1 1 1 0 0 1 0.0833 0.0833 
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Gene 
name 
Mutatio
n 
Position 
Product type 
EC 
Number 
Product 
Codon 
substrate 
Amino 
acid 
change 
Mutation call 
p-value for comparison of 
total mutant number Control 
Ag+ 
population 
AgNP 
population 
C
1 
C
2 
C
3 
C
4 
C
5 
C
1 
C
2 
C
3 
C
4 
C
5 
C
1 
C
2 
C
3 
C
4 
C
5 
Ag+ vs 
Contro
l 
AgNP 
vs 
Contro
l 
Ag+ vs 
AgNP 
thiL 605121 Enzyme 2.7.4.16 
Thiamine monophosphate 
kinase 
cGc/cAc R145H 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0.5 1 0.5 
thiL 605126 Enzyme 2.7.4.16 
Thiamine monophosphate 
kinase 
Agc/Tgc S147C 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0.5 1 0.5 
thiL 605131 Enzyme 2.7.4.16 
Thiamine monophosphate 
kinase 
ggT/ggC G148 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0.5 1 0.5 
hemH 863376 Enzyme 4.99.1.1 Ferrochelatase gcA/gcT A170 0 0 1 1 0 1 0 1 0 0 0 0 1 0 0 1 0.5833 0.5833 
PP_0861 999625 
Receptor/putati
ve transporter 
N/A 
Outer membrane ferric 
siderophore receptor/TonB-
dependent siderophore receptor 
gGc/gCc G182A 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0.5 1 0.5 
PP_0904 1044757 
ORF of 
unknown 
function 
N/A 
InaA protein ggctgcctgt
atggcaagca
cgta/gta 
GCLYG
KHV156
V 
0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0.5 0.5 
xcpY 1202854 N/A N/A 
Type II secretion pathway 
protein XcpY 
cAg/cCg Q228P 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0.5 1 0.5 
dtcD-II 1221046 Regulator N/A 
C4-dicarboxylate transport 
transcriptional regulatory 
protein 
gGc/gTc G87V 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.5 0.5 1 
PP_16S
E 
1326938 N/A N/A 
16S ribosomal RNA 
  1 0 0 0 0 1 1 1 1 1 0 0 0 0 0 0.0238 0.5 0.0039 
PP_1175 1350104 
ORF or 
unknown 
function 
N/A 
Conserved protein of unknown 
function (fragment) taG/taT *32Y 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0.5 1 0.5 
PP_1175 1350119 
ORF or 
unknown 
function 
N/A 
Conserved protein of unknown 
function (fragment) agT/agC S27 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0.5 0.5 1 
PP_1195 1370775 ORF of N/A Conserved exported protein of gaaaaggtc EKVE53 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0.5 0.5 
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Gene 
name 
Mutatio
n 
Position 
Product type 
EC 
Number 
Product 
Codon 
substrate 
Amino 
acid 
change 
Mutation call 
p-value for comparison of 
total mutant number Control 
Ag+ 
population 
AgNP 
population 
C
1 
C
2 
C
3 
C
4 
C
5 
C
1 
C
2 
C
3 
C
4 
C
5 
C
1 
C
2 
C
3 
C
4 
C
5 
Ag+ vs 
Contro
l 
AgNP 
vs 
Contro
l 
Ag+ vs 
AgNP 
unknown 
function 
unknown function gag/gag 5E 
PP_1256 1435822 
Putative 
enzyme 
1.2.1.26 
Putative alpha-ketoglutarate 
semialdehyde dehydrogenase 
Tgc/Agc C48S 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0.5 1 0.5 
PP_1325 1511070 Lipoprotein N/A Putative lipoprotein cAg/cTg Q166L 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0.5 0.5 
ftsZ 1530160 Cell process N/A 
GTP-binding tubulin-like cell 
division protein 
Cgt/Tgt R395C 0 0 0 0 0 0 1 0 0 0 1 1 1 1 1 0.5 0.0039 0.0238 
ftsZ 1530173 Cell process N/A 
GTP-binding tubulin-like cell 
division protein 
tAa/tCa *399S 1 1 1 1 1 1 1 1 1 1 0 0 0 0 0 1 0.0039 0.0039 
PP_1344 1531780 
ORF of 
unknown 
function 
N/A 
Conserved protein of unknown 
function Ccc/Acc P36T 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0.5 0.5 
gacS 1843091 N/A 2.7.13.3 Sensor protein GacS gTg/gGg V568G 1 1 1 0 1 1 1 1 1 1 0 0 0 0 1 1 0.1071 0.0238 
gacS 1844166 N/A 2.7.13.3 Sensor protein GacS Aag/Tag K210* 0 0 0 0 0 0 1 0 0 0 1 1 1 1 0 0.5 0.0238 0.1071 
PP_1666 1863240 
ORF of 
unknown 
function 
N/A 
Conserved exported protein of 
unknown function cTg/cAg L309Q 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0.5 0.5 
PP_1666 1863278 
ORF of 
unknown 
function 
N/A 
Conserved exported protein of 
unknown function Gcg/Ccg A322P 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0.5 0.5 1 
PP_1703 1901761 Enzyme 1.7.99.4 
Assimilatory nitrate 
reductase/sulfite reductase 
gAc/gTc D787V 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0.5 1 0.5 
PP_5491 2187722 
ORF of 
unknown 
function 
N/A 
Conserved protein of unknown 
function with SEC-C motif 
domain 
  0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0.5 1 0.5 
PP_2068 2354379 N/A N/A Putative Multidrug efflux MFS aaA/aaC K51N 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0.5 0.5 1 
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Gene 
name 
Mutatio
n 
Position 
Product type 
EC 
Number 
Product 
Codon 
substrate 
Amino 
acid 
change 
Mutation call 
p-value for comparison of 
total mutant number Control 
Ag+ 
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AgNP 
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C
1 
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3 
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4 
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1 
C
2 
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3 
C
4 
C
5 
C
1 
C
2 
C
3 
C
4 
C
5 
Ag+ vs 
Contro
l 
AgNP 
vs 
Contro
l 
Ag+ vs 
AgNP 
membrane fusion protein 
PP_2397 2742917 N/A N/A EF hand domain protein Cac/Tac H5Y 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0.5 1 0.5 
PP_2397 2742918 N/A N/A EF hand domain protein cAc/cGc H5R 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0.5 1 0.5 
PP_2478 2824518 N/A N/A 
Putative Isoquinoline 1-
oxidoreductase, beta subunit 
gAg/gCg E44A 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0.5 0.5 1 
PP_2638 3021030 N/A N/A 
Putative Cellulose synthase 
operon C protein 
cAg/cTg Q523L 0 0 1 0 0 0 0 1 0 0 1 0 0 1 0 1 0.5833 0.5833 
PP_2757 3141492 N/A N/A 
Putative Sugar-binding protein, 
similar to periplasmic binding 
protein/LacI transcriptional 
regulator 
gtc/ V137 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 0.5 0.5 
PP_2758 3142272 N/A N/A 
Putative Ribose ABC 
transporter, periplasmic ribose-
binding protein 
gCg/gTg A74V 0 0 0 0 0 0 0 0 0 0 1 1 1 1 0 1 0.0238 0.0238 
PP_3045 3430349 N/A N/A Putative ClpP protease tcG/tcC S189 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0.5 0.5 
PP_3221 3656539 N/A N/A 
ABC transporter, permease 
protein 
ccA/ccC P253 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0.5 0.5 
PP_5743
/PP_333
4 
3774247 
Putative 
membrane 
component/puta
tive regulator 
N/A 
Putative TonB-dependent 
receptor protein/putative lysR 
family transcriptional regulator 
(fragment) 
  1 0 0 0 0 1 0 0 0 0 0 0 0 0 0 1 0.5 0.5 
oprN 3881829 N/A N/A 
Multidrug efflux RND outer 
membrane protein OprN 
cAg/cTg Q163L 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0.5 0.5 1 
PP_3563 4042322 
ORF of 
unknown 
function 
N/A 
Conserved exported protein of 
unknown function cTc/cGc L137R 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0.5 1 0.5 
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Mutatio
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Number 
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Mutation call 
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Ag+ vs 
Contro
l 
AgNP 
vs 
Contro
l 
Ag+ vs 
AgNP 
PP_3573 4053476 N/A N/A 
Putative monooxygenase/ 
similar to FAD-dependent 
oxidoreductase 
cAg/cTg Q17L 0 1 0 0 1 0 0 1 0 0 0 0 1 0 0 0.5833 0.5833 1 
yrpB 4353296 Enzyme 
1.13.12.1
6 
2-nitropropane dioxygenase 
cCg/cGg P141R 0 0 0 0 0 0 0 1 0 0 1 0 0 0 0 0.5 0.5 1 
clpA 4518633 Enzyme 3.4.21.92 
ATP-dependent serine protease, 
chaperone activity/class III 
stress response-related ATPase, 
AAA+ superfamily 
gGc/gAc G296D 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0.5 0.5 
idh 4522716 Enzyme 1.1.1.- Isocitrate dehydrogenase Gca/Aca A189T 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0.5 0.5 1 
malQ 4568619 Enzyme 2.4.1.25 4-alpha-glucanotransferase gcC/gcG A183 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.5 0.5 1 
mccB 4590049 Enzyme 6.4.1.4 
Methylcrotonyl-CoA 
carboxylase biotin-containing 
subunit beta 
gTc/gCc V244A 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0.5 0.5 
uvrY 4635590 Regulator N/A 
Two-componenent system 
BarA/UvrY - regulatory subunit 
Aaa/Gaa K56E 1 1 1 1 1 1 1 1 1 1 0 0 0 0 1 1 0.0238 0.0238 
ccmE 4914726 Factor N/A 
Cytochrome c-type biogenesis 
protein CcmE 
cAg/cTg Q142L 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0.5 0.5 
fliF 4960263 Structure N/A Flagellar M-ring protein Ggc/Tgc G70C 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0.5 0.5 
astB 5087105 Enzyme 3.5.3.23 N-succinylarginine dihydrolase cTg/cAg L73Q 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 1 0.2222 0.2222 
hisZ 5559946 Enzyme 2.4.2.17 
Histidyl-tRNA synthetase-like 
component of ATP 
phophoribosyltransferase 
cAg/cTg Q185L 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0.5 1 0.5 
PP_4941 5623261 
ORF or 
unknown 
function 
N/A 
Conserved exported protein of 
unknown function caT/caA H159Q 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0.5 0.5 
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l 
AgNP 
vs 
Contro
l 
Ag+ vs 
AgNP 
metW 5821897 Enzyme N/A 
Methionine biosynthesis protein 
MetW 
cTg/cAg L173Q 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.5 0.5 1 
ubiH 5931283 Enzyme 1.14.-.- 
2-octaprenyl-6-methoxyphenol 
hydroxylase, FAD/NAD(P)-
binding 
Gtt/Ctt V263L 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0.5 0.5 
copA 6132511 Transporter N/A Copper resistance protein A Ggc/Agc G448S 0 0 0 0 1 1 0 0 0 1 0 0 0 1 0 0.5833 1 0.5833 
copA 6131525 Transporter N/A Copper resistance protein A gAg/gGg E443G 0 0 0 0 0 1 0 0 1 0 1 0 1 1 0 0.2222 0.0833 0.6032 
copA 6132542 Transporter N/A Copper resistance protein A gaT/gaC D437 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0.5 0.5 
 
 
 
 
 
